Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,platelet-derived growth factor binding (GO:0048407),-0.7755627008096764,-1.9539330954511285,0.0,0.13192124871531347,0.089,6/11,14.73%,COL4A1;COL3A1;PDGFRA;COL1A2;COL1A1;COL6A1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.792504940199572,1.858107974393072,0.0,0.01987091671727372,0.021,8/35,2.77%,SLA;PTK2B;BTK;FGR;LYN;HCK;SYK;TEC
prerank,phosphotyrosine residue binding (GO:0001784),0.7669323056511027,1.8034697993468924,0.0,0.058666516022427166,0.102,12/37,5.42%,VAV1;FGR;SH3BP2;HCK;SYK;STAP1;PLCG2;GRB2;VAV2;NCK2;LDLRAP1;SAMSN1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.7431337205754578,1.7604714409893194,0.0010905125408942203,0.11985632305657162,0.275,13/42,6.62%,VAV1;FGR;SH3BP2;HCK;SYK;STAP1;PLCG2;GRB2;VAV2;NCK2;LDLRAP1;SAMSN1;YWHAB
prerank,kinase activator activity (GO:0019209),0.7463224350600431,1.7555026633535942,0.0011737089201877935,0.10172016890985355,0.305,9/30,10.57%,NCKAP1L;TREM2;GPRC5B;FGF13;RGCC;WNK1;EPO;MALT1;DUSP19
prerank,purinergic nucleotide receptor activity (GO:0001614),0.8478772771248604,1.7506614189093073,0.0013404825737265416,0.09102772324770152,0.338,6/15,8.32%,PTAFR;P2RX1;P2RX7;P2RX4;P2RY12;GPR34
prerank,chemokine binding (GO:0019956),0.7553609355225394,1.7435873949770986,0.0,0.08752665696894377,0.373,6/30,5.85%,CX3CR1;CCR2;ITGA4;ITGB3;CXCR4;HMGB1
prerank,protein phosphatase 1 binding (GO:0008157),0.7863359197406391,1.7255427843844071,0.0,0.10692445662152049,0.492,3/21,5.90%,LILRB1;PPP1R3E;PPP1R11
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.8563836385325988,1.717087649534668,0.0,0.10976315900970243,0.548,4/13,4.55%,PIK3CG;PIK3CD;PIK3CB;PIP4K2A
prerank,SH2 domain binding (GO:0042169),0.7317844406200591,1.7037798054279225,0.003436426116838488,0.12595427633488843,0.629,6/31,3.76%,SLAMF1;LILRB1;BLNK;SH3PXD2B;NUP62;LAT2
prerank,chemokine receptor binding (GO:0042379),0.7244298081274819,1.7004058964886322,0.0011299435028248588,0.1203609812589151,0.648,12/35,18.57%,PF4;CX3CR1;CXCL5;CXCL2;CCL8;CCL14;CCL13;CCL2;ITCH;CXCL16;CCL25;CKLF
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.7334716213200568,1.69861158108301,0.0023094688221709007,0.11251584011339404,0.659,8/34,6.59%,BTK;MYO1G;ARHGAP9;DAPP1;IQGAP2;ARAP1;ADAP2;GAB2
prerank,anion:anion antiporter activity (GO:0015301),-0.5771504776392575,-1.6847954971194032,0.008403361344537815,1.0,0.799,8/17,25.58%,SLC26A2;SLC26A7;SLC25A4;SLC25A11;SLC19A1;SLC4A2;SLC25A5;SLC26A6
prerank,C-C chemokine receptor activity (GO:0016493),0.7635035145715362,1.6833818919451695,0.0048543689320388345,0.13838674142387053,0.763,3/21,4.58%,CX3CR1;CCR2;CXCR4
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.8641127951604304,1.6707007405654655,0.004366812227074236,0.1578755251273505,0.826,3/10,2.52%,CYBB;NCF4;NCF2
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.7972853142878654,1.6695930644589463,0.005361930294906166,0.14903187537955287,0.832,4/15,10.69%,CX3CR1;CCR2;GPR17;CMKLR1
prerank,CXCR chemokine receptor binding (GO:0045236),0.8406067734702378,1.6689035515752038,0.0027739251040221915,0.1406103916279464,0.833,3/11,2.27%,PF4;CXCL5;CXCL2
prerank,C-C chemokine binding (GO:0019957),0.7447041746464318,1.656053629377999,0.003601440576230492,0.1645855988814665,0.882,3/22,4.58%,CX3CR1;CCR2;CXCR4
prerank,phospholipase binding (GO:0043274),0.8035064300564834,1.641887236087534,0.012211668928086838,0.19208552826697925,0.923,3/13,0.95%,BTK;BLNK;SYK
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.7333985446336302,1.6343632627572056,0.014925373134328358,0.20259924081580133,0.945,3/21,5.57%,P2RX1;P2RX7;P2RX4
prerank,cytokine receptor activity (GO:0004896),0.6391179196575755,1.633780263646186,0.0010309278350515464,0.19377878934063167,0.947,15/83,5.93%,IL10RA;CX3CR1;FLT3;CCR2;CSF3R;CD74;CSF2RB;IL10RB;IL21R;IL12RB2;IL6R;IFNAR1;CD44;IFNGR2;GPR17
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.8004314214921342,1.6279848658185294,0.006793478260869565,0.20178442809326763,0.962,5/14,7.82%,CYBB;NCF4;NCF2;MICAL1;KMO
prerank,MHC protein binding (GO:0042287),0.7591054029941174,1.6277655570718446,0.006211180124223602,0.1926262334837758,0.963,3/20,1.33%,TUBB;LILRB1;CD74
prerank,chemokine activity (GO:0008009),0.7076879013087042,1.6264320150279075,0.008158508158508158,0.18748338954674487,0.964,10/31,18.57%,PF4;CXCL5;CXCL2;CCL8;CCL14;CCL13;CCL2;CXCL16;CCL25;CKLF
prerank,chemokine receptor activity (GO:0004950),0.7223116645607114,1.622805239320198,0.005995203836930456,0.18899998219286845,0.975,5/24,10.69%,CX3CR1;CCR2;CXCR4;GPR17;CMKLR1
prerank,amyloid-beta binding (GO:0001540),0.6461928706775124,1.6135213860236535,0.0,0.20687043653876033,0.987,19/79,9.31%,LILRB1;LILRB3;TREM2;GSAP;CALCR;ITGB2;FCGR2B;CD74;CLSTN1;TLR2;ITGA2;MSR1;APOE;LDLRAP1;APBA1;C1QA;CACNA1A;BCHE;ITGAM
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.7187556267543046,1.612854893831144,0.00984009840098401,0.2003366898752948,0.987,5/25,6.59%,MYO1G;DAPP1;PLEK;ADAP2;GAB2
prerank,lipase activity (GO:0016298),0.6739796225698333,1.6123673667289327,0.005470459518599562,0.19415996462757376,0.987,8/43,4.92%,PLBD1;LPL;DAGLB;ABHD12;DDHD1;CEL;LIPA;SMPD3
prerank,lipoprotein particle binding (GO:0071813),0.7471386447181567,1.5993698337470035,0.0163727959697733,0.22180428907164965,0.992,9/20,12.79%,TREM2;PCSK9;LPL;MSR1;STAB2;STAB1;LIPC;THBS1;SORL1
prerank,phospholipase activity (GO:0004620),0.6445400112492881,1.59256881041187,0.0021119324181626186,0.2343957114813104,0.996,20/67,17.09%,PLBD1;PLD4;PLCB2;PNPLA7;LPL;ABHD12;DDHD1;SMPD3;ASPG;PLD3;LIPC;ABHD4;PRDX6;ABHD3;GDE1;ABHD16A;GDPD3;PDIA3;PLAAT3;PNPLA3
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.7396766734604264,1.5820151416308703,0.02109181141439206,0.2601491280571812,0.998,11/22,14.61%,ATP6V0D2;ATP6V0E1;TCIRG1;ATP6V1C1;ATP6V1E1;ATP6V0A2;ATP6V0D1;ATP2C1;ATP6V0A1;ATP2A3;ATP6V0B
prerank,low-density lipoprotein particle binding (GO:0030169),0.7597083235323661,1.576005465151873,0.0199203187250996,0.27185306537489234,0.999,8/16,12.79%,TREM2;PCSK9;MSR1;STAB2;STAB1;LIPC;THBS1;SORL1
prerank,kinesin binding (GO:0019894),0.6889157665084201,1.5730553667952714,0.02122641509433962,0.27288171344458834,0.999,9/27,9.38%,PLEKHM2;NEFH;SPTBN5;CLSTN1;KLC2;NEK6;SNCA;ACTB;ATCAY
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.8075244359892807,1.5683693626024628,0.01912568306010929,0.280558419365317,1.0,3/11,6.71%,AQP1;HCN4;CNGB1
prerank,dynactin binding (GO:0034452),0.7808033120529447,1.5675253829766584,0.019553072625698324,0.27518208908466935,1.0,3/12,2.06%,HOOK3;SPTBN5;SNX5
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.621319015966973,1.5661824692876205,0.0020470829068577278,0.2713187213959404,1.0,19/100,8.70%,BTK;DENND1C;MYO1G;ARHGAP9;DAPP1;NCF4;PLEKHN1;SH3PXD2B;IQGAP2;ZFYVE26;ARAP1;SNX24;ZFYVE28;ADAP2;GAB2;DENND1A;TECPR1;SNX27;DENND1B
prerank,protein tyrosine kinase binding (GO:1990782),0.6224884908368042,1.5658354362298292,0.005213764337851929,0.264675203621918,1.0,15/71,7.98%,TREM2;BLNK;ITGAX;CASS4;SIRPA;CBL;ANGPT4;DUSP3;PTPN1;FIZ1;SHC2;TP53;NEDD9;DOCK4;FLT3LG
prerank,mannose binding (GO:0005537),0.78175531748116,1.5646459793350411,0.019498607242339833,0.2611343354313682,1.0,2/12,1.78%,CLEC4D;LMAN1L
prerank,GTPase activator activity (GO:0005096),0.6003566518595332,1.5612381272302884,0.0,0.26435735663636856,1.0,78/313,11.84%,ARHGAP45;ARHGAP30;NCKAP1L;FGD2;DOCK2;VAV1;CYTH4;DOCK8;DENND1C;ARHGAP25;RGS10;TBC1D9;PREX1;ARHGAP9;ABR;ARHGAP15;RIN2;SIPA1L2;SMAP2;ARHGAP39;IQGAP2;ARHGAP22;TBC1D10C;RIN3;RINL;THY1;ARHGAP24;GNAQ;ELMO1;VAV2;ARHGEF18;RASA4;ARAP1;FNIP1;ASAP1;RIC8A;RASGRP2;VAV3;ARFGEF1;RAB3GAP2;TBC1D16;TBC1D22A;TAGAP;RGL2;FGD6;USP6NL;DENND2C;RP2;DOCK11;MYO9B;DOCK10;GAPVD1;DOCK4;TBC1D10A;DENND1A;RASGRP3;FLCN;ITSN1;DENND1B;SIPA1;ARHGAP10;DENND4B;ARHGAP1;ACAP2;ARFGEF2;RAP1GAP2;EIF2B2;TBC1D2;DENND4C;ARHGEF17;TBC1D17;RAPGEF1;NRP1;DENND4A;TBC1D2B;ARHGAP27;CYTH1;ADAP1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.807246977644513,1.5588283365759634,0.022922636103151862,0.26484595263774846,1.0,3/10,2.72%,PIK3CG;PIK3CD;PIK3CB
prerank,triglyceride lipase activity (GO:0004806),0.7132835535251254,1.5575511238344533,0.03245942571785269,0.2617429176385212,1.0,6/20,17.09%,LPL;DAGLB;CEL;LIPC;LIPE;PNPLA3
prerank,receptor tyrosine kinase binding (GO:0030971),0.6263483601618536,1.553796701174732,0.010638297872340425,0.2671218947279224,1.0,17/56,13.66%,BLNK;ITGAX;STAP1;CBL;ANGPT4;DUSP3;PTPN1;FIZ1;SHC2;GAB2;TP53;DOCK4;FLT3LG;SH2B3;NRG1;GAS6;TRADD
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.7845232183455998,1.5501710796061712,0.022598870056497175,0.2712922485616173,1.0,3/12,2.72%,PIK3CG;PIK3CD;PIK3CB
prerank,phosphatidylinositol kinase activity (GO:0052742),0.7398717171604663,1.545610887808974,0.036601307189542485,0.27882365679476134,1.0,4/15,4.77%,PIK3CG;PIK3CD;PIK3CB;PI4K2A
prerank,cysteine-type endopeptidase activity (GO:0004197),0.6080072357005382,1.543776868151448,0.006276150627615063,0.2780828068174839,1.0,26/78,16.22%,CTSS;CTSB;LGMN;CTSC;CTSK;CTSL;ESPL1;CAPN15;PYCARD;USP35;CASP1;CFLAR;MALT1;CTSZ;USP7;USP48;CASP7;USP18;CASP8;USP9X;CAPN2;USP8;CAPN3;USP29;USP16;PDIA3
prerank,MHC class I protein binding (GO:0042288),0.774077832772914,1.5423298075736345,0.030095759233926128,0.2759777859662052,1.0,5/13,13.08%,TUBB;LILRB1;DERL1;TAP1;ATP5F1A
prerank,diacylglycerol kinase activity (GO:0004143),0.7767722625531589,1.535151234224698,0.04291845493562232,0.2926386750839135,1.0,7/11,12.73%,DGKZ;DGKK;DGKE;DGKG;DGKD;AGK;DGKI
prerank,carboxylic ester hydrolase activity (GO:0052689),0.6100245409486611,1.5346627173270122,0.006160164271047228,0.28788144871454,1.0,25/85,17.09%,PNPLA7;LPL;DAGLB;ABHD12;ESD;CEL;LIPA;ASPG;PON3;PLA2G7;BCHE;LIPC;PAFAH1B2;ABHD4;PGAP1;PRDX6;ABHD3;LIPE;GDE1;ABHD16A;GDPD3;TARS2;PGLS;PLAAT3;PNPLA3
prerank,GTPase regulator activity (GO:0030695),0.5915440334591742,1.530842935952205,0.0,0.29409762047207133,1.0,48/212,11.84%,ARHGAP45;ARHGAP30;NCKAP1L;ARHGAP25;RGS10;TBC1D9;PREX1;ARHGAP9;ABR;ARHGAP15;RIN2;SIPA1L2;SIRPA;SMAP2;ARHGAP39;IQGAP2;ARHGAP22;TBC1D10C;THY1;ARHGAP24;GNAQ;RASA4;ARAP1;ASAP1;RIC8A;VAV3;ARFGEF1;RAB3GAP2;TBC1D16;TBC1D22A;TAGAP;USP6NL;RP2;MYO9B;TBC1D10A;RASGRP3;FLCN;SIPA1;ARHGAP10;ARHGAP1;ACAP2;RAP1GAP2;TBC1D2;TBC1D17;NRP1;TBC1D2B;ARHGAP27;ADAP1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.7496931157542212,1.5296151635611843,0.03183023872679045,0.28556959807098514,1.0,7/16,10.51%,ATP6V0D2;ATP6V0E1;TCIRG1;ATP6V1C1;ATP6V0A2;ATP6V0D1;ATP6V0A1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.7496931157542212,1.5296151635611843,0.03183023872679045,0.28556959807098514,1.0,7/16,10.51%,ATP6V0D2;ATP6V0E1;TCIRG1;ATP6V1C1;ATP6V0A2;ATP6V0D1;ATP6V0A1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.591380153756342,1.5234250499993314,0.0010050251256281408,0.29795020266357847,1.0,38/147,11.79%,FGD2;DOCK2;VAV1;CYTH4;DOCK8;DENND1C;PREX1;ABR;RIN2;RIN3;RINL;ELMO1;VAV2;ARHGEF18;FNIP1;RIC8A;RASGRP2;VAV3;ARFGEF1;RAB3GAP2;RGL2;FGD6;DENND2C;DOCK11;DOCK10;GAPVD1;DOCK4;DENND1A;ITSN1;DENND1B;DENND4B;ARFGEF2;EIF2B2;DENND4C;ARHGEF17;RAPGEF1;DENND4A;CYTH1
prerank,aspartic-type peptidase activity (GO:0070001),0.7766646133475705,1.5231503220104539,0.03824362606232295,0.29286873985262896,1.0,4/10,9.82%,NAPSA;CTSD;DDI2;CTSE
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.42151968023032516,-1.5207863637084267,0.07086614173228346,1.0,0.993,11/32,21.70%,KCNQ3;KCNQ5;KCNA1;KCNS3;KCNA2;KCNB2;KCNC1;KCNC3;KCNH1;KCNQ2;KCNQ4
prerank,cysteine-type peptidase activity (GO:0008234),0.6008464530921971,1.5180601755318368,0.011398963730569948,0.3019942617581269,1.0,29/73,17.04%,CTSS;CTSB;LGMN;CTSC;OTULINL;CTSK;CTSL;ESPL1;OTULIN;USP35;CASP1;MALT1;CTSZ;TINAGL1;USP7;USP48;CASP7;USP18;GGH;CASP8;USP9X;CAPN2;USP8;CAPN3;USP29;USP21;USP16;PDIA3;ATG4A
prerank,tau protein binding (GO:0048156),0.6317352647249744,1.5106665342368943,0.028058361391694726,0.31863095296782035,1.0,21/40,21.61%,BAG2;LGMN;PPP2CB;S100B;SNCA;APOE;ACTB;HDAC6;FYN;PPP2CA;STUB1;GSK3A;HSP90AA1;BIN1;PICALM;TAOK1;ROCK2;GSK3B;MARK1;BRSK1;PIN1
prerank,protein tyrosine kinase activity (GO:0004713),0.5903018204882486,1.5077118542144972,0.006060606060606061,0.3215969440142191,1.0,12/108,4.28%,SLA;PTK2B;BTK;FGR;LYN;HCK;SYK;FLT3;CSF1R;TYK2;TEC;TTN
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.5663715882907666,-1.5076562819582893,0.04150943396226415,1.0,0.994,8/12,32.75%,CRYZL1;DHRS4;AIFM2;NQO2;CBR4;NDUFS7;CRYZ;NQO1
prerank,glutamate receptor activity (GO:0008066),-0.5075878068283599,-1.505939319900573,0.04932735426008968,1.0,0.994,5/19,10.77%,GRM7;GRIK4;GRIA2;GRM5;GRM1
prerank,WW domain binding (GO:0050699),0.6648625119948814,1.5056310939075095,0.036057692307692304,0.32221852744399954,1.0,6/26,11.45%,NFE2;TCEAL3;TCEAL6;KIF20B;LITAF;TCEAL8
prerank,ephrin receptor binding (GO:0046875),0.681203971539645,1.502020616131635,0.04810126582278481,0.3277180524927923,1.0,6/21,6.35%,LYN;PIK3CG;CBL;GRB2;PTPN1;EFNA2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.6744256974372015,1.5002733460964661,0.04534313725490196,0.3275132129616484,1.0,5/24,6.39%,PTK2B;MAPKAPK3;CAMK1D;MYLK3;MKNK1
prerank,CCR chemokine receptor binding (GO:0048020),0.6519676442878172,1.4855659816551836,0.04171494785631518,0.3690965679898198,1.0,5/28,11.55%,CCR2;CCL8;CCL14;CCL13;CCL2
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.7058115099265219,1.4833530426486405,0.05059920106524634,0.36384279332081104,1.0,6/16,15.44%,PTPRC;PTPRE;PTPRU;PTPRO;PTPRT;PTPRA
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.7058115099265219,1.4833530426486405,0.05059920106524634,0.36384279332081104,1.0,6/16,15.44%,PTPRC;PTPRE;PTPRU;PTPRO;PTPRT;PTPRA
prerank,Toll-like receptor binding (GO:0035325),0.7390023439606286,1.481004215506247,0.07591240875912408,0.36571173499332177,1.0,3/11,2.43%,TLR1;UNC93B1;TLR2
prerank,ankyrin binding (GO:0030506),0.6887247175667074,1.4761911781266046,0.04755784061696658,0.37489185732957875,1.0,3/19,3.19%,PTPRC;KCNJ11;SLC8A1
prerank,lipase activator activity (GO:0060229),0.7472913920245459,1.4720887823366584,0.06906906906906907,0.3825489408835688,1.0,5/10,17.78%,BTK;CCL8;FYN;SRC;PDPK1
prerank,chemoattractant activity (GO:0042056),0.6405473252696567,1.4705725206582498,0.06691449814126393,0.3820715995593656,1.0,5/26,8.95%,GPNMB;LGALS3;HMGB1;VEGFB;NTF3
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.7105551784172217,1.469876646643599,0.057455540355677154,0.37823161769099317,1.0,2/14,3.05%,AKR1A1;DHRS3
prerank,sterol transfer activity (GO:0120015),0.701513424576327,1.4681427158549638,0.05935483870967742,0.3781352297388848,1.0,7/17,19.11%,ABCA1;NPC2;ABCG1;OSBP;STARD4;STARD5;GRAMD1C
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.5925461336460156,1.4679517015282593,0.014629049111807733,0.3731551965201181,1.0,11/73,12.37%,CALCR;GP1BA;CX3CR1;CYSLTR2;EDNRB;GALR1;CCKBR;SORCS3;CYSLTR1;GPR37;LTB4R2
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.7352969745066901,1.4664561275701282,0.07596685082872928,0.3728579926045863,1.0,5/12,13.66%,BLNK;STAP1;GAB2;SH2B3;TRADD
prerank,ligand-gated channel activity (GO:0022834),-0.4178797832118902,-1.4664233176409658,0.05161290322580645,1.0,0.999,7/29,12.81%,GRIA3;GRIN3A;GRIK4;GRIA2;GABRB1;GRIN2B;GRIN1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.6369069944804148,1.4658278396069826,0.04946996466431095,0.36927815414958354,1.0,3/29,1.28%,MGAM;HPSE;GUSB
prerank,ligand-gated ion channel activity (GO:0015276),-0.415390552993103,-1.4654839499473915,0.039735099337748346,1.0,0.999,7/30,12.81%,GRIA3;GRIN3A;GRIK4;GRIA2;GABRB1;GRIN2B;GRIN1
prerank,water transmembrane transporter activity (GO:0005372),0.7495290978897536,1.4648430107595376,0.06524822695035461,0.36693607774856807,1.0,2/11,8.14%,AQP1;AQP11
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.6021342547084455,-1.4644718607601468,0.07384615384615385,1.0,0.999,6/10,22.86%,GNAS;IGSF11;SHANK3;SHANK1;SHANK2;SHISA7
prerank,phospholipase activator activity (GO:0016004),0.7428804121953524,1.4626999393395248,0.08047690014903129,0.3682450032293696,1.0,5/10,17.78%,BTK;CCL8;FYN;SRC;PDPK1
prerank,DNA replication origin binding (GO:0003688),0.6522281016378736,1.455023978635773,0.04727272727272727,0.38677320038979196,1.0,9/23,13.80%,MCM5;ORC3;DHX9;MCM6;MCM2;ORC4;MCM9;KAT7;CDC6
prerank,cholesterol transfer activity (GO:0120020),0.6934681407980904,1.4533592242121798,0.07096774193548387,0.387022721033502,1.0,6/16,19.11%,ABCA1;NPC2;ABCG1;STARD4;STARD5;GRAMD1C
prerank,3'-5' DNA helicase activity (GO:0043138),0.6927294951622956,1.450252651100665,0.06649282920469361,0.3919327337845281,1.0,5/16,10.17%,MCM5;DHX9;NAV2;MCM6;MCM2
prerank,P-type ion transporter activity (GO:0015662),0.7259309990197432,1.4490909117348452,0.06961178045515395,0.39050451697336896,1.0,6/12,13.42%,ATP7A;ATP6V1E1;ATP2C1;ATP2B1;ATP2B3;ATP2A3
prerank,steroid hydroxylase activity (GO:0008395),0.6976259111909344,1.44686595366637,0.07142857142857142,0.39256265920779465,1.0,1/16,0.47%,CYP1A1
prerank,acetylcholine receptor activity (GO:0015464),-0.44912321967988866,-1.4416893243908961,0.06878306878306878,1.0,1.0,5/22,21.96%,CHRM2;CHRFAM7A;CHRNA7;CHRM3;CHRNB1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.5726816170254919,1.4391312871357156,0.02481902792140641,0.4127178342298316,1.0,15/71,11.37%,PTPRC;PTPN7;UBASH3B;PTPRJ;DUSP3;PTPN1;PTPN18;PALD1;PTPRE;PTP4A2;MTMR3;PTP4A1;PTPRU;PTPRO;TIMM50
prerank,actin monomer binding (GO:0003785),0.6504797359134643,1.4315890534379438,0.07862407862407862,0.4317253871393999,1.0,9/22,12.65%,CORO1A;MYL3;MRTFA;MTSS1;TMSB4X;PFN2;PFN1;TWF2;TMSB10
prerank,lysophospholipase activity (GO:0004622),0.6629273397260016,1.429087133501242,0.06717363751584284,0.4342615771558021,1.0,7/20,15.84%,PNPLA7;ABHD12;ASPG;ABHD4;GDE1;ABHD16A;GDPD3
prerank,MAP kinase kinase activity (GO:0004708),0.676237817577793,1.4240795497236702,0.09933774834437085,0.44534509299927977,1.0,6/15,14.53%,MAPKAPK3;MAPK14;MAP2K6;MAP2K3;MAP2K2;LRRK2
prerank,thyroid hormone receptor binding (GO:0046966),0.6303416222448104,1.417668579073806,0.06996381182147166,0.4617388913386014,1.0,6/28,3.64%,BRD8;GAS2L1;MED17;GTF2H1;NSD1;TACC1
prerank,protein kinase activator activity (GO:0030295),0.5686523230057423,1.4164953280379178,0.039403620873269436,0.4597428530388514,1.0,23/60,19.11%,NCKAP1L;GPRC5B;FGF13;RGCC;WNK1;EPO;ABI1;DBF4;DUSP19;MAP2K2;PARP16;NRG1;GAS6;STK3;STRADA;ERCC6;ALS2;INCENP;IRGM;STK4;IQGAP1;TAOK1;RPTOR
prerank,retinoic acid binding (GO:0001972),-0.5436574407825918,-1.414855927833109,0.08620689655172414,1.0,1.0,1/12,0.35%,NR2F2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.674967074623117,1.4059681594100475,0.10875706214689265,0.4902860839604552,1.0,4/13,15.28%,EHHADH;SREBF2;ECI1;ECH1
prerank,metal ion:proton antiporter activity (GO:0051139),0.6969949429051082,1.404875263887141,0.09931972789115646,0.4885722221437616,1.0,4/13,7.37%,SLC11A1;SLC9A4;SLC9A9;SLC9A1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.5989600829085263,1.391106264583141,0.08108108108108109,0.5322733960334596,1.0,7/29,10.10%,MAPKAPK3;NFATC1;PTPRJ;MAPK14;GCH1;DUSP10;TPR
prerank,cytokine activity (GO:0005125),0.5426593766465342,1.387999163386471,0.008040201005025126,0.537361960993871,1.0,19/131,12.63%,PF4;TGFB1;CXCL5;IL1A;CXCL2;SLURP1;OSM;CCL8;TNF;IL18;TIMP1;NDP;HMGB1;EPO;CCL14;INHBA;CCL13;CCL2;NRG1
prerank,bHLH transcription factor binding (GO:0043425),0.6435034565195485,1.3844242532633093,0.10305343511450382,0.5443674070149244,1.0,5/19,8.71%,ASCL1;BHLHE41;USF1;LMO2;SMAD3
prerank,ligand-gated cation channel activity (GO:0099094),0.5484762100047547,1.3833201857677382,0.056308654848800835,0.5421061348582639,1.0,7/75,5.98%,PTK2B;KCNJ11;P2RX1;P2RX7;KCNK6;P2RX4;CCDC51
prerank,tumor necrosis factor receptor binding (GO:0005164),0.68669863480409,1.3786816036750338,0.09916201117318436,0.5523349354623257,1.0,6/12,9.92%,TNF;TRAF2;TRAF3;TRAP1;BABAM2;TRAF5
prerank,protein kinase regulator activity (GO:0019887),0.5448974187989248,1.3785406509412337,0.037871033776867964,0.5467761348140406,1.0,17/95,10.57%,NCKAP1L;GMFG;PRKAR2B;TAOK3;GPRC5B;FGF13;CCND3;SNCA;RGCC;DNAJC3;CCND2;YWHAB;WNK1;EPO;QARS1;CCNL1;DUSP19
prerank,endoribonuclease activity (GO:0004521),0.599020465148611,1.3729371738603653,0.09473684210526316,0.5619071002013366,1.0,8/32,11.72%,SLFN14;ERN1;NOB1;SND1;ZC3H12D;ENDOV;RNASEL;AGO3
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.7022450073412705,1.3662264057361564,0.1483050847457627,0.580411786847407,1.0,2/10,3.38%,PRKAR2B;PKIB
prerank,SH3 domain binding (GO:0017124),0.5478571439651753,1.3636911441316355,0.06389776357827476,0.5838366323966208,1.0,14/62,12.53%,SH3BP2;CD3E;CBL;GRB2;ELMO1;WIPF1;AKAP5;DNM2;MICAL1;WASF2;ABI1;ZNF106;ARHGAP27;SYNJ1
prerank,transforming growth factor beta receptor binding (GO:0005160),0.6312268437383557,1.362589880661132,0.1375796178343949,0.5817427294873178,1.0,6/18,12.94%,TGFB1;TGFBR1;TGFBR2;TGFBRAP1;SMAD3;BAMBI
prerank,signaling receptor complex adaptor activity (GO:0030159),0.5795275928023501,1.3620126272559305,0.10643015521064302,0.5778004404857384,1.0,9/38,8.72%,BLNK;CD3E;STAP1;LAT;NUP62;NCK2;LDLRAP1;GAB2;MMS19
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.6768694460410347,1.361030799516607,0.1232876712328767,0.5752906374605148,1.0,3/13,3.63%,ITGB3;PTPRJ;ERN1
prerank,hormone activity (GO:0005179),0.5499575930904635,1.3599733755163577,0.07675675675675675,0.5731740076371388,1.0,6/54,10.81%,TSHB;METRNL;PPY;VGF;INHBA;CHGB
prerank,cholesterol binding (GO:0015485),0.5638065909273302,1.3586851842310488,0.09347826086956522,0.5719502539671651,1.0,18/47,21.45%,TSPO;ABCA1;NPC2;ABCG1;NPC1;SOAT2;ERLIN1;ERLIN2;OSBPL10;STARD4;VDAC2;VDAC1;OSBPL8;STARD5;GRAMD1C;OSBPL7;STARD3;SCARB2
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.49052864480853414,-1.351300964447542,0.12605042016806722,1.0,1.0,7/14,14.48%,RECK;COL4A3;TIMP2;SPOCK2;TIMP3;NGF;BST2
prerank,carbohydrate kinase activity (GO:0019200),0.688584850474292,1.3504140394727788,0.13509749303621169,0.5953341941168003,1.0,5/11,15.88%,HK3;NAGK;POMK;HK2;XYLB
prerank,G protein-coupled receptor activity (GO:0004930),0.5244171577926439,1.3437221927028968,0.009009009009009009,0.6151373451777365,1.0,26/239,11.03%,GPR141;CNR2;LPAR6;CALCR;PTAFR;CX3CR1;ADGRE1;P2RY6;CYSLTR2;ADGRG5;ADGRE5;FFAR2;MRGPRF;CXCR4;LGR6;S1PR4;GALR1;ADGRG3;GPR17;P2RY12;GPR34;GPR183;XPR1;CYSLTR1;CMKLR1;GPR37
prerank,copper ion binding (GO:0005507),0.5560664604211267,1.34093960195845,0.0918141592920354,0.6192868160514979,1.0,7/42,6.70%,IL1A;SNCA;ATP7A;ATOX1;RNF7;P2RX4;TP53
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.6892346675915836,1.3378997085015896,0.14693295292439373,0.6245980166467423,1.0,3/10,13.48%,APOBEC1;CDA;LACC1
prerank,GABA receptor binding (GO:0050811),0.6687190120182831,1.3349186292802895,0.17963224893917965,0.6299530749592663,1.0,3/11,9.62%,PLCL2;AKAP5;ARFGEF2
prerank,phospholipase inhibitor activity (GO:0004859),0.6863843399740195,1.3343412007709896,0.1783625730994152,0.626015762239935,1.0,4/10,9.80%,ANGPTL3;SNCA;ANXA1;ANXA4
prerank,serine-type endopeptidase activity (GO:0004252),0.5288261828751288,1.3326390011737128,0.060450819672131145,0.626406993658819,1.0,5/80,4.68%,KLK3;PCSK9;F10;MASP1;RHBDF2
prerank,hexosaminidase activity (GO:0015929),0.6577518670166768,1.3315957546687025,0.1704225352112676,0.6248001809862632,1.0,3/12,6.91%,HEXB;HEXA;OGA
prerank,protein phosphatase binding (GO:0019903),0.5236108806940288,1.3302837260469,0.03842264914054601,0.6238424338688727,1.0,29/117,17.47%,CD22;LILRB1;LGALS3;SIRPA;PPP1R3E;KCNN4;MAPK14;PPP6R1;TRAF2;AKAP5;TRAF3;PPP1R11;CTNNB1;TP53;MAP3K5;SLC9A1;MTMR3;ENSA;STRN;BOD1L1;ADCY8;CTTNBP2NL;PTPRT;PTPA;CD33;SMG7;PPP3CB;IQGAP1;ANK1
prerank,sodium channel regulator activity (GO:0017080),0.5580671817521878,1.3290147724795658,0.1204954954954955,0.622569488578499,1.0,12/37,20.22%,PCSK9;SCN4B;FGF13;PKP2;PRSS8;NEDD4L;FXYD5;SGK3;YWHAH;FXYD6;PTPN3;FXYD1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.4127027850504751,-1.3257691082776681,0.12777777777777777,1.0,1.0,3/22,6.88%,CHRM2;HTR2C;HTR7
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.4127027850504751,-1.3257691082776681,0.12777777777777777,1.0,1.0,3/22,6.88%,CHRM2;HTR2C;HTR7
prerank,serotonin receptor activity (GO:0099589),-0.4127027850504751,-1.3257691082776681,0.12777777777777777,1.0,1.0,3/22,6.88%,CHRM2;HTR2C;HTR7
prerank,protein phosphatase inhibitor activity (GO:0004864),0.5887543079898917,1.3215757908467305,0.14691943127962084,0.6445503820114193,1.0,6/26,11.23%,LGALS3;MGAT5;SAG;PPP1R11;ENSA;BOD1L1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.5322426723846649,1.321016469451701,0.08921161825726141,0.6407295375264643,1.0,18/74,14.30%,HK3;PIK3CG;DGKZ;PIK3CD;PIK3CB;CHKB;DGKK;DGKE;NADK;DGKG;DGKD;AGK;FAM20C;PAPSS1;POMK;DGKI;SHPK;HK2
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.5390812885717795,-1.3209185714472595,0.16225165562913907,1.0,1.0,6/10,14.50%,ATF2;USP22;HAT1;BRCA2;NAA60;MSL3
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.3242856174773962,-1.3204327027316896,0.01694915254237288,1.0,1.0,13/60,7.11%,ROR1;CRIM1;NTRK3;AXL;EGFR;ALK;EPHA7;EFEMP1;EPHA3;EPHB4;EPHB2;PDGFRA;ROR2
prerank,single-stranded DNA helicase activity (GO:0017116),0.6077688660037049,1.3192234972869414,0.15668789808917197,0.642024119109718,1.0,5/19,13.34%,MCM5;DHX9;MCM6;MCM2;DNA2
prerank,cation:chloride symporter activity (GO:0015377),-0.5371535129271954,-1.3137858615928348,0.16037735849056603,1.0,1.0,2/10,1.03%,SLC12A2;SLC12A7
prerank,E-box binding (GO:0070888),0.5722086719051938,1.3136913907652095,0.1318181818181818,0.6558838764932442,1.0,7/34,8.69%,ASCL1;SREBF2;MITF;BHLHE41;TAL1;SNAI1;CIART
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.507476265529991,1.3129721246333588,0.02702702702702703,0.6528596805150634,1.0,46/188,14.61%,RUNX1;AHRR;CIITA;GATA1;NFE2L2;POU2F2;BASP1;DHX9;TNF;SNCA;ATF3;CEBPA;FOXO3;DDIT3;SPI1;MAFK;HDAC5;HMGB1;XRCC5;FLI1;TFEB;TP53;TBL1XR1;NKX2-1;TAL1;YY1;CREB3L1;CEBPB;MEF2C;SMAD3;HSF1;HNRNPL;ARID4A;HDAC4;RNF10;TBL1X;CREB3L2;RBBP5;ATF6B;NFKB1;FOXK1;SOX6;IRF1;SOX2;BRD7;SOX4
prerank,C2H2 zinc finger domain binding (GO:0070742),0.6783013514902112,1.3096431838335059,0.17579250720461095,0.6587449600458276,1.0,1/11,1.17%,GATA1
prerank,ribosomal large subunit binding (GO:0043023),-0.4933759870099004,-1.302533389533033,0.14385964912280702,1.0,1.0,6/11,25.32%,CPSF6;NEMF;DHX33;NPM1;NMD3;MRRF
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.5674282421455557,1.2998584406531355,0.17717003567181927,0.6897964522053518,1.0,8/28,18.46%,MAPKAPK3;MAPK14;MAP2K6;MAP2K3;MAP2K2;LRRK2;RPS6KA2;MAP2K5
prerank,glutamate receptor binding (GO:0035254),-0.4481087951248358,-1.299191654397479,0.1459227467811159,1.0,1.0,9/17,15.99%,GNAS;SYNDIG1;IGSF11;HOMER3;SHANK3;SHANK1;SHANK2;CAMK2A;HOMER2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.4602919190782725,-1.2962183684110005,0.125,1.0,1.0,6/15,30.78%,SLC26A2;SLC26A7;SLC39A8;SLC26A6;CFTR;SLC26A8
prerank,calcium channel inhibitor activity (GO:0019855),-0.5016433095362403,-1.2930707968297668,0.18305084745762712,1.0,1.0,4/11,26.19%,FKBP1A;SLC30A1;PACSIN3;CALM2
prerank,phosphatase inhibitor activity (GO:0019212),0.5977536477292196,1.2919213190937873,0.1748768472906404,0.7140396941077811,1.0,5/20,11.23%,LGALS3;MGAT5;SAG;ENSA;BOD1L1
prerank,CoA-ligase activity (GO:0016405),-0.4641297436227684,-1.2879664921054919,0.14624505928853754,1.0,1.0,6/14,29.45%,ACSL1;ACSS2;ACSS1;ACSBG1;SLC27A2;AACS
prerank,chemorepellent activity (GO:0045499),-0.3917470211510151,-1.2841308563931195,0.1511627906976744,1.0,1.0,8/25,8.55%,SEMA6A;SEMA5A;EPHA7;SEMA3A;SEMA6D;NRG3;SEMA3C;SEMA3D
prerank,aspartic-type endopeptidase activity (GO:0004190),0.6341061607784741,1.2795493729991663,0.21849865951742628,0.7550948352564013,1.0,5/12,14.82%,NAPSA;DDI2;SPPL3;CTSE;SPPL2A
prerank,1-phosphatidylinositol binding (GO:0005545),0.6122360195535614,1.2764468087231389,0.20844686648501362,0.7608764861656644,1.0,8/15,18.20%,SNX9;ZFYVE9;WDFY1;EPB41;FRMPD2;WDFY3;SNX10;PICALM
prerank,MAP kinase phosphatase activity (GO:0033549),0.6404016744166904,1.2758807874517206,0.22423398328690808,0.7568123694744608,1.0,3/12,8.91%,DUSP3;DUSP29;DUSP10
prerank,sterol binding (GO:0032934),0.5239452430422611,1.2715315434738113,0.15102481121898598,0.7672539438191139,1.0,16/56,15.24%,TSPO;ABCA1;NPC2;ABCG1;NPC1;OSBPL11;SOAT2;ERLIN1;ERLIN2;OSBPL10;GPR183;OSBP;STARD4;VDAC2;VDAC1;OSBPL8
prerank,receptor antagonist activity (GO:0048019),0.6034702033179539,1.2691943987804142,0.18494055482166447,0.769554231167554,1.0,3/17,13.45%,DKK2;IL18BP;PXDN
prerank,phosphatase binding (GO:0019902),0.5009079734579218,1.2677255936238652,0.0821501014198783,0.7687454259755276,1.0,16/105,8.71%,CD22;LGALS3;SIRPA;CTSC;KCNN4;MAPK14;PPP6R1;TRAF2;TRAF3;CTNNB1;CEP192;TP53;MAP3K5;WNK1;MTMR3;SMAD3
prerank,Hsp90 protein binding (GO:0051879),0.5470169558100456,1.2674576060743732,0.1896551724137931,0.7636186353813487,1.0,12/33,17.78%,CYP1A1;PTGES3;ERN1;CSNK2A1;HSF1;AHSA1;HDAC6;NOD2;STUB1;CHORDC1;HIF1A;NPAS2
prerank,insulin-like growth factor I binding (GO:0031994),0.6228184617476977,1.2644102850688677,0.2292225201072386,0.7695401675704562,1.0,2/13,3.96%,ITGB3;ITGA6
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.6058027771215827,1.263276818522757,0.2204515272244356,0.7682134252263194,1.0,4/14,10.15%,BLVRB;CRYM;QDPR;PYCR2
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.3459704867694883,-1.2632723210354126,0.13861386138613863,1.0,1.0,5/38,4.45%,APP;SERPINH1;SERPINE2;SERPING1;TFPI
prerank,DNA polymerase activity (GO:0034061),-0.3940753369017374,-1.2625723737198862,0.12105263157894737,1.0,1.0,12/22,22.73%,REV3L;REV1;PRIMPOL;POLN;POLA1;POLE4;TERT;POLG;POLE2;POLQ;POLK;POLI
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5624163062415283,1.262086669565538,0.19853836784409257,0.7667124876228496,1.0,2/23,2.02%,PLCB2;PLCG2
prerank,Hsp70 protein binding (GO:0030544),0.5513610667996863,1.2618770059091353,0.18806306306306306,0.7613161383906057,1.0,7/31,13.60%,CYP1A1;ERN1;SNCA;DNAJC8;GPR37;NOD2;STUB1
prerank,glycerophospholipid flippase activity (GO:0140333),0.6315370265180759,1.258661406495684,0.2357142857142857,0.7671223581354951,1.0,5/11,15.27%,ATP8A1;ATP8A2;ABCB4;ABCA4;ABCA3
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.5457899238454008,1.257716000275408,0.20965842167255594,0.76462319288495,1.0,12/28,21.10%,EXO1;ELAC2;ENDOV;RPP38;ELAC1;AGO3;RNASEH1;RPP14;PRORP;AGO2;RNASEH2A;DICER1
prerank,protein kinase C binding (GO:0005080),0.526744136652783,1.2574709588715194,0.17861080485115766,0.7598260059033711,1.0,11/43,12.19%,PLEK;PKP2;PRKD2;ADCY6;HDAC5;PRKCB;HINT1;PKN1;NELL1;HDAC9;TWF2
prerank,alanine transmembrane transporter activity (GO:0022858),0.636143081367692,1.2512781966234647,0.20926966292134833,0.7772699404261687,1.0,6/12,23.02%,SLC7A8;SLC36A1;SLC36A4;SLC1A4;SLC38A7;SLC6A6
prerank,cytokine receptor binding (GO:0005126),0.4973648094753248,1.251127431071611,0.12768130745658834,0.771947838576138,1.0,17/83,13.69%,SYK;TYK2;OSM;IL6R;PYCARD;IL18;CD300LF;VEGFB;EPO;TGFBRAP1;SMAD3;SH2B3;TIMM50;SDCBP;PRLR;PXDN;ERAP1
prerank,insulin-like growth factor binding (GO:0005520),0.6057407647898718,1.2506449418821504,0.23237597911227154,0.7678583241897307,1.0,2/15,3.96%,ITGB3;ITGA6
prerank,transcription cis-regulatory region binding (GO:0000976),0.4800542913048477,1.2503356899098148,0.016,0.7632155012922451,1.0,83/406,14.65%,RUNX1;NFE2;NPAS4;MMP12;AHRR;ASCL1;CIITA;GATA1;NFE2L2;POU2F2;BASP1;RREB1;CREB3;BARX2;RXRB;NR1H4;TNF;SNCA;MLXIP;NFXL1;ATF3;CEBPA;FOXO3;DDIT3;SPI1;MAFK;HOXC8;HDAC5;HMGB1;XRCC5;FLI1;TEAD1;TRPS1;TFEB;ZFP69;ZNF177;TP53;MEF2A;ACTN4;TBL1XR1;NKX2-1;TAL1;LONP1;YY1;CREB3L1;ZFP90;CEBPB;FOXN2;SNAI1;MEF2C;CDC5L;TFAP2B;RB1;SMAD3;IRF2;HSF1;CREBRF;HNRNPL;ARID4A;HDAC4;NFX1;RNF10;TBL1X;CREB3L2;RBBP5;SOX9;NR2C2;ETV6;E2F6;ATF6B;SNAPC3;MAX;TIPARP;FOXN3;NFKB1;FOXK1;SOX6;CUX1;IRF1;SOX2;BRD7;SOX4;SREBF1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.49622940832065254,-1.2491408429483617,0.22443181818181818,1.0,1.0,5/11,35.23%,KCND3;KCNJ3;KCNJ8;KCNE4;KCNH2
prerank,protein kinase binding (GO:0019901),0.4773474438066599,1.2464237859837055,0.009,0.7721761135773876,1.0,89/479,12.82%,PTPRC;CD226;TREM2;IRF5;BLNK;FGR;PLEK;CD3E;ITGB2;CASS4;HCLS1;STAP1;LYST;NEFH;MAPKAPK3;LAT;SIRPA;PRKAR2B;PLCG2;GPRC5B;PRKCD;PTPRJ;THY1;MAD2L2;DUSP3;GRB2;PTPN1;RFFL;MAP2K6;TRIM5;NEK6;PKP2;CCND3;GCH1;RGCC;PRKD2;TUBA4A;CIR1;TTN;SKI;TRAF2;DNAJC3;FOXO3;ADCY6;NBEAL2;CCND2;HDAC5;SHC2;PRKCB;MAP2K3;BCL2L1;CEP192;ACTB;MAPRE1;TP53;USF1;NEDD9;WNK1;TICAM1;HINT1;TRAP1;CHEK2;KIF14;AP1B1;TRIM27;MAP3K1;SMAD3;DUSP10;HSF1;QARS1;IBTK;BCAR1;TPR;DUSP19;PKN1;SH2B3;LIMS1;CLTC;SOX9;NELL1;BECN1;ADIPOR1;PRDX3;HDAC9;TWF2;NOD2;MAP3K12;TBL2;EXOC2
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.42585295790885996,-1.2461339181244135,0.16289592760180996,1.0,1.0,4/17,4.78%,EPHA7;EPHA3;EPHB4;EPHB2
prerank,ephrin receptor activity (GO:0005003),-0.42585295790885996,-1.2461339181244135,0.16289592760180996,1.0,1.0,4/17,4.78%,EPHA7;EPHA3;EPHB4;EPHB2
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.5241687963734186,1.2438728426650585,0.2041942604856512,0.7757519612135391,1.0,7/38,8.38%,NCF4;SH3PXD2B;ZFYVE26;ZFYVE28;DENND1A;TECPR1;SNX27
prerank,lipoprotein particle receptor binding (GO:0070325),0.5590403444153917,1.2393716280810174,0.22169811320754718,0.7865761138095239,1.0,9/27,19.92%,PCSK9;APOE;LDLRAP1;CLTC;LRP1;AP2M1;MESD;PICALM;RELN
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5750853810704647,1.2352661119638633,0.22481572481572482,0.7961394548111287,1.0,8/18,22.07%,TNFAIP8;SNCA;PRDX3;GAS6;PRDX5;BIRC2;BIRC3;MT3
prerank,Notch binding (GO:0005112),-0.39298993443978064,-1.2333223444302455,0.17575757575757575,1.0,1.0,13/22,35.85%,CCN3;SNED1;SNW1;AAK1;JAG1;JAG2;NOTCH4;HIF1AN;TCIM;KCTD10;GALNT11;DLL4;DLL1
prerank,semaphorin receptor activity (GO:0017154),0.6341811458074417,1.2294594116238053,0.23684210526315788,0.812318174045508,1.0,3/11,11.23%,PLXNC1;PLXNB2;NRP1
prerank,endonuclease activity (GO:0004519),0.5083900905143841,1.2286312808435698,0.21297297297297296,0.8098547560874733,1.0,13/49,17.90%,SLFN14;ERN1;NOB1;SND1;ZC3H12D;RNASEL;AGO3;ERCC5;REXO4;OGG1;ZC3H12C;N4BP2;AGO2
prerank,acid-thiol ligase activity (GO:0016878),-0.4606354845540268,-1.2285431933479103,0.2116788321167883,1.0,1.0,6/13,30.53%,ACSL1;ACSS2;ACSS1;SLC27A2;AACS;AASDH
prerank,acylglycerol lipase activity (GO:0047372),0.6074280942561924,1.2281199640607727,0.27472527472527475,0.8058760668672118,1.0,4/11,15.35%,ABHD12;ABHD3;LIPE;ABHD16A
prerank,kinase inhibitor activity (GO:0019210),0.5292534457808777,1.2270384796439686,0.22170900692840648,0.8043989642943316,1.0,7/33,10.57%,GMFG;TAOK3;SNCA;DNAJC3;YWHAB;QARS1;DUSP19
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.5655440131604601,1.227023369411185,0.26262626262626265,0.7988134988431569,1.0,4/18,12.33%,PIK3R5;WDR91;CCKBR;WDR81
prerank,actin binding (GO:0003779),0.4774859708910715,1.2261914238345726,0.09227683049147442,0.7962363066740106,1.0,46/170,14.92%,MYO1F;LCP1;SPTBN5;IQGAP2;CORO1A;MYL3;SNCA;GAS2L3;CXCR4;MYH9;SYNE1;FLII;MRTFA;MACF1;MYO9B;CAPZB;MTSS1;ACTN4;KCNMA1;LDB3;TMSB4X;MICAL1;P4HB;CAPZA1;CAP1;TNNT3;MYO19;TLNRD1;VCL;PFN2;MAP1B;PARVB;MAEA;PFN1;TWF2;NOD2;COTL1;TMSB10;SMTN;SSH2;ADCY8;SYNPO;MYH10;LRRK2;PDLIM1;FXYD5
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.6107308786722325,1.2254252828742849,0.2549295774647887,0.7935380439202632,1.0,5/11,12.90%,PYCARD;CASP1;CFLAR;CASP7;CASP8
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.302131648205035,-1.2203184171479524,0.06451612903225806,1.0,1.0,14/60,8.94%,ROR1;NTRK3;AXL;EGFR;ALK;EPHA7;EPHA3;EPHB4;ACVR1;EPHB2;ACVRL1;PDGFRA;ROR2;ACVR1B
prerank,nuclear receptor coactivator activity (GO:0030374),0.5023392589741194,1.220229886976618,0.21831735889243875,0.8070210533708164,1.0,20/52,22.17%,BRD8;MED17;TACC1;ZMIZ2;PRKCB;CCAR1;ACTN4;PPARGC1A;RNF4;ACTN1;PKN1;SRA1;BUD31;THRAP3;TMF1;MED4;MED13;SFR1;FGF2;MED30
prerank,GABA receptor activity (GO:0016917),-0.3964747601539911,-1.2188428904381798,0.19553072625698323,1.0,1.0,6/21,10.55%,GABRB2;GABRB1;GABRA2;GPR156;GABBR2;GABRB3
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.39293376622180004,-1.2173400622727615,0.19806763285024154,0.9796416113862157,1.0,4/21,10.77%,CHRFAM7A;CHRNA7;GRM5;GRM1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.5522703365554665,1.2168450523898033,0.25240384615384615,0.8138064100468948,1.0,5/22,10.57%,DUSP3;DUSP29;MTMR3;DUSP10;DUSP19
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.5028569124766216,1.2168057363708922,0.21030042918454936,0.8084355875640635,1.0,11/54,13.99%,KLK3;ASPG;PIGL;HDAC5;HINT1;ACER3;HDAC4;HDAC6;HDAC9;DARS1;HDAC11
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.4071598375460135,-1.2167181334634782,0.21076233183856502,0.9534275153406687,1.0,7/18,20.96%,STXBP6;CNN3;BAIAP2L1;BAIAP2;S100A11;ANXA2;PPP1CA
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6160434929233994,1.2148834229160814,0.28005464480874315,0.8098938574211039,1.0,5/12,12.41%,ARSB;GNS;IDS;SULF2;ARSA
prerank,leucine zipper domain binding (GO:0043522),0.6286104111396102,1.2141738951029455,0.27474150664697194,0.8070430889601312,1.0,4/10,12.42%,DDIT3;MRTFA;NRL;PMF1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.5639774256993464,1.2141401353281411,0.2558139534883721,0.8018300282168008,1.0,7/22,18.20%,PCSK9;APOE;LDLRAP1;CLTC;AP2M1;MESD;PICALM
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.47071115494814086,1.2140764620436648,0.08962739174219536,0.7967664882969495,1.0,37/173,13.82%,BATF3;ASCL1;IRF8;BCL11A;ZEB2;SREBF2;MITF;SKI;ATF3;FOXO3;LRRFIP1;MYT1L;ZBTB12;ZBTB39;MAFK;BHLHE41;BACH1;TRPS1;ZFP69;ZNF177;YY1;CREB3L1;ZFP90;CEBPB;SNAI1;GTF2IRD1;HSF1;NFX1;TGIF1;JDP2;ETV6;E2F6;GZF1;MAX;NFKB1;FOXK1;ZFHX3
prerank,phosphoric diester hydrolase activity (GO:0008081),0.5183078031195703,1.2139127828444038,0.2231121281464531,0.7921896869433628,1.0,9/35,16.22%,PLD4;PLCB2;SMPD3;PLD3;PLCXD3;PDE11A;GDE1;GDPD3;PDIA3
prerank,protein kinase C activity (GO:0004697),0.5928495833379466,1.213418925034448,0.2596026490066225,0.7886369918301789,1.0,6/14,10.83%,PRKCD;PRKCB;PRKCQ;SMG1;PRKCH;PKN1
prerank,serine-type peptidase activity (GO:0008236),0.47782760731929114,1.2130488535399315,0.16191446028513237,0.7850324621631632,1.0,5/96,4.68%,KLK3;PCSK9;F10;MASP1;RHBDF2
prerank,metalloaminopeptidase activity (GO:0070006),-0.4154762279031785,-1.2107261308873087,0.21161825726141079,0.9489795918367346,1.0,7/16,20.31%,LTA4H;MMP14;MMP16;RNPEPL1;NPEPPS;ENPEP;MMP15
prerank,fatty acid synthase activity (GO:0004312),-0.5000664235245151,-1.2102129449669283,0.22012578616352202,0.9245204283002169,1.0,7/10,42.93%,ELOVL5;CBR4;ELOVL1;OXSM;MCAT;ELOVL4;ELOVL2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.57332295448072,1.2098196452414929,0.27249022164276404,0.7915794396686116,1.0,2/16,4.46%,ALOX12;HAAO
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.530705081211133,1.2076224780271538,0.2408256880733945,0.7944871044902808,1.0,11/30,22.07%,TNFAIP8;PTTG1;CST7;SNCA;PRDX3;GAS6;PRDX5;UBE2Z;BIRC2;BIRC3;MT3
prerank,inward rectifier potassium channel activity (GO:0005242),0.5406637225401301,1.2071550254770689,0.26772616136919314,0.7911595309982403,1.0,2/24,3.18%,KCNJ11;KCNK6
prerank,ribonuclease activity (GO:0004540),0.4947721092973947,1.2070714757553533,0.21382978723404256,0.7864217312131934,1.0,20/56,22.63%,SLFN14;ERN1;NOB1;EXOSC1;SAMHD1;SND1;ELAC2;ZC3H12D;RNASEL;AGO3;RNASEH1;ZC3H12C;AGO2;RNASEH2A;EXOSC3;DIS3L2;DICER1;RNASE6;CNOT7;EXOSC2
prerank,solute:anion antiporter activity (GO:0140323),-0.43623571121736315,-1.2045609267539807,0.19927536231884058,0.9188405790811367,1.0,5/14,30.78%,SLC26A2;SLC26A7;SLC4A2;SLC26A6;SLC26A8
prerank,endopeptidase activity (GO:0004175),0.46130692703304527,1.2033140569030698,0.071,0.7943576376629431,1.0,47/257,16.23%,CTSS;KLK3;MMP12;CTSB;PCSK9;NAPSA;F10;LGMN;CTSC;CTSK;CTSL;ADAMTS8;MASP1;ECE2;EEF1AKMT4-ECE2;ESPL1;RHBDF2;USP35;CASP1;DDI2;PSMB10;MALT1;ZMPSTE24;CTSZ;NLN;CTSE;MMP19;USP7;PSMA2;USP48;CASP7;USP18;PARL;CASP8;PCSK7;PSMB5;USP9X;KLK2;ECEL1;USP8;USP29;PSMB9;PMPCB;USP16;IDE;PDIA3;RHBDF1
prerank,CARD domain binding (GO:0050700),0.5825399266817209,1.2032583720170218,0.27248322147651005,0.7896176879027383,1.0,4/14,16.30%,CARD11;CASP1;NOD2;IRGM
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.37938647565375483,-1.20037617678996,0.19597989949748743,0.9091692811164602,1.0,11/21,22.73%,REV3L;REV1;PRIMPOL;POLN;POLA1;POLE4;POLG;POLE2;POLQ;POLK;POLI
prerank,ADP binding (GO:0043531),0.5379750316933383,1.1946373691988255,0.2669039145907473,0.8152391119870795,1.0,9/25,14.20%,ERN1;ABCG1;MYH9;MYO9B;LONP1;ABCD1;TAP1;ATP5F1A;MYH10
prerank,retinoid X receptor binding (GO:0046965),0.6128071966910158,1.194441799459381,0.2820143884892086,0.8109574795947958,1.0,3/11,11.82%,NSD1;TACC1;NRIP1
prerank,DNA-binding transcription factor binding (GO:0140297),0.4616691688582143,1.1926357266765446,0.11711711711711711,0.8125554797358812,1.0,29/189,8.71%,ASCL1;CIITA;HCLS1;GATA1;NFE2L2;NFATC1;MAD2L2;DHX9;TLE3;NEK6;SKI;DDIT3;SPI1;FIZ1;BHLHE41;HDAC5;HMGB1;TAF1;CTNNB1;MTA3;TP53;MEF2A;TAL1;USF1;MYOCD;LMO2;MEF2C;RB1;SMAD3
prerank,RNA stem-loop binding (GO:0035613),0.5955489890999724,1.1911789844455913,0.28907330567081607,0.8127864433879376,1.0,6/12,14.20%,DHX9;RC3H2;RC3H1;EPRS1;CPEB3;MYH10
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.45439778923312174,1.1883799840400546,0.019,0.817363881217244,1.0,103/597,14.65%,RUNX1;BATF3;NFE2;IRF5;AHRR;ASCL1;CIITA;MEOX1;IRF4;IRF8;MCM5;GATA1;NFE2L2;ORC3;POU2F2;BASP1;NFATC1;HES7;ELF4;DHX9;CREB3L4;CREB3;BARX2;RXRB;FOXD2;TNF;SNCA;SREBF2;RFX1;ATF3;CEBPA;FOXO3;DDIT3;SPI1;ZBTB12;MAFG;MAFK;HOXC8;BHLHE41;HDAC5;HMGB1;XRCC5;FLI1;TEAD1;TFEB;ZNF177;TP53;KLF6;TBL1XR1;NKX2-1;NRL;TAL1;USF1;YY1;CREB3L1;CEBPB;FOXN2;SNAI1;MEF2C;TFAP2B;GMEB2;SMAD3;IRF2;HSF1;ZNF32;HNRNPL;ARID4A;GMEB1;MCM6;HDAC4;MCM2;TGIF1;HOXA6;RNF10;NFIC;TBL1X;KLF13;CREB3L2;RBBP5;ELF2;SOX9;ORC4;JDP2;NR2C2;ZNF740;HSF5;ATF6B;CREB1;MCM9;KAT7;NR4A1;MAX;NFKB1;FOXK1;RFX7;SOX6;CUX1;CDC6;IRF1;SOX2;BRD7;SOX4;SREBF1
prerank,kinase binding (GO:0019900),0.45539626834607194,1.187694608577991,0.045,0.8148945658050487,1.0,91/434,15.47%,PTPRC;CD226;IRF5;BLNK;FGR;CD3E;ITGB2;HCLS1;STAP1;LYST;NEFH;LAT;PLCG2;GPRC5B;PRKCD;PTPRJ;THY1;DUSP3;GRB2;PTPN1;RFFL;PFKL;MAP2K6;TRIM5;NEK6;CCND3;RGCC;TUBA4A;CIR1;TTN;SKI;TRAF2;DNAJC3;CEBPA;FOXO3;ADCY6;NBEAL2;CASP1;WWC2;CCND2;SHC2;MAP2K3;CTNNB1;BCL2L1;CEP192;ACTB;MAPRE1;TP53;USF1;WNK1;TAX1BP1;TICAM1;TRAP1;CHEK2;SNAI1;KIF14;DGKD;AP1B1;RB1;TRIM27;MAP3K1;SMAD3;HSF1;QARS1;IBTK;BCAR1;LIMS1;CLTC;BECN1;ADIPOR1;PARP16;PRDX3;NOD2;MAP3K12;TBL2;EXOC2;STUB1;MOB1B;CEP152;TRADD;CDC6;NISCH;KCNA5;LRBA;PPP1CC;VDAC1;PIH1D1;TBC1D14;SRC;BCAR3;STRADA
prerank,amino acid binding (GO:0016597),-0.3344633263203206,-1.1870463066326717,0.1897810218978102,0.931107449205471,1.0,9/31,20.08%,GRIN3A;GRM7;CASTOR2;GRIN2B;NOS3;GRIN1;GLRB;NOS1;ASS1
prerank,death domain binding (GO:0070513),0.6007933466288036,1.1868326874523345,0.2987012987012987,0.8130742050658161,1.0,5/11,16.30%,BCL2L1;CRADD;DAP;TRADD;IRGM
prerank,peptide hormone receptor binding (GO:0051428),-0.4848569749536048,-1.1860811353869356,0.2523364485981308,0.9108477726747174,1.0,5/11,34.94%,PSMC5;PTHLH;ADCYAP1;GNRH1;CCK
prerank,gated channel activity (GO:0022836),0.5740745522114704,1.185630075128591,0.2970430107526882,0.8125183691680268,1.0,3/14,10.20%,TMC6;PACC1;TMEM63A
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.3905511363434369,-1.1852250264157245,0.25757575757575757,0.8919709833178753,1.0,7/21,16.99%,PDE10A;PDE7A;PDE1C;PDE8A;PDE9A;PDE2A;PDE8B
prerank,metal ion transmembrane transporter activity (GO:0046873),0.52041345224719,1.183132822901304,0.2943980929678188,0.8166390162488089,1.0,12/27,21.67%,SLC11A1;AQP1;ATP2B1;ZDHHC13;ITPR2;ATP2B3;ATP2A3;TMEM165;MMGT1;TUSC3;MAGT1;SLC12A3
prerank,hydro-lyase activity (GO:0016836),0.49489138576334335,1.1789718100140585,0.26823793490460157,0.8260125931646662,1.0,13/41,20.10%,TBXAS1;EHHADH;ENO3;IREB2;HACD4;ECHS1;ECI1;ACO1;CDYL;NAXD;CBS;ECHDC1;ENO1
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.39217584634440006,-1.176768498506945,0.2463768115942029,0.8982912522023198,1.0,8/20,26.16%,SLC39A13;SLC39A8;SLC30A1;SLC39A1;SLC39A14;SLC39A3;SLC39A10;SLC39A12
prerank,chloride transmembrane transporter activity (GO:0015108),-0.40211778889125327,-1.1743296508285952,0.23694779116465864,0.8849837696288152,1.0,3/16,5.22%,SLC26A2;CLCN6;SLC26A7
prerank,receptor ligand activity (GO:0048018),0.4522048771164789,1.1739168043684793,0.13226452905811623,0.8385889944529857,1.0,30/245,13.41%,TSHB;GPNMB;LGALS3;SHH;TGFB1;IL1A;METRNL;SLURP1;MDK;ANGPTL3;OSM;SEMA4D;TNF;IL18;TIMP1;NDP;HMGB1;VEGFB;EPO;PPY;NTF3;VGF;INHBA;SEMA4A;CHGB;ARTN;GRN;NRG1;TAFA1;GAS6
prerank,potassium:proton antiporter activity (GO:0015386),0.6068232886491723,1.1729268188384179,0.3090909090909091,0.8371491960030404,1.0,4/10,14.66%,SLC9A4;SLC9A9;SLC9A1;SLC9A8
prerank,phospholipase C activity (GO:0004629),0.52150172506479,1.172457836826932,0.27283653846153844,0.8339748700084689,1.0,2/25,2.02%,PLCB2;PLCG2
prerank,voltage-gated ion channel activity (GO:0005244),0.5689973433239531,1.1700181942210257,0.3148148148148148,0.8376172654438927,1.0,6/14,20.98%,PKD2;VDAC3;VDAC2;VDAC1;HVCN1;HCN1
prerank,glycine binding (GO:0016594),-0.44282465678548055,-1.168185734905818,0.24375,0.8846982884471644,1.0,4/11,17.41%,GRIN3A;GRIN2B;GRIN1;GLRB
prerank,syntaxin binding (GO:0019905),0.4764762340183457,1.1676811795764162,0.26105263157894737,0.841019345801712,1.0,15/61,14.53%,SYT17;ABCA1;VAMP3;VPS18;SYT2;STXBP3;CACNA1A;VPS11;SYT10;SNAP29;VPS54;RAB11A;SNAP23;STX8;LRRK2
prerank,phosphatidic acid binding (GO:0070300),0.5324618463046717,1.1634957722815764,0.31518987341772153,0.8503704547708625,1.0,3/19,6.76%,PLEKHN1;SMPD3;MICALL1
prerank,sodium:proton antiporter activity (GO:0015385),0.5992505316514226,1.1627067541437839,0.3141654978962132,0.8484264791315147,1.0,4/11,14.66%,SLC9A4;SLC9A9;SLC9A1;SLC9A8
prerank,vinculin binding (GO:0017166),-0.4526872175287552,-1.1608101732707021,0.2805755395683453,0.890399287712687,1.0,4/11,9.70%,UTRN;DMD;SORBS3;SYNM
prerank,ATPase regulator activity (GO:0060590),0.4845682279982906,1.160444903913255,0.29003359462486,0.8515155644192298,1.0,10/38,14.38%,BAG2;FNIP2;FNIP1;ATP5IF1;AHSA1;PFN1;ATP1B3;TOR1AIP2;ATP1B2;BAG1
prerank,hormone receptor binding (GO:0051427),0.555069675456249,1.1594976055768975,0.3193863319386332,0.8501545672665759,1.0,1/14,2.15%,TYK2
prerank,kinase activity (GO:0016301),0.45420599542346013,1.1591899842131062,0.23248730964467004,0.8465920160997911,1.0,21/109,13.18%,LYN;PIK3CG;DGKZ;PIK3CD;MTOR;PIK3CB;CHKB;CKB;DGKK;DGKE;TAF1;NADK;CERK;DGKG;DGKD;CSNK2A1;AGK;PAPSS1;POMK;DGKI;SHPK
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.4851173097728253,1.1582109009800468,0.2718006795016987,0.8450338693464373,1.0,16/37,22.57%,VARS1;FARSB;GARS1;RARS1;QARS1;EPRS1;LARS2;CARS2;DARS1;DARS2;TARS2;FARS2;TARS1;YARS1;SARS1;SARS2
prerank,protein kinase inhibitor activity (GO:0004860),0.4844776494123103,1.1567527529443609,0.2922222222222222,0.845483462665889,1.0,8/42,10.57%,GMFG;TAOK3;SNCA;DNAJC3;YWHAB;QARS1;IBTK;DUSP19
prerank,cardiolipin binding (GO:1901612),0.5883584801999882,1.1566109629756047,0.3218884120171674,0.8413615609117496,1.0,1/10,1.51%,PLEKHN1
prerank,protein heterodimerization activity (GO:0046982),0.44732713761923965,1.1556466938078527,0.19,0.8400359714015143,1.0,40/178,16.30%,NPAS4;CYBB;CD3E;IRAK2;MLXIPL;ABCG1;ATF3;HEXA;DDIT3;BHLHE41;FZD9;TAF1;BCL2L1;TP53;MEF2A;USF1;P4HB;MEF2C;DGKD;TFAP2B;PAFAH1B2;BAK1;ALG2;HSF1;TPM4;VAPB;METTL3;SDCBP;PPP2CA;IKBKG;KATNA1;NR4A1;ADCY8;ATP1B2;UBA2;MIGA1;SNX2;YWHAH;TOP2A;HIF1A
prerank,glutathione transferase activity (GO:0004364),0.5288234829238148,1.1554078959091671,0.3008631319358816,0.836298002855255,1.0,2/23,3.21%,GSTT4;HPGDS
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.45283950601923745,1.1546510372875325,0.1891891891891892,0.8344418800854232,1.0,45/181,17.27%,HCLS1;GATA1;NFE2L2;NFATC1;MAD2L2;DHX9;MAPK14;TACC1;NR1H4;SPI1;FIZ1;BHLHE41;HDAC5;TAF1;CTNNB1;MTA3;ACTB;TP53;SETD6;MEF2A;ACTN4;TAL1;MYOCD;LMO2;RB1;SMAD3;ARID1A;MDFIC;PPARGC1A;ANXA4;HDAC4;NRIP1;CREB1;SMARCD3;SMARCB1;RERE;PTPRT;BUD31;PIAS1;MTDH;RBPJ;HIF1A;FAF1;TRIP4;PPARD
prerank,fibroblast growth factor binding (GO:0017134),0.5267525235228661,1.152214655011364,0.3240152477763659,0.8381570790723,1.0,6/21,17.43%,ITGB3;RPS2;FGFBP3;THBS1;FIBP;SCN5A
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.45654995126017284,-1.149613779782226,0.2980769230769231,0.9067286155547613,1.0,7/11,27.37%,TRPC1;ITPR3;RPH3A;TRPC4;TRPC7;TRPC3;CYTH2
prerank,double-stranded RNA binding (GO:0003725),0.46386504258238725,1.1468035164503552,0.284375,0.8512552528398419,1.0,20/70,17.90%,RFTN1;DHX9;TLR8;TLR7;LRRFIP1;RC3H2;EIF4A1;ADAR;RC3H1;AGO4;EIF4H;ACTN1;APTX;CLTC;AGO3;ADARB1;PRKRA;MTDH;TARBP2;AGO2
prerank,secondary active transmembrane transporter activity (GO:0015291),0.47301900535414854,1.1444730987998841,0.2982832618025751,0.8547332890815879,1.0,10/51,15.59%,SLC16A10;SLCO2B1;SLC25A16;SLC7A8;SLC16A2;TMEM241;SLC20A2;SLC25A30;SLCO1B1;CLCN4
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.4025046718868037,-1.1441887917086109,0.2880658436213992,0.9058663023988104,1.0,3/14,6.22%,SLC25A12;SLC17A6;SLC25A13
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.40828676972873656,-1.1428099705323733,0.27705627705627706,0.891635185155447,1.0,3/16,1.33%,MTM1;SACM1L;MTMR7
prerank,endopeptidase inhibitor activity (GO:0004866),-0.26573885254774554,-1.14154860317735,0.2,0.8775277518509974,1.0,19/82,14.48%,APP;SERPINH1;SERPINE2;CAST;SERPING1;RECK;TFPI;COL4A3;TIMP2;SPOCK2;USP14;TIMP3;BIRC6;NGF;ROCK1;SERPINB9;SERPINF1;UBE2O;BST2
prerank,G protein-coupled receptor binding (GO:0001664),0.44497870346591945,1.140876652705553,0.2318548387096774,0.8622868135689545,1.0,11/132,8.28%,GNA15;ARRB2;GPRC5B;GNAQ;GRK3;GNAZ;SAG;NDP;GNA13;GNA12;PPY
prerank,phosphatidylinositol binding (GO:0035091),0.4473097807142605,1.139432553643579,0.2899590163934426,0.8625121221536478,1.0,23/91,18.20%,DENND1C;PLEKHN1;MYO1E;SNX5;THY1;SNX9;SNX24;PLEKHF2;DENND1A;ZFYVE9;SNX27;ITPR2;DENND1B;WDFY1;EPB41;EXOC8;FRMPD2;SNX2;SNX13;APPL2;WDFY3;SNX10;PICALM
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.5502410871011757,1.1386250388824724,0.3299856527977044,0.8609210719557235,1.0,4/14,19.38%,CAPN15;CAPN2;CAPN3;CAPNS1
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.5742097369718004,1.1376740685700224,0.33518005540166207,0.859658584049949,1.0,6/12,22.80%,SLC9A4;SLC9A9;SLC9A1;SLC9A8;SLC9A7;LETM1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.43908652668024906,1.137606079309633,0.17417417417417416,0.855478145178316,1.0,47/254,14.68%,RUNX1;IRF5;NPAS4;IRF4;GATA1;NFATC1;RREB1;ELF4;SP7;CREB3;BARX2;RXRB;FOXD2;NR1H4;MLXIP;MITF;ATF3;CEBPA;FOXO3;DDIT3;TP53;KLF6;MEF2A;NRL;YY1;CREB3L1;MEF2C;NKRF;CDC5L;TFAP2B;SMAD3;IRF2;CREBRF;GMEB1;LITAF;NFIC;SOX9;NR2C2;ATF6B;CREB1;SMARCD3;NR4A1;ZNF445;NFKB1;IRF1;SOX4;MEIS1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.5447979511542659,1.1369749162869276,0.3360107095046854,0.8531700716780279,1.0,2/15,6.97%,PIK3R5;CCKBR
prerank,thioesterase binding (GO:0031996),0.5775635779217899,1.136437954152297,0.3403361344537815,0.850510779319404,1.0,5/11,17.93%,TRAF2;TRAF3;TRAF5;ARF6;CDC42
prerank,calcium ion binding (GO:0005509),0.43655988427669695,1.134208923466456,0.139,0.8534076055083865,1.0,51/323,13.37%,MMP12;SHH;SYT17;LCP1;PCDHB6;SMOC2;LPL;TPD52;CABP4;ADAM8;S100B;SDF4;SLC8A1;IDS;HPGDS;MASP1;MAN1C1;SNCA;PKD2;TTN;KCNIP2;MCTP1;RASGRP2;PGS1;ASPH;S100A2;ANXA1;AIF1;AGRN;SYT2;CETN3;RASGRP3;TPT1;ITSN1;ITPR2;PDCD6;SYT10;TPM4;CDH8;ANXA4;ACER3;NAALADL1;DYSF;CDH9;THBS1;CDH12;ARSA;CAMKK2;BRAF;CDH23;NDUFAB1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.48328270775861193,1.1257898993243605,0.34543325526932084,0.8770449192592534,1.0,3/30,4.90%,SLC11A1;ATP7A;SLC25A37
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.5663141773571513,1.1245440149730277,0.3514285714285714,0.8766291468357648,1.0,1/11,1.72%,NEIL2
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.48311797128801875,1.1236918046945534,0.33295063145809417,0.8749370354155191,1.0,11/32,23.02%,SLC7A8;SLC38A6;SLC36A1;SLC43A2;SLC25A38;SLC36A4;SLC1A4;SLC43A1;SFXN2;SLC38A7;SLC6A6
prerank,high voltage-gated calcium channel activity (GO:0008331),0.5794120657871589,1.123148028941466,0.3522727272727273,0.8723482337359105,1.0,6/10,16.61%,CACNA1A;CACNB4;CACNB2;CACNB1;CACNA1B;CACNA1D
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.3913977574082916,-1.1218442722043163,0.27927927927927926,0.9232993961973279,1.0,4/15,9.48%,SLC25A12;SLC17A6;SLC25A13;SLC1A5
prerank,retinoic acid receptor binding (GO:0042974),0.5390683058262006,1.1216522322850897,0.3539253539253539,0.8728007674507704,1.0,4/17,11.82%,NSD1;TACC1;ACTN4;NRIP1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4070377941296506,-1.1204706205970285,0.3321554770318021,0.9099784248231666,1.0,4/14,16.36%,SLC26A2;SLC26A7;SLC25A14;SLC25A11
prerank,alkali metal ion binding (GO:0031420),0.5524514564629763,1.1201062968648317,0.3597222222222222,0.8735410839240719,1.0,3/13,14.81%,KCNJ11;HDAC4;CAPN3
prerank,transmitter-gated ion channel activity (GO:0022824),-0.32417541870185784,-1.118398083326559,0.25,0.8992520097932643,1.0,6/29,10.55%,GABRB2;GRIK4;GRIA2;GABRB1;GABRA2;GABRB3
prerank,ATP hydrolysis activity (GO:0140603),0.472570014990939,1.1159404187624664,0.34835164835164834,0.8829426055781311,1.0,14/41,17.99%,MYO1E;DHX9;ABCD1;KIF14;KIF20B;MYO19;ATP2B1;TOR3A;ABCA4;DNA2;TOR1A;ABCA3;HSP90AA1;ABCD2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.5630979234138923,1.115638952005077,0.3678321678321678,0.8796807978367561,1.0,2/11,13.95%,SLC25A20;SLC25A45
prerank,ubiquitin protein ligase binding (GO:0031625),0.42829923421137567,1.1105729838778924,0.214,0.8917365289561359,1.0,57/253,17.05%,ARRB2;TUBB;PRKAR2B;RPL23;LAPTM5;RFFL;SNX9;NEK6;MAP1LC3B;SKI;TANK;TRAF2;CXCR4;TRAF3;CKB;HLTF;XRCC5;ATXN3;ERLIN2;TP53;CASC3;CHEK2;RB1;SMAD3;PPARGC1A;DERL1;ACTG1;VCL;TRAF5;USP7;GPR37;HDAC6;BECN1;RNF40;GPI;NLK;PRKACB;TNFRSF1B;SPOP;DET1;PRDX6;IKBKG;CASP8;STUB1;WFS1;BAG1;UBE2J2;SLF2;RTN4;HIF1A;RPL11;FAF1;FZD8;HSP90AA1;FANCL;CBS;UBE2N
prerank,vitamin D receptor binding (GO:0042809),0.5416791899743452,1.110375329965893,0.37894736842105264,0.8881817557151563,1.0,7/14,22.17%,MED17;THRAP3;RXRA;TAF11;MED4;MED13;MED30
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.57674986778051,1.1086769452494576,0.39060205580029367,0.8893378408576506,1.0,3/10,10.14%,NSD1;ASH1L;SETD2
prerank,phosphatidate phosphatase activity (GO:0008195),0.5494243608250663,1.1078968863182799,0.3702185792349727,0.8875045310962663,1.0,2/13,8.67%,LPIN2;PLPPR1
prerank,amino acid transmembrane transporter activity (GO:0015171),0.45278819725488145,1.1074588105814263,0.352557127312296,0.884688550285915,1.0,10/47,13.28%,SLC7A7;SLC7A8;SLC38A6;SLC36A1;SLC38A4;SLC16A2;SLC43A2;SLC36A4;SLC66A1;SLC38A10
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.3306426062103011,-1.1065573969433795,0.25766871165644173,0.9201143128623785,1.0,8/26,14.69%,ABCG2;SLC16A12;SLC16A9;SLC16A11;SLC5A6;SLC16A4;SLC6A11;SLC27A1
prerank,acetylation-dependent protein binding (GO:0140033),-0.37278057403414544,-1.1057817219390835,0.30256410256410254,0.8888052707184901,1.0,6/20,7.33%,SMARCA4;MLLT3;PSME4;BRD9;ATAD2B;BRD4
prerank,lysine-acetylated histone binding (GO:0070577),-0.37278057403414544,-1.1057817219390835,0.30256410256410254,0.8888052707184901,1.0,6/20,7.33%,SMARCA4;MLLT3;PSME4;BRD9;ATAD2B;BRD4
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.3690915305943706,-1.10575256688558,0.2985781990521327,0.8730004198172076,1.0,6/18,9.87%,FAR1;AKR1B1;ALDH2;ALDH1A1;ALDH3A2;ALDH1A2
prerank,voltage-gated sodium channel activity (GO:0005248),0.5066466870826309,1.1015515551646868,0.37330037082818296,0.8991946884049147,1.0,3/22,4.10%,SCN4B;HCN4;PKD2
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.4191693182613098,-1.0967739411872695,0.3333333333333333,0.8841911433259407,1.0,6/11,43.03%,SLC5A3;SLC5A11;SLC2A9;SLC23A1;SLC23A2;SLC2A10
prerank,carboxylic acid binding (GO:0031406),-0.2978702999722442,-1.0948477147960023,0.24509803921568626,0.8746756443367473,1.0,11/38,19.71%,GRIN3A;GRM7;UBR2;SESN3;CASTOR2;GRIN2B;NOS3;GRIN1;GLRB;HIF1AN;NOS1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.5646000131094904,1.0940909399371608,0.3985294117647059,0.9190954237767665,1.0,2/10,3.69%,SIRPA;PKP2
prerank,ionotropic glutamate receptor activity (GO:0004970),0.5108585809696141,1.09111886369992,0.3870558375634518,0.9244132629053915,1.0,1/17,0.31%,PTK2B
prerank,ATPase binding (GO:0051117),0.43416070580285687,1.088908903094762,0.3607924921793535,0.9272962435391848,1.0,24/71,18.68%,ABCA1;TCIRG1;PKD2;ALDOB;ATP6V1E1;FBL;ATP6V0A2;ATXN3;SVIP;ATP5IF1;DERL1;TMTC4;ATP6V0A1;ATP1B3;TOR1AIP2;ATP1B2;WFS1;PIH1D1;SRC;NUFIP1;ZNHIT6;ANK1;SNX10;PTPN3
prerank,NADPH binding (GO:0070402),-0.40784936771174796,-1.087215027125347,0.34210526315789475,0.8815773501053878,1.0,10/13,34.82%,HMGCR;DUS2;MTRR;CBR4;DHFR;LBR;NDOR1;CRYZ;CBR3;GRHPR
prerank,metalloexopeptidase activity (GO:0008235),-0.26894063693427855,-1.0842325920734261,0.22535211267605634,0.8760110215399108,1.0,16/51,21.21%,AGBL4;LTA4H;MMP14;FOLH1;CPM;CPQ;ACE;MMP16;RNPEPL1;NPEPPS;CPXM2;CPD;CPXM1;ENPEP;MMP15;AGBL1
prerank,semaphorin receptor binding (GO:0030215),-0.33962950904051936,-1.0839084610768839,0.3225806451612903,0.8624866792748471,1.0,6/23,8.55%,SEMA6A;SEMA5A;SEMA3A;SEMA6D;SEMA3C;SEMA3D
prerank,alpha-tubulin binding (GO:0043014),0.4784095348944185,1.0835658742626295,0.39556592765460913,0.9406618617431107,1.0,16/31,24.44%,TBCEL;SNCA;DIP2B;ARL8A;SETD2;HDAC6;FYN;INO80;ARL8B;EML4;TAOK1;CDK5R1;TTLL7;DNAL1;ARL4C;FNTA
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.5471943060997155,1.0834178701388943,0.4014285714285714,0.9368110328335238,1.0,4/10,12.90%,CASP1;CFLAR;CASP7;CASP8
prerank,histone demethylase activity (GO:0032452),-0.331714346677861,-1.0816179180628085,0.4,0.8550793293936279,1.0,10/27,18.26%,PHF2;KDM5C;JMJD1C;KDM3A;KDM4B;KDM4A;KDM2A;KDM4D;KDM6A;KDM8
prerank,calcium activated cation channel activity (GO:0005227),0.5084603813676281,1.0807886713278005,0.4007832898172324,0.9413944456587833,1.0,3/17,10.20%,KCNN4;KCNMA1;TMEM63A
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.41101566807789786,1.0775099613944856,0.182,0.9480229007618819,1.0,118/731,13.89%,RUNX1;BATF3;NFE2;IRF5;NPAS4;ASCL1;MEOX1;IRF4;IRF8;IKZF1;GATA1;STAT5A;NFE2L2;POU2F2;NLRC5;NFATC1;HES7;RREB1;BCL11A;NSD1;MLXIPL;ELF4;DHX9;ZEB2;SP7;CREB3L4;CREB3;RXRB;FOXD2;NR1H4;DNMT3A;SREBF2;RFX1;MLXIP;BPTF;MITF;ZFP30;SKI;ATF3;CEBPA;FOXO3;LRRFIP1;DDIT3;SPI1;MYT1L;ZBTB12;PGBD1;ZBTB39;HIVEP3;MAFG;MAFK;BHLHE41;HDAC5;BACH1;TEAD1;TFEB;CCAR1;TP53;KLF6;MEF2A;NKX2-1;NRL;TAL1;USF1;YY1;CREB3L1;STAT4;CEBPB;ST18;SNAI1;MEF2C;NKRF;TFAP2B;GMEB2;CIART;SMAD3;ZFP14;GTF2IRD1;IRF2;HSF1;ZNF32;GMEB1;STAT5B;HDAC4;NFE2L1;LITAF;ZNF83;TGIF1;HOXA6;NFIC;KLF13;CREB3L2;TRIM24;ZSCAN26;OLIG1;SOX9;HDAC6;JDP2;NR2C2;ZNF740;NRIP1;E2F6;ZNF628;GZF1;HSF5;ATF6B;SNAPC3;CREB1;ZSCAN18;NR4A1;MAX;ZNF445;NFKB1;FOXK1;RFX7;SOX6;ZFHX3;IRF1
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.41528551706203753,1.0754409401467169,0.311,0.9501782052878696,1.0,60/268,17.43%,ARRB2;TUBB;PRKAR2B;RPL23;LAPTM5;RFFL;SNX9;NEK6;MAP1LC3B;SKI;TANK;TRAF2;CXCR4;TRAF3;CKB;HLTF;XRCC5;ATXN3;ERLIN2;TP53;CASC3;CHEK2;RB1;SMAD3;PPARGC1A;DERL1;ACTG1;VCL;TRAF5;USP7;GPR37;HDAC6;BECN1;RNF40;GPI;NLK;PRKACB;TNFRSF1B;SPOP;DET1;PRDX6;IKBKG;CASP8;ITCH;STUB1;WFS1;BAG1;UBE2J2;SLF2;RTN4;HIF1A;RPL11;FAF1;FZD8;HSP90AA1;FANCL;CBS;UBE2N;TRIP4;SCN5A
prerank,UDP-glycosyltransferase activity (GO:0008194),0.4292888228703366,1.0752420186559797,0.3883089770354906,0.9465252783568768,1.0,15/70,19.87%,HEXB;LFNG;GCNT1;HEXA;B4GALT1;CHSY3;POGLUT2;POGLUT1;B3GALNT1;CHSY1;LARGE1;MGAT4B;B4GALNT1;CHPF;GXYLT1
prerank,nuclear receptor binding (GO:0016922),0.4280664509940009,1.074918003785974,0.3653061224489796,0.9432632952129613,1.0,34/111,19.48%,BRD8;GAS2L1;MED17;GTF2H1;NSD1;TACC1;NR1H4;TAF1;PRKCB;CTNNB1;ACTN4;SMAD3;MMS19;ARID1A;PPARGC1A;STRN;STAT5B;PKN1;NRIP1;SMARCD3;NR4A1;BUD31;YWHAH;THRAP3;HIF1A;TMF1;GTF2B;TRIP4;KDM4C;RXRA;TAF11;MED4;DCAF1;MED13
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.41025655265066413,1.0748410239497634,0.197,0.9392964935125553,1.0,117/732,13.89%,RUNX1;BATF3;NFE2;IRF5;NPAS4;ASCL1;MEOX1;IRF4;IRF8;IKZF1;GATA1;STAT5A;NFE2L2;POU2F2;NLRC5;NFATC1;HES7;RREB1;BCL11A;NSD1;MLXIPL;ELF4;DHX9;ZEB2;SP7;CREB3L4;CREB3;RXRB;FOXD2;NR1H4;DNMT3A;SREBF2;RFX1;MLXIP;BPTF;MITF;ZFP30;SKI;ATF3;CEBPA;FOXO3;LRRFIP1;DDIT3;SPI1;MYT1L;ZBTB12;PGBD1;ZBTB39;HIVEP3;MAFG;MAFK;BHLHE41;HDAC5;BACH1;TEAD1;TFEB;CCAR1;TP53;KLF6;MEF2A;NKX2-1;NRL;TAL1;USF1;YY1;STAT4;CEBPB;FOXN2;ST18;SNAI1;MEF2C;NKRF;TFAP2B;GMEB2;CIART;SMAD3;ZFP14;GTF2IRD1;IRF2;HSF1;ZNF32;GMEB1;STAT5B;HDAC4;NFE2L1;LITAF;ZNF83;TGIF1;HOXA6;NFIC;KLF13;ZSCAN26;OLIG1;SOX9;HDAC6;JDP2;NR2C2;ZNF740;NRIP1;E2F6;ZNF628;GZF1;HSF5;ATF6B;SNAPC3;CREB1;ZSCAN18;NR4A1;ZNF445;TIPARP;FOXN3;NFKB1;FOXK1;RFX7;SOX6;ZFHX3;IRF1
prerank,cAMP binding (GO:0030552),-0.4047739096735186,-1.0734188589607172,0.3691275167785235,0.8646787926801416,1.0,4/11,16.49%,PDE10A;RAPGEF4;RAPGEF2;PDE2A
prerank,potassium channel activity (GO:0005267),0.4276343759157189,1.07304848099901,0.38739669421487605,0.9405820701746599,1.0,10/89,7.51%,KCNJ11;AQP1;HCN4;KCNN4;KCNK6;PKD2;CCDC51;TMEM38A;KCNMA1;KCNK13
prerank,ion channel inhibitor activity (GO:0008200),0.4602865884761832,1.0725664697063932,0.38063063063063063,0.9379913787557099,1.0,7/35,15.94%,PCSK9;WNK1;ENSA;NEDD4L;STX8;WNK4;RASA1
prerank,calcium channel regulator activity (GO:0005246),-0.2912844466377629,-1.0717651481341273,0.3148148148148148,0.8557379821589157,1.0,10/37,27.17%,SRI;FKBP1A;PRKG1;SLC30A1;CACNG8;REM1;PACSIN3;CALM2;CACNB3;NRXN2
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.515901700673522,1.0691497015528215,0.4169014084507042,0.9445551918458139,1.0,5/14,14.18%,MINDY4;ATXN3;USP7;MINDY1;USP9X
prerank,ATP binding (GO:0005524),0.4140733658699802,1.068200965814765,0.31431431431431434,0.9434496166255496,1.0,57/266,17.64%,MYO1F;BTK;KCNJ11;MAP4K1;ABCA1;ABCC6;TGFBR1;P2RX7;MTHFS;DHX9;PFKL;ERN1;NEK6;ATP7A;ABCG1;PI4K2A;MYH9;P2RX4;TLK1;MYO9B;MKNK1;CDK11B;MAP3K5;PIM1;LONP1;ABCD1;WNK1;KIF14;TRIP13;MCM6;STK17B;EIF2B2;TAP1;CARS2;RPS6KA4;NLK;PRKACB;TWF2;CDK6;ATP5F1A;STK3;UBA2;MYH10;DARS2;NIM1K;WNK4;PTPA;ERCC6;IDE;TAP2;HSP90AA1;STK4;GCK;RPS6KA5;KSR1;SIK2;N4BP2
prerank,hexosyltransferase activity (GO:0016758),0.41776998617506533,1.0679818938198984,0.38657171922685657,0.9400338057566416,1.0,17/101,12.61%,HEXB;PIGM;LFNG;GCNT1;HEXA;GYG1;B4GALT1;CHSY3;PIGV;POGLUT2;GBE1;POGLUT1;FUT9;B3GALNT1;TMTC4;CHSY1;B4GALT7
prerank,ribosome binding (GO:0043022),0.4419125164912752,1.067599342456127,0.3988950276243094,0.9371271424019151,1.0,19/46,25.37%,SLFN14;YTHDF3;TMEM147;CPEB3;NOMO1;SRP19;CPEB4;CCDC47;CPEB2;MTIF3;SERBP1;PYM1;NAA15;EIF3C;EFL1;RACK1;EIF2A;EIF2S1;C1QBP
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3202228361690817,-1.0662883042292048,0.3089887640449438,0.8577561714364771,1.0,7/27,16.36%,SLC26A2;SLC26A7;SLC25A14;SLC39A8;SLC22A6;SLC39A14;SLC25A11
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.42750439367311077,-1.0659494343979052,0.38741721854304634,0.8456461292005357,1.0,9/11,57.27%,CHRNA7;CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,monocarboxylic acid binding (GO:0033293),0.4984340661304172,1.0657590886555244,0.4115384615384615,0.9390756625020493,1.0,2/18,3.77%,PSAP;NR1H4
prerank,nuclear localization sequence binding (GO:0008139),-0.3572020297062317,-1.0631360951559572,0.38493723849372385,0.8409747415287386,1.0,9/18,31.83%,IPO5;NUP153;RANBP6;NFKBIA;CABP1;TNPO2;KPNA2;POM121;KPNA6
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.3690148302500307,-1.0620190193744279,0.3395348837209302,0.8315723996433105,1.0,6/18,8.94%,BMPR1A;LTBP4;ACVR1;TGFBR3;ACVRL1;ACVR1B
prerank,ribosomal small subunit binding (GO:0043024),0.5105493763311729,1.0571184752911487,0.41888297872340424,0.9630615311409584,1.0,7/17,18.92%,PIM1;ERAL1;EIF1;LARP1;EIF4H;CPEB2;MTIF3
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.404933776912937,-1.0559954725619674,0.37373737373737376,0.8363850456901559,1.0,12/12,59.54%,OPN3;GPR88;ELOVL4;GPR52;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,protein serine/threonine kinase activity (GO:0004674),0.4070167122799258,1.05585197576879,0.337,0.9630624139538123,1.0,71/334,16.10%,PTK2B;SYK;MAPKAPK3;IRAK2;MAP4K1;TAOK3;TGFBR1;PRKCD;CAMK1D;MTOR;BMP2K;MAPK14;GRK3;ERN1;NEK6;CDK14;PRKD2;TTN;MYLK3;CDK8;RPS6KC1;MAP3K14;TLK1;TAF1;PRKCB;MKNK1;CDK11B;STK10;TGFBR2;MAP3K5;PIM1;PLK4;WNK1;PIM2;SRPK3;TNIK;PLK2;ATP23;CSNK1G2;CHEK2;PRKCQ;CSNK2A2;CSNK2A1;MAP3K1;CASK;SMG1;PRKCH;CDK7;STK17B;STK32C;FAM20C;PKN1;RPS6KA4;NLK;CSNK1A1;ALPK1;MAP3K12;CDK6;BRAF;STK24;STK3;LRRK2;NIM1K;WNK4;GAK;TESK2;SGK3;GSK3A;RPS6KA2;CDK15;MAP3K11
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.3022367131416841,-1.0557748989619946,0.34459459459459457,0.8251478536558509,1.0,6/29,9.48%,SLC25A12;SLC26A2;SLC26A7;SLC25A13;SLC25A14;SLC1A5
prerank,microtubule minus-end binding (GO:0051011),0.5225786916309239,1.0555486430214842,0.4100135317997294,0.9597819279161252,1.0,4/13,15.94%,MACF1;TUBGCP6;TUBGCP4;CAMSAP2
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.39201360087978127,-1.0553324665819503,0.3916349809885932,0.8147355355152498,1.0,4/13,8.95%,GDI2;GDI1;GPSM2;GPSM1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.390014219853169,-1.0522225248329922,0.3806228373702422,0.8114747041652391,1.0,3/13,6.30%,CDH5;BMP4;BMP5
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.40119590108559283,1.0512624344085035,0.265,0.9692955534962682,1.0,130/831,13.89%,RUNX1;BATF3;NFE2;IRF5;NPAS4;ASCL1;MEOX1;IRF4;IRF8;IKZF1;GATA1;STAT5A;NFE2L2;POU2F2;NLRC5;NFATC1;HES7;RREB1;BCL11A;NSD1;MLXIPL;ELF4;DHX9;ZEB2;SP7;CREB3L4;CREB3;BARX2;RXRB;FOXD2;NR1H4;DNMT3A;SREBF2;RFX1;MLXIP;BPTF;MITF;ZFP30;SKI;NFXL1;ATF3;CEBPA;FOXO3;LRRFIP1;DDIT3;SPI1;MYT1L;ZBTB12;PGBD1;ZBTB39;HIVEP3;MAFG;MAFK;HOXC8;BHLHE41;HDAC5;TAF1;BACH1;TEAD1;TRPS1;TFEB;ZFP69;CCAR1;ZNF177;TP53;KLF6;MEF2A;ACTN4;NKX2-1;NRL;TAL1;USF1;YY1;STAT4;ZFP90;CEBPB;ST18;SNAI1;MEF2C;NKRF;CDC5L;TFAP2B;RB1;GMEB2;CIART;SMAD3;ZFP14;GTF2IRD1;IRF2;HSF1;ZNF32;CREBRF;GMEB1;STAT5B;HDAC4;NFX1;NFE2L1;LITAF;ZNF83;TGIF1;HOXA6;NFIC;KLF13;ZSCAN26;OLIG1;SOX9;HDAC6;JDP2;NR2C2;ETV6;ZNF740;NRIP1;E2F6;ZNF628;GZF1;HSF5;ATF6B;SNAPC3;CREB1;ZSCAN18;NR4A1;MAX;ZNF445;NFKB1;FOXK1;RFX7;SOX6;CUX1;ZFHX3;IRF1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.5174575231099782,1.051041920663363,0.4472573839662447,0.9657909769108656,1.0,4/13,14.04%,EXO1;ENDOV;DNA2;SLX4
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.534948996791651,1.048654320980175,0.4228486646884273,0.9692043638316905,1.0,3/10,6.99%,TNFAIP3;ATXN3;STAMBPL1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.4971891981194148,1.0469605225005925,0.424,0.9704728947929353,1.0,1/15,1.63%,SH3PXD2B
prerank,endopeptidase activator activity (GO:0061133),0.539218350976891,1.04396440114229,0.44622093023255816,0.9756508786519112,1.0,2/10,12.48%,VSIR;PSME3
prerank,GTPase binding (GO:0051020),0.4070231013487399,1.0436990178076921,0.4202607823470411,0.9724555044524651,1.0,67/194,23.63%,FGD2;LCP1;UNC13D;IQGAP2;ABCA1;CYRIB;RIN3;RAB34;MYO5A;PPP6R1;RAB3GAP2;FGD6;USP6NL;MYO9B;MICALL1;DOCK4;ARHGAP1;CHML;EPRS1;ARHGDIB;PKN1;ATP6AP1;CYFIP1;BECN1;BICD2;EXOC8;RANBP9;SORL1;EXOC2;EXOC5;BRAF;FNBP1L;GGA2;LRRK2;TMEM127;RNF152;RASA1;ALS2;RABGEF1;NOX1;HSP90AA1;ARFIP2;ARHGEF2;IQGAP1;LAMTOR1;MYO1C;PICALM;ATG14;RAB29;DNM1L;OPTN;ENO1;KIF3A;FMNL1;LZTR1;AIMP1;RIMS1;RRAGB;FLNA;RAPGEF6;TNFAIP1;CCDC186;MYO5B;GOLGA4;OCRL;MYCBP2;FGD3
prerank,exonuclease activity (GO:0004527),-0.27376578994105566,-1.041939949504752,0.4044943820224719,0.8286079673443242,1.0,20/46,24.02%,REV3L;FAN1;MRE11;ENPP3;ERI1;EXOSC7;APLF;WRN;ISG20L2;EXD2;EXOSC8;APEX2;ZC3H12A;EXOG;EXOSC9;POLG;ENPP2;DCLRE1B;EXD1;EXOSC5
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.41257745285849134,-1.041810886480389,0.4125874125874126,0.8177469245645955,1.0,5/12,5.20%,BMPR1A;LTBP4;ACVR1;TGFBR3;ACVRL1
prerank,heme binding (GO:0020037),0.4244657229389006,1.0416599516527068,0.42171189979123175,0.9747512604685977,1.0,13/65,20.71%,TBXAS1;CYBB;BACH1;CYB5A;CYB561D2;PXDN;SRC;CBS;SDHD;PTGES2;PGRMC1;THAP4;HMOX2
prerank,phosphate ion binding (GO:0042301),-0.41849447339545504,-1.0416239694165854,0.39090909090909093,0.80742441760877,1.0,5/10,20.60%,ADSS2;RELA;RPH3A;PDE2A;MTHFD2
prerank,metallocarboxypeptidase activity (GO:0004181),-0.3048904991223569,-1.0385077819650337,0.37349397590361444,0.8050045513401309,1.0,10/26,26.59%,AGBL4;FOLH1;CPM;CPXM2;CPD;CPXM1;AGBL1;CPA6;ACE2;CPE
prerank,small GTPase binding (GO:0031267),0.40512883147340284,1.0370815910484388,0.4397590361445783,0.9850689915260857,1.0,56/169,23.63%,FGD2;UNC13D;IQGAP2;ABCA1;CYRIB;RIN3;RAB34;MYO5A;PPP6R1;RAB3GAP2;FGD6;USP6NL;MYO9B;MICALL1;DOCK4;ARHGAP1;CHML;ARHGDIB;PKN1;ATP6AP1;CYFIP1;BICD2;EXOC8;RANBP9;SORL1;EXOC2;EXOC5;BRAF;GGA2;LRRK2;TMEM127;RNF152;ALS2;RABGEF1;NOX1;ARFIP2;ARHGEF2;IQGAP1;MYO1C;PICALM;RAB29;DNM1L;OPTN;KIF3A;FMNL1;LZTR1;RIMS1;FLNA;RAPGEF6;TNFAIP1;CCDC186;MYO5B;GOLGA4;OCRL;MYCBP2;FGD3
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.45109832211450607,1.0349937022332898,0.46557759626604434,0.9874187743729403,1.0,6/28,9.92%,TNF;TRAF2;TRAF3;TRAP1;BABAM2;TRAF5
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.4659612035038529,1.0340870690430906,0.4429447852760736,0.9821251001625986,1.0,6/21,15.88%,CDK14;CDK8;CDK11B;CDK7;CDK6;CDK15
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.4659612035038529,1.0340870690430906,0.4429447852760736,0.9821251001625986,1.0,6/21,15.88%,CDK14;CDK8;CDK11B;CDK7;CDK6;CDK15
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3970647975492218,1.0333068689638534,0.4,0.9804260099961292,1.0,91/431,17.99%,MYO1F;TUBB;TUBB1;BTK;KCNJ11;MAP4K1;ABCA1;ABCC6;RAB39A;TGFBR1;P2RX7;RAB32;MTHFS;DHX9;PFKL;RAP2A;ERN1;NEK6;TUBB3;GCH1;ATP7A;ABCG1;TUBA4A;PI4K2A;RAB14;MYH9;RAP1B;RAB7A;P2RX4;TLK1;ARL8A;MYO9B;MKNK1;CDK11B;DNM2;MAP3K5;PIM1;LONP1;ABCD1;WNK1;RAP2B;KIF14;RAB28;TRIP13;RAB31;ARL5B;ARL4A;MCM6;STK17B;RAB1B;EIF2B2;TAP1;CARS2;RPS6KA4;NLK;ATL1;GBP3;PRKACB;TWF2;CDK6;ATP5F1A;RRAS2;STK3;ARF6;UBA2;TSR1;MYH10;LRRK2;RAP1A;DARS2;NIM1K;WNK4;TUBB6;PTPA;ERCC6;IDE;ARL8B;TAP2;RAB27B;HSP90AA1;STK4;GCK;ARFIP2;RPS6KA5;KSR1;SIK2;N4BP2;RHOA;MTG2;CDC42;ABCD2
prerank,mechanosensitive ion channel activity (GO:0008381),0.5099649942998634,1.0324291339516536,0.4649243466299862,0.9788715138976775,1.0,2/12,10.20%,TMC6;TMEM63A
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.3292022572317005,-1.0319134336681755,0.4072164948453608,0.8118280422044554,1.0,7/23,16.99%,PDE10A;PDE7A;PDE1C;PDE8A;PDE9A;PDE2A;PDE8B
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.4301363619741224,1.03159836343615,0.44288793103448276,0.9774292084047363,1.0,16/44,23.08%,SMYD5;NSD1;CXXC1;ASH1L;DOT1L;SETD2;RBBP5;TTLL12;SMYD3;SUV39H1;SETD1B;WDR82;EED;SETD5;NSD3;SETDB1
prerank,double-stranded DNA binding (GO:0003690),0.39462569692593824,1.0309391170997746,0.386,0.9753880607758391,1.0,69/531,13.64%,BATF3;NFE2;IRF5;ASCL1;MEOX1;IRF4;IRF8;GATA1;PCID2;AIM2;POU2F2;NFATC1;HES7;ELF4;DHX9;CREB3L4;CREB3;BARX2;RXRB;FOXD2;SREBF2;RFX1;ATF3;FOXO3;ZBTB12;MAFG;HOXC8;BHLHE41;HMGB1;XRCC5;FLI1;TEAD1;TFEB;ZNF177;KLF6;NRL;USF1;YY1;CREB3L1;CEBPB;FOXN2;SNAI1;MEF2C;TFAP2B;GMEB2;IRF2;HSF1;ZNF32;GMEB1;TGIF1;HOXA6;NFIC;KLF13;APTX;ELF2;SOX9;JDP2;NR2C2;ZNF740;HSF5;ATF6B;MBD1;CREB1;NR4A1;MAX;ZNF445;FOXK1;RFX7;CUX1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.40144007275089183,-1.029397942423836,0.41118421052631576,0.8081373156968932,1.0,4/11,16.41%,DAB2IP;TRAF6;ROR2;PPEF2
prerank,calcium-activated potassium channel activity (GO:0015269),0.521581169638974,1.029158290415176,0.48567335243553006,0.9768062320886638,1.0,2/11,7.14%,KCNN4;KCNMA1
prerank,GTPase activity (GO:0003924),0.39876564910194146,1.029092058887236,0.437875751503006,0.9730806841131526,1.0,51/192,19.75%,GNA15;RAB8B;RAB32;GNAQ;GNGT2;GFM1;RAP2A;GCH1;GNAZ;RAB14;RAP1B;RAB7A;ARL8A;DNM2;GNA13;GTPBP1;GNA12;GSPT1;TBCC;RAP2B;RAB28;GPN1;RAB31;RAB11A;ARHGDIB;RAB1B;ATL1;GBP3;ABCA4;SAR1A;RRAS2;MMUT;RAB33B;GNAI3;TSR1;LRRK2;RAP1A;GNB5;IRGM;ARL8B;RAB27B;RHOA;MTG2;CDC42;GNAI2;ATL2;RAB29;DNM1L;RHOD;ATL3;MFN1
prerank,protein phosphatase regulator activity (GO:0019888),0.4279911041696883,1.0284503606199609,0.47071352502662406,0.9712245120384196,1.0,15/53,22.18%,LGALS3;MGAT5;PPP6R1;SAG;ENSA;BOD1L1;RCAN1;PPP4R4;PTPA;PPP2R5C;PPP4R2;ANKLE2;PPP2R3A;PPP4R1;RCAN3
prerank,estrogen receptor binding (GO:0030331),0.4419881822825181,1.0275820042332229,0.47719298245614034,0.9698674532448028,1.0,10/32,22.44%,NSD1;TACC1;CTNNB1;MMS19;STRN;NRIP1;TRIP4;DCAF1;PADI2;CNOT1
prerank,LRR domain binding (GO:0030275),0.49463538951385544,1.027050736265056,0.435506241331484,0.9676085485619178,1.0,5/14,18.10%,DDIT3;MRTFA;NRL;PMF1;LRRFIP2
prerank,protein homodimerization activity (GO:0042803),0.3944549571912374,1.0257979902206609,0.396,0.9675020453180427,1.0,125/589,17.18%,LILRB1;SLC11A1;PLEK;IRAK2;LPL;TPD52;CORO1A;PEX11A;CSF1R;RPE;DUSP29;RABEP1;MLXIPL;S100B;HPGDS;MASP1;SNX9;CST7;PSAP;ERN1;TRIM5;ATG7;GCH1;PKD2;ABCG1;APOE;CRYM;IL6R;ATF3;PIP4K2A;CEBPA;ATIC;PYCARD;LRRFIP1;DDIT3;GYG1;COQ9;MUC13;NDP;MYH9;XDH;BHLHE41;TBC1D22A;SYNE1;FZD9;MYO9B;CDA;BCL2L1;TYROBP;STK10;ACTN4;USF1;MAP3K5;TMEM192;KLHL7;ABCD1;PON3;DPY30;CEBPB;KYNU;CHEK2;DGKD;TFAP2B;KIF20B;TRIM27;ATP5IF1;SMAD3;PAFAH1B2;BAK1;PDCD6;SPPL3;TPM4;EPRS1;VAPB;F11R;TPR;ACTN1;NAALADL1;TRIM8;TAP1;SLC8B1;ZDHHC3;PAPSS1;MID2;PTPRO;RNF40;GBP3;PEX7;TPST1;DEFA6;MAP3K12;IKBKG;B2M;MMUT;ADCY8;STUB1;SOX6;CUBN;PTPRT;MIGA1;CADM1;LRRK2;SNX2;DARS2;PRKRA;SPPL2A;ERCC5;PTPA;PSMD7;PDCD6IP;TOP2A;IDE;MAP3K11;ALS2;ZBTB7B;DCK;TARS2;APPL2;HSP90AA1;STK4;CBS;TARBP2;GALM;CPOX;PECAM1
prerank,sequence-specific DNA binding (GO:0043565),0.39090689179626426,1.0226130792796533,0.395,0.9730144106168742,1.0,81/590,13.64%,BATF3;NFE2;IRF5;MMP12;ASCL1;MEOX1;IRF4;IRF8;GATA1;NFE2L2;POU2F2;NFATC1;HES7;ELF4;ZEB2;CREB3L4;CREB3;BARX2;RXRB;FOXD2;NR1H4;SREBF2;TET3;RFX1;BPTF;ATF3;FOXO3;CXXC1;ZBTB12;MAFG;MAFK;HOXC8;BHLHE41;XRCC5;TAF1;FLI1;TEAD1;TFEB;ZNF177;KLF6;MEF2A;NRL;USF1;LONP1;YY1;CREB3L1;CEBPB;FOXN2;SNAI1;MEF2C;TFAP2B;GMEB2;SMAD3;IRF2;HSF1;PPARGC1A;ZNF32;SMG1;GMEB1;HDAC4;TGIF1;HOXA6;NFIC;KLF13;ELF2;SOX9;JDP2;NR2C2;STN1;ZNF740;GZF1;HSF5;ATF6B;MBD1;CREB1;NR4A1;MAX;FOXK1;SAFB2;RFX7;CUX1
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.4505075845134126,1.0226074749666691,0.44733727810650886,0.9692320542107419,1.0,6/27,14.66%,SLC9A4;SLC8A1;SLC9A9;SLC9A1;SLC8B1;SLC9A8
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.4270889484898457,1.0218446156710779,0.48366013071895425,0.9677324215400234,1.0,5/46,4.73%,HEXB;MGAT5;LFNG;GCNT1;HEXA
prerank,adenyl nucleotide binding (GO:0030554),0.5138845476782872,1.0206949748624943,0.4684813753581662,0.9636426453266597,1.0,3/11,14.38%,BAG2;PFN1;BAG1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.5138845476782872,1.0206949748624943,0.4684813753581662,0.9636426453266597,1.0,3/11,14.38%,BAG2;PFN1;BAG1
prerank,ubiquitin binding (GO:0043130),0.4048731743060916,1.0180416722571644,0.49117341640706125,0.9675098398572066,1.0,21/73,20.78%,OTULINL;NUP62;RNF19B;CXCR4;TNFAIP3;DDI2;SMAD3;IKBKG;MVB12B;TOP2A;USP16;FAF1;VPS28;UBE2N;BIRC2;UBXN2A;PLAA;HSPB1;RAD23B;NSFL1C;PRKN
prerank,BMP receptor binding (GO:0070700),-0.39001816026111846,-1.0158821670618041,0.42857142857142855,0.8334795206330415,1.0,3/12,6.30%,CDH5;BMP4;BMP5
prerank,potassium ion antiporter activity (GO:0022821),0.4918841674676871,1.0145001104238605,0.46596858638743455,0.974135347247688,1.0,3/15,7.37%,SLC9A4;SLC9A9;SLC9A1
prerank,phosphatidylcholine transporter activity (GO:0008525),0.4794390169830759,1.0134436342128297,0.479328165374677,0.973588241210895,1.0,3/17,6.00%,ABCA1;ABCG1;ABCB4
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.4736038504970648,1.0133342734902926,0.47066326530612246,0.9702281803785056,1.0,2/16,5.45%,NEIL2;OARD1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.41187086669352496,-1.0102041469894547,0.4513888888888889,0.8370465457990751,1.0,3/11,4.60%,RYR2;RYR3;ITPR3
prerank,outward rectifier potassium channel activity (GO:0015271),0.5173519902473469,1.00875894783994,0.47478991596638653,0.9793344028218406,1.0,4/11,14.28%,PKD2;KCNIP2;KCNT1;KCNA5
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.3914838616403654,-1.0085947261680372,0.4541984732824427,0.8305384462271452,1.0,6/12,16.80%,PHF2;JMJD1C;KDM3A;KDM4B;KDM4A;KDM4D
prerank,ubiquitin protein ligase activity (GO:0061630),0.3930951521852358,1.0082449853271687,0.49247743229689067,0.9770170895053282,1.0,55/228,18.32%,CBL;RNF180;MYLIP;TRIM25;RFFL;RNF149;ZNRF2;RNF19B;TRIM5;MKRN1;UBE2D3;FBXL22;MSL2;VPS18;MGRN1;RNF7;HLTF;PPP1R11;RNF111;HECTD1;RNF150;RC3H2;VPS11;TRIM27;RNF114;RC3H1;RING1;UBE4B;NFX1;NEDD4L;RNF10;TRIM56;TRIM24;TRIM35;RNF216;RNF135;ITCH;STUB1;RNF144B;HUWE1;AREL1;NEURL1B;NEURL3;DTX4;ZNRF1;RNF152;SMURF1;FANCL;TRIM62;ZNRF3;ANAPC11;UBE2K;CDC42;BIRC2;FBXO44
prerank,death receptor activity (GO:0005035),0.5157575003365678,1.0076782703664169,0.4676258992805755,0.9750088958325879,1.0,3/11,19.33%,TNFRSF11A;TNFRSF1B;EDA2R
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.5080054339702577,1.004145487575281,0.49722991689750695,0.9815212201294768,1.0,4/12,13.42%,PYCARD;CASP1;APAF1;ATP2A3
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.4961120442372017,1.003113036942096,0.5107238605898123,0.98090937336704,1.0,4/14,13.42%,PYCARD;CASP1;APAF1;ATP2A3
prerank,GTPase inhibitor activity (GO:0005095),0.5009315722184444,1.0027454278013461,0.48137931034482756,0.9782126218487104,1.0,4/13,17.31%,IQGAP2;GPS2;CPEB2;IQGAP1
prerank,nucleoside-triphosphatase activity (GO:0017111),0.3891000255268039,1.0025673860032982,0.494,0.9750662337737063,1.0,67/248,20.03%,GNA15;RAB8B;MYO1E;RAB32;GNAQ;DHX9;GNGT2;GFM1;RAP2A;GCH1;GNAZ;RAB14;MYH9;RAP1B;RAB7A;ARL8A;DNM2;GNA13;GTPBP1;GNA12;GSPT1;TBCC;ABCD1;RAP2B;KIF14;RAB28;GPN1;KIF20B;MYO19;ATP2B1;RAB31;TOR3A;RAB11A;ARHGDIB;RAB1B;ATL1;GBP3;ABCA4;SAR1A;RRAS2;MMUT;DNA2;TOR1A;RAB33B;GNAI3;TSR1;KIF2A;LRRK2;RAP1A;ABCA3;GNB5;IRGM;ARL8B;RAB27B;HSP90AA1;RHOA;MTG2;CDC42;ABCD2;GNAI2;ATL2;RAB29;DNM1L;RHOD;ATL3;MFN1;MYL6
prerank,nucleotide diphosphatase activity (GO:0004551),0.4886572890426841,1.0023783657316097,0.46963562753036436,0.9719395746360475,1.0,2/14,6.79%,NUDT17;NUDT4
prerank,death receptor binding (GO:0005123),-0.35759036623944873,-0.9996824997832506,0.421455938697318,0.8446025736031384,1.0,4/15,9.81%,EDA;DAB2IP;NGF;TMBIM1
prerank,growth factor receptor binding (GO:0070851),0.3898883550437481,0.9972768424558873,0.5111788617886179,0.9826015249406215,1.0,14/95,15.27%,ITGB3;PTPRJ;GRB2;ERN1;IL6R;PYCARD;CD300LF;VEGFB;TIMM50;SDCBP;FYN;ERAP1;SNX2;SRC
prerank,palmitoyltransferase activity (GO:0016409),0.4386586583791237,0.9952730156843326,0.48651960784313725,0.9847039191454291,1.0,8/28,14.36%,ZDHHC14;ZDHHC7;ZDHHC13;ZDHHC16;ZDHHC3;YKT6;ZDHHC1;ZDHHC24
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.38712198871323106,0.9921522226076884,0.5425425425425425,0.9897988868476549,1.0,63/232,21.34%,CBL;RNF180;MYLIP;TRIM25;RFFL;RNF149;ZNRF2;RNF19B;TRIM5;MKRN1;UBE2D3;FBXL22;MSL2;VPS18;MGRN1;RNF7;HLTF;PPP1R11;RNF111;HECTD1;RNF150;RC3H2;VPS11;TRIM27;RNF114;RC3H1;RING1;NFX1;NEDD4L;RNF10;TRIM56;TRIM24;TRIM35;RNF216;RNF135;ITCH;STUB1;RNF144B;HUWE1;AREL1;NEURL1B;NEURL3;DTX4;ZNRF1;RNF152;PIAS1;SMURF1;FANCL;TRIM62;ZNRF3;ANAPC11;CDC42;BIRC2;FBXO44;NEURL4;WWP1;KCMF1;CUL3;PRKN;BIRC3;HERC2;RNF125;NSMCE2
prerank,single-stranded RNA binding (GO:0003727),0.4176099065710235,0.9913941618297384,0.49504950495049505,0.9883088600639125,1.0,19/43,25.80%,DHX9;TLR8;TLR7;LONP1;ENDOV;AGO4;EIF4H;SRA1;AGO3;AGO2;CNBP;HNRNPF;PTBP1;DDX60;ILF3;ZFR;DDX11;AGO1;JMJD6
prerank,transforming growth factor beta binding (GO:0050431),0.44402135291838807,0.9903872644508052,0.47911547911547914,0.987587303556125,1.0,7/23,18.76%,NRROS;TGFBR1;TGFBR2;THBS1;VASN;CD36;LTBP3
prerank,nucleotidase activity (GO:0008252),0.47724541152673916,0.9889838651218784,0.4821192052980132,0.9877864469028257,1.0,3/15,10.21%,NT5C3B;BPNT1;NT5DC3
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.48449618302691,0.9827670642390087,0.481994459833795,1.0,1.0,6/13,20.55%,PRKAR2B;SOX9;GSK3A;CSK;GSK3B;PRKAR1A
prerank,RNA polymerase II complex binding (GO:0000993),0.41846465770065616,0.9826722827136548,0.5068337129840547,0.997873415609588,1.0,11/32,17.90%,DHX9;ZNF326;UVSSA;SCAF1;PCIF1;RTRAF;ELOF1;ERCC5;GTF2B;PCF11;AGO2
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.37621122324655715,-0.9809012108929915,0.4962121212121212,0.8835484860820465,1.0,5/12,22.66%,IRS1;GNAS;SHC1;SOCS2;IGF2
prerank,beta-tubulin binding (GO:0048487),0.41974246605054966,0.9782623074705814,0.5278093076049943,1.0,1.0,11/31,21.23%,UXT;FGF13;ARL8A;GJB6;VAPB;CCT5;ARL8B;EML4;TAOK1;CDK5R1;TTLL7
prerank,adenyl ribonucleotide binding (GO:0032559),0.3785171854481559,0.9760890732479951,0.586,1.0,1.0,58/291,17.64%,MYO1F;BTK;KCNJ11;MAP4K1;ABCA1;ABCC6;TGFBR1;P2RX7;MTHFS;DHX9;PFKL;ERN1;NEK6;ATP7A;ABCG1;PI4K2A;MYH9;P2RX4;TLK1;MYO9B;MKNK1;CDK11B;MAP3K5;PIM1;LONP1;ABCD1;WNK1;KIF14;TRIP13;MCM6;STK17B;EIF2B2;TAP1;CARS2;RPS6KA4;PDE4A;NLK;PRKACB;TWF2;CDK6;ATP5F1A;STK3;UBA2;MYH10;DARS2;NIM1K;WNK4;PTPA;ERCC6;IDE;TAP2;HSP90AA1;STK4;GCK;RPS6KA5;KSR1;SIK2;N4BP2
prerank,hexose transmembrane transporter activity (GO:0015149),0.4761177037368771,0.9737570468885491,0.521497919556172,1.0,1.0,1/12,4.15%,SLC2A3
prerank,poly-pyrimidine tract binding (GO:0008187),-0.30508087482632873,-0.9736701101424539,0.4919786096256685,0.8924241346718542,1.0,6/23,12.34%,DAZAP1;SSB;U2AF2;FMR1;RBMS3;HNRNPU
prerank,gamma-tubulin binding (GO:0043015),-0.3190045634415715,-0.9719139907688915,0.4748858447488584,0.8859954053563872,1.0,8/21,14.98%,DIXDC1;PAK1;TUBGCP2;CDK5RAP2;BRCA2;NDRG1;MARK4;BLOC1S2
prerank,phosphatidylglycerol binding (GO:1901611),0.4724236956435089,0.9693890292328152,0.5,1.0,1.0,1/13,1.51%,PLEKHN1
prerank,single-stranded DNA binding (GO:0003697),0.3808022907410782,0.96883981977328,0.5685071574642127,1.0,1.0,23/93,20.39%,MCM5;FAM111A;DHX9;NABP1;HMGB1;SAMHD1;LONP1;MCM6;MCM2;APTX;STN1;MCM9;PCBP1;ERCC5;TWNK;REXO4;RAD51B;ERCC1;TOP1;FUBP3;RAD51D;CDC45;RAD23B
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.45536779839322794,0.967726100798311,0.5196335078534031,1.0,1.0,1/17,1.52%,BLVRB
prerank,sodium channel activity (GO:0005272),0.41520799415691517,0.9667333967660129,0.5565819861431871,1.0,1.0,3/37,4.10%,SCN4B;HCN4;PKD2
prerank,metal ion binding (GO:0046872),0.37096469642989344,0.9660067178248448,0.634,1.0,1.0,73/477,15.36%,MMP12;SHH;SYT17;LCP1;PCDHB6;SMOC2;LPL;TPD52;CABP4;ADAM8;RPE;S100B;SDF4;SLC8A1;IDS;HPGDS;MASP1;RAP2A;ERN1;NEK6;MAN1C1;SNCA;PKD2;APOE;TTN;KCNIP2;MCTP1;PI4K2A;RASGRP2;PGS1;ASPH;RP2;S100A2;ANXA1;AIF1;MAP3K5;AGRN;SYT2;CERK;CETN3;RASGRP3;ENDOV;TPT1;TRIM27;ITSN1;ITPR2;PPA2;PDCD6;SYT10;TPM4;CDH8;ANXA4;ACER3;NAALADL1;DYSF;CDH9;THBS1;NLK;PRKACB;CDH12;ARSA;CAMKK2;BRAF;CDH23;NDUFAB1;STK3;UBA2;LRRK2;NIM1K;CAPN3;LRP1;EFHD2;CCDC47
prerank,rRNA binding (GO:0019843),0.4099125897036445,0.9653414786641605,0.56,1.0,1.0,9/42,16.38%,RPL23;EMG1;CIRBP;GTF3A;ERAL1;RPS14;RRS1;RCC1L;RPL11
prerank,symporter activity (GO:0015293),-0.39708763935276375,-0.9636106056705546,0.5149501661129569,0.8979501407179904,1.0,9/10,57.30%,SLC5A6;MFSD2A;SLC4A4;SLC46A2;SLC28A2;SLC28A3;SLC5A8;SLC28A1;SLC5A12
prerank,MHC class II protein complex binding (GO:0023026),0.4926724239846314,0.9627744856904078,0.5495750708215298,1.0,1.0,1/11,1.33%,CD74
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.3877969746226194,0.9618034608530358,0.5559071729957806,1.0,1.0,15/60,17.79%,PPM1H;PPP2CB;MTMR3;RPAP2;TIMM50;PPP2CA;ILKAP;LRRC39;LRRK2;PPP1CC;PHLPP1;PTEN;PPP3CB;PPM1M;PPP4C
prerank,chloride channel regulator activity (GO:0017081),0.47062398205275124,0.9593071424275558,0.5138705416116248,1.0,1.0,7/14,23.15%,WNK1;STX8;WNK4;SGK3;VAMP8;SGK1;STX7
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.4354004139106459,0.9590456820884836,0.5485854858548586,1.0,1.0,9/22,19.53%,TNFAIP3;PRPF8;WDR81;TAB2;IKBKG;RNF169;TAB3;PARP10;OPTN
prerank,hyaluronic acid binding (GO:0005540),0.49493883397030414,0.9583661118793326,0.5228276877761414,1.0,1.0,2/10,5.80%,CD44;STAB2
prerank,phospholipase A2 activity (GO:0004623),0.42176645925856754,0.9572185749438228,0.5465393794749404,1.0,1.0,8/26,23.52%,PLA2G7;PRDX6;ABHD3;PLAAT3;PNPLA3;PLA2G5;PLA2G6;PLA2G4E
prerank,endodeoxyribonuclease activity (GO:0004520),0.4440176657547914,0.9566856673190532,0.5499351491569391,1.0,1.0,9/20,25.95%,EXO1;ENDOV;DNA2;ERCC5;ERCC1;DCLRE1C;ERCC4;ZRANB3;MBD4
prerank,neuropeptide receptor activity (GO:0008188),0.42125710423397555,0.9556910450200117,0.5380249716231555,1.0,1.0,4/29,11.59%,GALR1;SORCS3;GPR37;TACR1
prerank,myosin binding (GO:0017022),0.3844681383505142,0.9521914879430947,0.5589189189189189,1.0,1.0,9/55,9.82%,CORO1A;NCKIPSD;CXCR4;PYCARD;RAB14;ARFGEF1;SPATA6;RAB39B;RAB11A
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.38455987075475867,0.9517940659290209,0.5737009544008483,1.0,1.0,12/53,16.73%,SLC7A7;SLC7A8;SLC38A6;SLC36A1;SLC43A2;SLC25A38;SLC36A4;SLC66A1;SLC25A18;CTNS;SLC1A4;SLC43A1
prerank,transferrin receptor binding (GO:1990459),-0.38127910246114494,-0.9516511724515901,0.49666666666666665,0.9196149853516202,1.0,4/10,13.29%,SNX4;RGMA;CHUK;CD81
prerank,RNA polymerase binding (GO:0070063),-0.3134372083865735,-0.9510825260641754,0.502127659574468,0.9107770601700458,1.0,5/18,7.97%,SCAF8;PPIB;ANP32B;PHRF1;CCNT1
prerank,RNA methyltransferase activity (GO:0008173),0.43278100693456245,0.9508069330325108,0.5314861460957179,1.0,1.0,4/19,14.11%,FBL;METTL4;METTL3;BCDIN3D
prerank,retinoid binding (GO:0005501),-0.2983984687429406,-0.9505648609993388,0.5051546391752577,0.9019419696987194,1.0,2/22,9.87%,NR2F2;ALDH1A2
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.49120451438154783,0.9497210606978662,0.5647226173541963,1.0,1.0,1/11,2.81%,AKR1A1
prerank,GABA-A receptor activity (GO:0004890),-0.3271098173221497,-0.9482282110677901,0.5441176470588235,0.8981016079993147,1.0,4/18,10.55%,GABRB2;GABRB1;GABRA2;GABRB3
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3943120500395286,0.9465463142609365,0.5744908896034298,1.0,1.0,7/49,10.73%,SYT17;MCTP1;ANXA1;SYT2;SYT10;ANXA4;DYSF
prerank,chloride channel inhibitor activity (GO:0019869),0.4934174092496372,0.9460742097668245,0.5728571428571428,1.0,1.0,5/10,23.15%,WNK1;STX8;WNK4;VAMP8;STX7
prerank,GTP binding (GO:0005525),0.36416494401188926,0.9460195788003274,0.6306306306306306,1.0,1.0,38/172,19.75%,TUBB;TUBB1;RAB39A;RAB32;RAP2A;TUBB3;GCH1;TUBA4A;RAB14;RAP1B;RAB7A;ARL8A;DNM2;RAP2B;RAB28;RAB31;ARL5B;ARL4A;RAB1B;EIF2B2;ATL1;GBP3;RRAS2;ARF6;TSR1;LRRK2;RAP1A;TUBB6;ARL8B;RAB27B;ARFIP2;RHOA;MTG2;CDC42;ATL2;RAB29;RHOD;ATL3
prerank,aminopeptidase activity (GO:0004177),-0.28154492313604806,-0.9448984567978832,0.4880952380952381,0.8974638381916131,1.0,9/26,20.31%,LTA4H;MMP14;MMP16;RNPEPL1;NPEPPS;BLMH;KDM8;ENPEP;MMP15
prerank,zinc ion binding (GO:0008270),0.3637890024315667,0.9425648020190196,0.678,1.0,1.0,86/293,22.72%,MMP12;SHH;ADAM8;PTPN1;NSD1;S100B;SNCA;TET3;GCH1;SKI;RBSN;TIMP1;SORD;P2RX4;SAMHD1;CDA;TP53;KDM7A;CRIP2;SMAD3;RC3H1;WDFY1;EPRS1;ACER3;HDAC4;LITAF;HPF1;NAALADL1;TRIM8;POLR2L;TRIM24;LIMS1;RASSF1;SEC24D;ZCCHC4;MBD1;TAB2;ERAP1;CHORDC1;ATAD3A;CSRP1;TAB3;USP16;IDE;GTF2B;PITRM1;ARHGEF2;RPS27;KDM4C;BIRC2;RXRA;SLU7;TNFSF10;MSRB2;KLF7;CHD4;RNPEP;TET2;KDM5A;SMPD1;KDM5B;ATP13A2;ZMYND11;TES;PRKN;SIRT5;RNF125;CDADC1;TARS1;KDM2B;CXXC5;MT3;ZFP37;MT1G;MT1B;MT1E;MT1F;MT1A;MT1X;MT1M;MT1H;MDM4;ADAMTS3;LNPEP;GRIN2A;NUDT12
prerank,RNA polymerase core enzyme binding (GO:0043175),0.397530943951914,0.942491623269566,0.5587229190421893,1.0,1.0,10/33,17.90%,DHX9;ZNF326;UVSSA;RTRAF;ELOF1;ERCC5;SPTY2D1;GTF2B;PCF11;AGO2
prerank,regulatory RNA binding (GO:0061980),0.4010648821708782,0.9417203199527026,0.5739514348785872,1.0,1.0,12/38,21.10%,DHX9;TLR7;RC3H1;PUM2;AGO4;AGO3;SOX2;TUT7;TARBP2;AGO2;ZC3H7A;DICER1
prerank,adenylyltransferase activity (GO:0070566),-0.30917197597932444,-0.9414767076745696,0.5459459459459459,0.896785822506591,1.0,8/21,17.43%,ABL1;PAPOLA;SELENOO;PAPOLG;NMNAT1;GPHN;TUT1;KARS1
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.36022131231391086,-0.9411668486358737,0.545774647887324,0.8880128040424803,1.0,4/12,10.55%,GABRB2;GABRB1;GABRA2;GABRB3
prerank,muscle alpha-actinin binding (GO:0051371),0.4498057658084188,0.9407731564182787,0.5562913907284768,1.0,1.0,3/15,7.20%,PKD2;TTN;LDB3
prerank,voltage-gated cation channel activity (GO:0022843),0.37106476562200486,0.9403831298102614,0.6122448979591837,1.0,1.0,12/97,14.36%,PTK2B;KCNJ11;HCN4;PKD2;KCNMA1;CACNA1A;CACNB4;CACNB2;CACNB1;CACNA1B;KCNA5;KCNA6
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.4020381338591214,0.9389677710819613,0.572737686139748,1.0,1.0,11/31,17.82%,UBE2D3;TAF1;UBE2S;UBE2E3;UBE2H;CDC34;UBE2G2;UBE2J2;UBE2N;UBE2Z;UBE2K
prerank,protease binding (GO:0002020),0.37174635445701754,0.9387494350986801,0.620162932790224,1.0,1.0,26/99,20.78%,ITGB3;RFFL;PSAP;TNF;TTN;PYCARD;TNFAIP3;TIMP1;CFLAR;TP53;CRADD;DERL1;CLTC;CCBE1;TWNK;A2M;PTEN;FURIN;TRIP4;BIN1;FLOT1;ITGB1;RIOK3;DPP4;GSK3B;PRKN
prerank,enoyl-CoA hydratase activity (GO:0004300),0.48359306492885584,0.9387383048277873,0.5642540620384048,1.0,1.0,3/10,11.36%,EHHADH;ECHS1;ECI1
prerank,anion channel activity (GO:0005253),0.3763578601614106,0.9377844632925021,0.5775681341719078,0.9995507832233015,1.0,13/61,15.59%,LRRC8D;CLCC1;VDAC3;CLIC1;GABRA5;CLCN7;GLRA2;GABRA4;VDAC2;VDAC1;SLC1A4;LRRC8C;CLCN4
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.4901000079750864,0.9371965632266057,0.5444287729196051,0.9977449387573862,1.0,2/10,4.82%,RPE;RENBP
prerank,ferrous iron binding (GO:0008198),0.42765524016530354,0.9367602692046967,0.5518072289156627,0.9956823963660436,1.0,6/21,19.68%,SNCA;HAAO;FTL;FTH1;TET2;FTO
prerank,organic cation transmembrane transporter activity (GO:0015101),0.44876827492524685,0.9367482886789326,0.55,0.9925455312126121,1.0,2/16,8.66%,SLC7A8;SLC44A2
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.42665222158969196,0.9332679155308362,0.5538847117794486,0.997249923262611,1.0,3/20,9.18%,CARD11;MPP1;CASK
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.4165962231785473,0.9314874155889531,0.5763975155279503,0.9980382092540264,1.0,8/24,21.36%,ZDHHC14;ZDHHC7;ZDHHC3;YKT6;ZDHHC1;ZDHHC24;ZDHHC21;ZDHHC2
prerank,GDP binding (GO:0019003),0.3754696128717842,0.9313787547059118,0.6104033970276008,0.9951556241152649,1.0,14/63,16.64%,RAB8B;RAP2A;RAB14;RAP1B;RAB7A;RAP2B;RAB28;RAB31;RRAS2;ARF6;GNAI3;RAP1A;ARL8B;RAB27B
prerank,MAP-kinase scaffold activity (GO:0005078),-0.3582177463558871,-0.9312430249097079,0.5183946488294314,0.9032977835057182,1.0,4/11,9.06%,SH3RF1;AKAP13;SPAG9;MAPK8IP3
prerank,guanyl ribonucleotide binding (GO:0032561),0.3586359848560083,0.9299594990074455,0.6770310932798396,0.9953226203260901,1.0,38/196,17.93%,TUBB;TUBB1;RAB8B;RAB39A;RAB32;RAP2A;TUBB3;GCH1;TUBA4A;RAB14;RAP1B;RAB7A;ARL8A;DNM2;CNGB1;RAP2B;RAB28;RAB31;ARL5B;ARL4A;RAB1B;EIF2B2;PDE11A;ATL1;GBP3;RRAS2;ARF6;GNAI3;TSR1;LRRK2;RAP1A;TUBB6;ARL8B;RAB27B;ARFIP2;RHOA;MTG2;CDC42
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.3527862500047576,-0.9296824197621157,0.5310077519379846,0.8978374161572997,1.0,7/13,17.11%,ALDH2;ALDH1A1;ALDH3A2;ALDH1A2;ADH5;ALDH1L1;ALDH1L2
prerank,DNA polymerase binding (GO:0070182),0.4292529769405047,0.9285774531002425,0.5568475452196382,0.9953407237278802,1.0,3/18,6.95%,PTGES3;HMGB1;LONP1
prerank,cell adhesion mediator activity (GO:0098631),0.4138455357384098,0.9277309683554442,0.5682087781731909,0.9941088599095246,1.0,8/24,20.03%,SIRPA;EMB;NINJ1;NPTN;CD47;VSTM2L;PALLD;CNTN4
prerank,methylated histone binding (GO:0035064),0.3755376190096201,0.925491852300231,0.6302521008403361,0.9960407202607524,1.0,18/62,20.17%,BPTF;NCAPG2;CXXC1;MORC3;TAF1;KDM7A;ATRX;CHD1;TRIM24;RBBP5;TTLL12;MTF2;CDYL;MORC4;LRWD1;PHF1;KDM5A;ZMYND11
prerank,transition metal ion binding (GO:0046914),0.3567188225976698,0.9250952468543495,0.755,0.9938710122982453,1.0,120/397,24.04%,MMP12;SHH;IL1A;ADAM8;MGAT5;PTPN1;NSD1;S100B;SNCA;TET3;GCH1;ATP7A;SKI;RBSN;ATOX1;GYG1;RNF7;TIMP1;SORD;P2RX4;SAMHD1;B4GALT1;CDA;TP53;PIM1;KDM7A;CRIP2;SMAD3;RC3H1;FTL;WDFY1;EPRS1;ACER3;HDAC4;LITAF;HPF1;NAALADL1;ADPRM;TRIM8;FAM20C;POLR2L;TRIM24;LIMS1;RASSF1;SEC24D;ZCCHC4;MBD1;TAB2;B4GALT7;AGMO;LACC1;ERAP1;GALNT2;CHORDC1;ATAD3A;FTH1;CSRP1;TAB3;LARGE1;MGAT5B;USP16;IDE;GTF2B;PITRM1;ARHGEF2;PPM1M;RPS27;GALNT1;KDM4C;FDX1;BIRC2;LOXL3;RXRA;SLU7;TNFSF10;MSRB2;KLF7;CHD4;RNPEP;TET2;KDM5A;MGAT1;SMPD1;KDM5B;ATP13A2;ZMYND11;TES;PRKN;SIRT5;NEK4;RNF125;CDADC1;TARS1;KDM2B;CXXC5;XXYLT1;MT3;ZFP37;MT1G;MT1B;MT1E;MT1F;MT1A;MT1X;MT1M;MT1H;MDM4;ADAMTS3;LNPEP;GRIN2A;NUDT12;HMGCL;SCD;EEA1;MYCBP2;TIMM8B;POMGNT1;UBA5;GALNT3;RNF2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.3632144090873242,-0.9245039208367909,0.5494880546075085,0.9014359383029291,1.0,6/12,29.47%,PDE7A;PDE8A;PDE2A;PDE8B;PDE4D;PDE4C
prerank,histone methyltransferase binding (GO:1990226),0.4591426277888716,0.9227832975933783,0.5771428571428572,0.9960340811669071,1.0,6/11,25.15%,PRDM12;CTNNB1;PHF1;LCORL;WIZ;HSP90AB1
prerank,titin binding (GO:0031432),-0.3494108364004231,-0.9224426383160409,0.5609756097560976,0.8974417023818353,1.0,7/13,36.78%,ACTN2;CALM3;TRIM63;MYBPC1;CALM2;CAMK2D;ANKRD23
prerank,mRNA methyltransferase activity (GO:0008174),-0.3586864132412382,-0.9218740218595692,0.5756457564575646,0.889871557564444,1.0,5/12,14.68%,METTL14;NSUN2;METTL16;RNMT;CMTR1
prerank,transcription coregulator binding (GO:0001221),0.3769332213518355,0.9217694663206608,0.6186348862405201,0.9952636147447395,1.0,19/50,24.34%,RPL23;NEK6;CTNNB1;LMO2;FAM89B;SMAD3;HDAC6;MTF2;PPARD;PHF1;CTBP2;PER1;EED;CTBP1;WIZ;UBE2I;TEAD2;CHD6;CNOT2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.4568164699974894,0.9206115281510773,0.5687679083094556,0.9948113514477833,1.0,11/11,54.35%,DDAH1;PADI2;ALLC;PADI6;PADI3;AGMAT;PADI4;PADI1;ARG1;DDAH2;ARG2
prerank,I-SMAD binding (GO:0070411),0.4551300519542427,0.9198271735824384,0.5586592178770949,0.9934677064401579,1.0,3/13,8.71%,TGFBR1;CTNNB1;SMAD3
prerank,Wnt-activated receptor activity (GO:0042813),0.44276639157487646,0.9196840798833998,0.5856573705179283,0.9907619458183651,1.0,4/15,9.91%,FZD10;FZD9;FZD3;LRP5
prerank,solute:proton symporter activity (GO:0015295),-0.32044937821323677,-0.9164309371172257,0.5491071428571429,0.8948871746758438,1.0,2/16,1.66%,SLC2A13;SLC33A1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.37553170799148117,0.9138383942835243,0.6209503239740821,1.0,1.0,12/55,17.42%,SLC7A8;SLC38A6;SLC36A1;SLC38A4;SLC16A2;SLC36A4;SLC16A1;ABCC1;SLC38A10;SLC16A6;SLC13A3;SLC16A13
prerank,PDZ domain binding (GO:0030165),0.371014131705342,0.9116373561117523,0.6213080168776371,1.0,1.0,23/61,24.41%,GNG12;FZD3;DOCK4;TBC1D10A;KIF14;ATP2B1;F11R;MAP2K2;SNTG2;ATP2B3;CADM1;PLEKHA1;GRIA1;FZD8;PTEN;KIDINS220;PLEKHA2;FZD2;PRKN;GNG5;NSF;ATP2B4;ATP2B2
prerank,clathrin adaptor activity (GO:0035615),0.4429960804999054,0.9116060919616017,0.6141732283464567,0.9987829987792441,1.0,5/15,15.42%,LDLRAP1;AP2S1;STON2;STON1;AP2M1
prerank,antiporter activity (GO:0015297),0.4179051644489267,0.9115402122973841,0.5922208281053952,0.9959313719067664,1.0,9/20,28.62%,SLC25A16;TMEM241;SLC25A30;CLCN4;SLC35C2;SLC35E1;SLC35A1;SLC35E2B;SLC35E2A
prerank,DNA binding (GO:0003677),0.34911743607552637,0.910068846663104,0.851,0.996043552980014,1.0,143/694,20.43%,NFE2;IRF5;MMP12;CIITA;MEOX1;IRF4;MCM5;IKZF1;GATA1;PCID2;FAM111A;AIM2;NFE2L2;POU2F2;HES7;MLXIPL;DHX9;TLR8;ZEB2;SP7;BARX2;YAF2;NABP1;FOXD2;NR1H4;DNMT3A;BPTF;CEBPA;FOXO3;LRRFIP1;DDIT3;EXO1;MAFK;HMGB1;XRCC5;TAF1;SAMHD1;BRIP1;FLI1;GTF3C4;TEAD1;TP53;MEF2A;NKX2-1;NRL;USF1;LONP1;YY1;RC3H2;CEBPB;CDC5L;ENDOV;TFAP2B;SMAD3;ARID1A;IRF2;HSF1;PPARGC1A;ARID3B;SURF6;RPL6;RNF4;ARID4A;MCM6;HDAC4;MCM2;APTX;SOX9;DENND4A;NR2C2;STN1;GZF1;MTF2;MBD1;SNAPC3;MCM9;PMS1;NR4A1;MAX;SMARCB1;DNA2;SAFB2;SOX6;CUX1;PCBP1;IRF1;INO80;HUWE1;MBD5;SOX2;ZDHHC1;SREBF1;MEIS1;POU6F1;C1D;ERCC5;SPTY2D1;TWNK;NR2C1;REXO4;ERCC6;THRAP3;TOP2A;NUFIP1;OGG1;RBPJ;SMARCAD1;HIF1A;RAD51B;APLP2;SNAPC4;PPARD;ZGPAT;TIGD2;NFYA;RPS27;NPAS2;CNBP;ZNF638;ZNF35;RXRA;JUNB;PHF1;CUX2;POU2F3;CHD4;ERCC1;MAFB;TOP1;FUBP3;ZIC4;TINF2;RAD51D;QRICH1;KDM5A;MAU2;KDM5B;HHEX;ZMYND11;CRLF3;CDC45;RAD23B;POU2F1
prerank,endopeptidase regulator activity (GO:0061135),0.391115560649795,0.9097978785618703,0.6215621562156216,0.9935430028273704,1.0,6/40,15.74%,VSIR;CST7;RENBP;SPINT2;PSME3;A2M
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.3419932110986479,-0.9096439868951322,0.593103448275862,0.9022791142086332,1.0,4/12,13.91%,NUDT5;ENTPD5;SLC25A42;CANT1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3627923825659661,0.9092657340713638,0.6412930135557873,0.9917042100357308,1.0,19/69,23.52%,CERS6;ASPG;SOAT2;ZDHHC14;ZDHHC7;ZDHHC13;ZDHHC16;ZDHHC3;ZDHHC1;PLAAT3;GTF2B;DGAT2;MOGAT1;NMT1;ZDHHC21;NAA15;ZDHHC2;CERS4;PLA2G4E
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3513247719448507,0.9085497571048609,0.778,0.9902340164108068,1.0,76/346,18.32%,CBL;RNF180;MYLIP;TRIM25;RFFL;RNF149;ZNRF2;RNF19B;TRIM5;MKRN1;CDC23;UBE2D3;TRAF2;SEL1L;FBXL22;MSL2;VPS18;MGRN1;RNF7;TNFAIP3;TRAF3;HLTF;PPP1R11;TAF1;RNF111;HECTD1;KLHL21;UBE2S;RNF150;RC3H2;MALT1;VPS11;TRIM27;RNF114;UBE2E3;RC3H1;RNF4;RING1;TRAF5;NFX1;NEDD4L;UBE2H;RNF10;TRIM56;TRIM24;MAEA;RNF40;TRIM35;CDC34;RNF216;FBXL3;RMND5B;RNF135;ITCH;UBE2G2;STUB1;RNF144B;HUWE1;AREL1;NEURL1B;NEURL3;UBE2J2;DTX4;ZNRF1;RNF152;SMURF1;FANCL;UBE2N;TRIM62;ZNRF3;ANAPC11;UBE2Z;UBE2K;CDC42;BIRC2;FBXO44
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.3632580715092977,0.9070117966522577,0.6652892561983471,0.9906285146160885,1.0,14/75,17.68%,EHHADH;AKR1A1;DHRS3;HPGD;SORD;DHRS11;HSD17B11;SPR;SDR42E1;ME3;LDHA;IMPDH2;PHGDH;PGD
prerank,cadherin binding (GO:0045296),0.3477144837738554,0.9058900745324886,0.765,0.9898952757905208,1.0,98/315,20.60%,CBL;SNX5;TRIM25;PTPRJ;PTPN1;KLC2;SNX9;PKP2;ASAP1;ITGA6;RPS2;ATIC;LRRFIP1;MYH9;P2RX4;MACF1;CTNNB1;ANXA1;CAPZB;MAPRE1;YWHAB;MICALL1;ARGLU1;SND1;GAPVD1;CLIC1;WASF2;TBC1D10A;CLINT1;CAPZA1;PLIN3;LARP1;CCT8;ARHGAP1;ABI1;RARS1;RPL6;CDH8;EIF4H;VCL;VAPB;F11R;PRDX1;AHSA1;TBC1D2;SCYL1;PFN1;CDH9;PTPRO;YKT6;CDH12;TLN1;TWF2;PRDX6;NUMB;STX5;VASN;FNBP1L;CDH23;STK24;HCFC1;PCBP1;ARHGAP18;PTPRT;EXOC3;SNX2;PDLIM1;USP8;FXYD5;EPS15;ATXN2L;FASN;GOLGA3;SRC;EFHD2;RTN4;DCHS1;CDH19;LDHA;ARFIP2;GCN1;IQGAP1;GIPC1;ADD1;PICALM;ITGB1;SCRIB;SERBP1;RPL7A;LASP1;RPL15;MB21D2;ENO1;RPL29;CDK5R1;USO1;PKM;TES
prerank,manganese ion binding (GO:0030145),0.3740409794230013,0.9048475941592028,0.6256800870511425,0.9890965815797506,1.0,20/48,24.59%,MGAT5;GYG1;B4GALT1;PIM1;ADPRM;FAM20C;B4GALT7;GALNT2;LARGE1;MGAT5B;PPM1M;GALNT1;MGAT1;ATP13A2;NEK4;XXYLT1;HMGCL;POMGNT1;GALNT3;ABL2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.3626752427753997,0.9046223103995514,0.6584107327141383,0.9866967705918075,1.0,11/72,12.29%,MYO1G;LDLRAP1;ADAP2;FLII;SLC9A1;AMER1;PFN2;PFN1;TWF2;EXOC1;SDCBP
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.38125526527565623,0.9020666073067278,0.6193693693693694,0.9889811580254069,1.0,11/34,17.82%,UBE2D3;TAF1;UBE2S;UBE2E3;UBE2H;CDC34;UBE2G2;UBE2J2;UBE2N;UBE2Z;UBE2K
prerank,ubiquitin-dependent protein binding (GO:0140036),0.4638776515677609,0.9015742513915582,0.601078167115903,0.987066068813859,1.0,3/10,16.09%,LAPTM5;ANKRD13A;IDE
prerank,histone deacetylase activity (GO:0004407),0.4204789930781675,0.8968263382902817,0.602827763496144,0.9937637731704557,1.0,5/19,13.99%,HDAC5;HDAC4;HDAC6;HDAC9;HDAC11
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.4490122061310863,0.8964704452728586,0.5946704067321178,0.9915268362968975,1.0,2/12,8.98%,TENT4B;TENT5C
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4714219265039108,0.896169577016974,0.6095380029806259,0.9892370421904164,1.0,3/10,12.61%,B4GALT1;A3GALT2;B4GALT7
prerank,flavin adenine dinucleotide binding (GO:0050660),0.37232062952620226,0.8946865437612519,0.6505376344086021,0.9894272560981732,1.0,7/53,10.09%,CYBB;CYB5R1;XDH;ACADL;MICAL1;KMO;ILVBL
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.37345361155296064,-0.8942908947974668,0.5944055944055944,0.9311501029021196,1.0,8/10,54.46%,SLC6A11;SLC6A1;SLC10A1;SLC10A3;SLC10A6;SLC6A13;SLC10A4;SLC10A5
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.3720100109293615,-0.8918238561856769,0.6287625418060201,0.9277924299216089,1.0,6/10,39.28%,INCA1;KAT2B;CDKN1A;CDKN2C;CDKN2D;CDKN2B
prerank,voltage-gated potassium channel activity (GO:0005249),0.35347492320031065,0.8903842442507837,0.6849173553719008,0.9950756264878646,1.0,6/80,7.14%,KCNJ11;HCN4;KCNK6;PKD2;KCNIP2;KCNMA1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.3932491964158201,0.8898572462012887,0.6319444444444444,0.993241300741582,1.0,2/29,3.38%,PRKAR2B;PKIB
prerank,tropomyosin binding (GO:0005523),0.42627889838209304,0.8895873801528782,0.6098535286284953,0.9908779436478586,1.0,2/16,8.17%,PYCARD;TNNT3
prerank,voltage-gated chloride channel activity (GO:0005247),-0.36789727343338363,-0.8883369319303519,0.5801282051282052,0.927121946686756,1.0,2/10,10.19%,CLCN6;CLCN2
prerank,adrenergic receptor binding (GO:0031690),-0.31449808740723,-0.8875334107760827,0.6412556053811659,0.9201578898282473,1.0,6/16,18.12%,ARRDC3;GNAS;RAPGEF2;SAV1;MAGI2;UCHL1
prerank,microtubule binding (GO:0008017),0.341752522085932,0.8860659903683179,0.7957957957957958,0.9949462623751888,1.0,40/222,15.94%,HOOK3;UXT;NEFH;GAS2L1;FGF13;MAP1LC3B;GAS2L3;CCDC88B;MDM1;TPGS1;CCDC69;MACF1;MAPRE1;DNM2;CLIP2;IRAG2;GJB6;STARD9;CETN3;KIF14;KIF20B;KIF23;VAPB;RAB11A;TUBGCP6;TUBGCP4;MAP1B;CCDC181;MID2;HDAC6;CEP57L1;KATNA1;HAUS8;HOOK2;KIF2A;LRRK2;FMN1;DST;SVBP;CAMSAP2
prerank,translation elongation factor activity (GO:0003746),0.43312919644319137,0.8856508591341647,0.6270949720670391,0.9929231005819479,1.0,2/14,6.89%,GFM1;GTPBP1
prerank,growth factor activity (GO:0008083),0.3534262341230837,0.8844279816224789,0.6785714285714286,0.9924651934772757,1.0,9/74,12.63%,MDK;ANGPTL3;OSM;VEGFB;NTF3;INHBA;ARTN;GRN;NRG1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.43859963139180624,0.8841896590923586,0.6153846153846154,0.9901200930382877,1.0,4/13,19.04%,GABRA5;GLRA2;GABRA4;GABRG1
prerank,BMP binding (GO:0036122),-0.35074589143104506,-0.8839601663871323,0.6195286195286195,0.9198929122008517,1.0,1/11,2.45%,NBL1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.3265155093421007,-0.8817369967500897,0.6196078431372549,0.9164276563924063,1.0,2/14,1.33%,MTM1;MTMR7
prerank,tRNA binding (GO:0000049),0.35879711792118524,0.8804371512580378,0.6440489432703004,0.994550875503946,1.0,12/43,22.57%,SEPSECS;ELP1;TRMT10A;CTU1;DARS2;YRDC;FARS2;AIMP1;RPUSD4;ELP5;SARS1;SARS2
prerank,O-acyltransferase activity (GO:0008374),0.3855888720833326,0.8800240658093573,0.6371061843640606,0.9924450057356866,1.0,4/30,12.21%,LPCAT1;SOAT2;LPCAT2;PRDX6
prerank,glucuronosyltransferase activity (GO:0015020),0.403790030176585,0.8778547216742314,0.6479591836734694,0.9936787339155668,1.0,5/19,25.68%,CHSY1;LARGE1;CHPF;B3GAT2;EXT2
prerank,tau-protein kinase activity (GO:0050321),-0.2874522688466692,-0.8776420362388215,0.6153846153846154,0.9179355447551171,1.0,7/20,16.86%,TAOK2;DYRK1A;ROCK1;PHKG2;MARK4;SIK3;TTBK1
prerank,mannosyltransferase activity (GO:0000030),0.4015416099144381,0.8769944278581597,0.6386138613861386,0.9925677955450686,1.0,4/21,10.14%,PIGM;PIGV;ALG2;TMTC4
prerank,histone deacetylase binding (GO:0042826),0.3470452982942869,0.8729616291155647,0.6899383983572895,0.9972303341217171,1.0,24/88,20.96%,CIR1;SPI1;BHLHE41;HDAC5;MTA3;YWHAB;TP53;MEF2A;TAL1;USF1;MEF2C;HDAC4;PKN1;ZMYND15;HDAC6;HDAC9;AKAP8L;TOP2A;HSP90AA1;DACT1;CHD4;RBBP4;PRKN;TFAP4
prerank,methylation-dependent protein binding (GO:0140034),0.3574451508007793,0.8719537789753972,0.7009544008483564,0.9963397305075788,1.0,16/57,20.17%,BPTF;NCAPG2;CXXC1;MORC3;KDM7A;ATRX;CHD1;TRIM24;RBBP5;MTF2;CDYL;MORC4;LRWD1;PHF1;KDM5A;ZMYND11
prerank,calcium-release channel activity (GO:0015278),0.4127649120925281,0.871134075840771,0.6371794871794871,0.9949704439140511,1.0,3/17,8.68%,RASA3;PKD2;ITPR2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.40265992374317366,0.8710889846650609,0.638676844783715,0.9923060332509341,1.0,5/20,19.24%,OTULINL;USP7;USP9X;USP21;DESI2
prerank,phospholipid transfer activity (GO:0120014),-0.2813465717667734,-0.8701994680958138,0.656084656084656,0.9258571565366754,1.0,9/21,23.14%,PITPNM2;PITPNC1;TNFAIP8L3;GLTP;PITPNB;MTTP;PRELID2;PRELID3A;PLTP
prerank,frizzled binding (GO:0005109),-0.24838161275330578,-0.8699959145582618,0.664,0.9179567797269392,1.0,11/34,25.99%,WNT4;RNF43;WNT5A;WNT6;WNT5B;FZD1;MYOC;CCDC88C;WNT16;DVL2;WNT11
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3935295661867131,0.8691443562880673,0.6313065976714101,0.9931171552083802,1.0,6/21,17.71%,AKAP5;ARFGEF1;WASF2;ARFGEF2;AKAP8L;AKAP9
prerank,channel activity (GO:0015267),0.36195115399394495,0.8691104193159944,0.6577480490523969,0.990433429388489,1.0,4/41,13.92%,AQP1;AQP11;TMEM120A;TRPV3
prerank,androgen receptor binding (GO:0050681),-0.26579800145995636,-0.8677205729076568,0.6795580110497238,0.9145785644211903,1.0,11/25,24.54%,FOXP1;SMARCA4;KDM3A;CALR;SNW1;RNF14;PARK7;TGFB1I1;ARID5A;PRPF6;TRIM68
prerank,intracellular chloride channel activity (GO:0061778),-0.2949458530867157,-0.8666255581018338,0.6345381526104418,0.9004803093112246,1.0,9/16,37.92%,TTYH3;ANO4;TTYH1;ANO5;ANO8;ANO2;ANO6;ANO1;NMUR2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.2949458530867157,-0.8666255581018338,0.6345381526104418,0.9004803093112246,1.0,9/16,37.92%,TTYH3;ANO4;TTYH1;ANO5;ANO8;ANO2;ANO6;ANO1;NMUR2
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.36119362010808836,0.8647686807020742,0.6606942889137738,0.9953915123248666,1.0,12/35,23.10%,MMP12;TAF1;TP53;SNAPC3;SMARCB1;PIH1D1;GTF2B;AGO2;POU2F1;TAF1C;H3-3A;GTF2A1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.4431611049817973,0.8618577976090862,0.6214689265536724,0.9977870387011888,1.0,1/10,2.23%,SLCO2B1
prerank,glucose transmembrane transporter activity (GO:0005355),0.40071655639225756,0.8612876088715363,0.6453715775749674,0.996053614840495,1.0,1/17,4.15%,SLC2A3
prerank,nuclear import signal receptor activity (GO:0061608),-0.30069973481612416,-0.8594064163529758,0.636734693877551,0.909197105021419,1.0,7/15,31.83%,TNPO3;IPO5;RANBP6;HIKESHI;TNPO2;KPNA2;KPNA6
prerank,cation transmembrane transporter activity (GO:0008324),0.35311736206491046,0.859025378179561,0.6903225806451613,0.9972121708282587,1.0,7/48,11.14%,SLC7A8;SLC38A6;SLC36A1;SLC25A38;SLC36A4;SLC8B1;SLC66A1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.34181617454079544,0.8579050869653264,0.746938775510204,0.9965285304019929,1.0,22/91,21.19%,MYO1G;SH3PXD2B;LDLRAP1;ADAP2;FLII;SLC9A1;AMER1;PFN2;PFN1;TWF2;EXOC1;SDCBP;SNX14;SNX18;PLEKHA5;PICALM;TULP3;LAPTM4B;FCHO2;ATP13A2;KCNJ2;MARK1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.43650365948568615,0.8571241475028566,0.6717241379310345,0.9951844364292217,1.0,3/10,16.09%,LAPTM5;ANKRD13A;IDE
prerank,solute:sodium symporter activity (GO:0015370),-0.2509488728530615,-0.8568687862391734,0.7133333333333334,0.9065491967328394,1.0,6/27,27.58%,SLC4A10;SLC5A6;SLC5A7;SLC5A3;SLC5A11;SLC20A1
prerank,ribonuclease P activity (GO:0004526),0.4332642432426823,0.8531015631803083,0.6608695652173913,0.9993204214425279,1.0,3/11,15.02%,RPP38;RPP14;PRORP
prerank,NADP binding (GO:0050661),-0.24158031697058982,-0.8518096453392932,0.7165354330708661,0.9098670209794897,1.0,18/32,31.80%,ME1;CRYZL1;HMGCR;GMDS;DUS2;NOS3;MTRR;CBR4;NOS1;NNT;DHFR;LBR;NDOR1;DHCR7;CRYZ;CBR3;TM7SF2;HSD11B1
prerank,galactosyltransferase activity (GO:0008378),0.43122253059909144,0.8513775321928108,0.6568047337278107,0.9994043258777505,1.0,5/11,21.71%,B4GALT1;A3GALT2;B4GALT7;B4GALT6;B4GALT2
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.41189229335131355,0.848521323971793,0.6748299319727891,1.0,1.0,5/14,20.72%,ELAC2;RPP38;RPP14;PRORP;TSEN2
prerank,R-SMAD binding (GO:0070412),0.39653832398515987,0.8449003095945825,0.6654228855721394,1.0,1.0,4/18,17.39%,RGCC;SMAD3;SMURF1;LDLRAD4
prerank,RNA binding (GO:0003723),0.32308800340621574,0.8440666608705603,0.992,1.0,1.0,331/1321,21.58%,SEPSECS;LGALS3;APOBEC1;RBM47;RFTN1;PCSK9;PCID2;CORO1A;RPL23;RPL17;RBM38;MYO5A;TRIM25;EMG1;GRB2;PTPN1;DHX9;TLR8;TLR7;RPL10A;GFM1;KCTD12;UTP20;PCDH20;ACIN1;NPM3;SF3B2;SF3B1;MKRN1;FBL;ZNF326;BCCIP;ELP1;PPIE;RBM39;RPS2;DHX38;EXOSC1;TENT4B;LRRFIP1;EIF5B;RRBP1;NXF1;MYH9;SCAF11;LAS1L;SAMSN1;IREB2;THOC2;SYNE1;HLTF;HMGB1;ANP32A;XRCC5;SAMHD1;RPL18A;BTF3;CHCHD1;CIRBP;MACF1;CDK11B;MRPL41;MAPRE1;CCAR1;FASTKD3;ACTN4;NUDT4;SND1;GTPBP1;RPS15A;LONP1;TNRC6A;GSPT1;YY1;TCF20;YTHDF3;RC3H2;CSTF1;TMSB4X;P4HB;CASC3;SNRPD2;TRAP1;ELAC2;ZC3H12D;GRSF1;EIF4A1;NKRF;CDC5L;ERAL1;ENDOV;TPT1;LARP4B;MOV10;RBM15B;EIF1;PRPF38B;ADAR;LARP1;CMSS1;RC3H1;KRR1;PPARGC1A;ZCCHC7;TDRD7;SMG1;PCBP3;RPP38;EPRS1;PUM2;SURF6;AGO4;RPL6;DDX27;FASTKD1;HNRNPL;EIF4H;CPEB3;MCRS1;NFX1;PRDX1;RBMX2;TPR;ACTN1;NAP1L1;DDX39B;RBM27;ZC3H18;RPL26;SON;TRMT1;TRIM56;RPS20;SNIP1;RNASEL;LGALS1;LUC7L3;DIAPH1;EIF4G3;APTX;FAU;PFN1;RPS16;CLTC;TRMT10A;CHERP;ACO1;CTU1;ZNF106;PTBP2;GRN;SECISBP2;AGO3;RNASEH1;METTL3;DDX18;PRPF8;PIN4;TRA2B;TWF2;DYNC1H1;UTP11;NOP9;HEATR1;RPS14;TBL2;PPIL4;RRS1;ADARB1;ATP5F1A;RPP14;RPGR;DNA2;FAM50A;SAFB2;DARS1;MSI2;RPL19;POLDIP3;PCBP1;ZYX;UPF3B;RCC1L;HUWE1;RTRAF;MRPL15;DDX1;TSR1;MYH10;HNRNPD;RO60;ALKBH5;SRP19;CSRP1;DARS2;YRDC;NOC2L;PPP1CC;PUM3;PRKRA;IGF2BP3;IMP3;PPIG;RPL9;MRPS9;ATXN2L;PES1;C1D;LRP1;CPEB4;FASN;RBM42;NOC3L;FAM120C;AKAP8L;CCDC47;METAP2;MTDH;REXO4;NOL7;HEATR6;THRAP3;TOP2A;NUFIP1;EWSR1;RPS11;RTN4;PDIA3;PUS7;LSM8;RPL11;SMG7;ZC3H12C;MEX3D;CPEB2;TEP1;TUT7;TASOR;RPS23;HSP90AA1;FARS2;TARBP2;GCN1;UBE2N;RPS4X;MRPS21;LRRC47;NGDN;MRPL39;MANF;CRNKL1;RPS27;RBPMS2;PCF11;AGO2;SEC63;CNBP;DDX41;ZNF638;RPL4;MRPS14;ADD1;DDX31;RBM34;PABPC4;GOLGB1;FYTTD1;MRPL3;FCF1;RBMS2;TOP1;FUBP3;DUSP14;SNRNP200;HNRNPF;SRSF6;ERH;SNRNP35;PNN;SERBP1;WDR75;SRSF2;CLNS1A;PYM1;ROCK2;PABPN1;MRPS26;RPL7A;RPL15;HSPB1;ENO1;EXOSC3;SART1;MRPL10;RPL29;ZC3H7A;USO1;SLBP;DDX51;RRP7A;UTP3;SRSF10;SRSF3;VIRMA;ARCN1;PKM;MRPL54;TES;NCOA5;NAA15;HEXIM1;AIMP1;SRFBP1;STRAP;R3HDM2;RPL22;BAG4;IMP4;RPS7;RIMS1;DICER1;PTBP1;TOE1;HNRNPA0;ZFP36L1;EIF2S2;LSM14A;DCP1B;RPUSD4;LIN28B;YARS1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.34811812304154377,0.8437420060261691,0.7066381156316917,1.0,1.0,3/48,4.10%,P2RX1;AQP1;PKD2
prerank,mRNA 5'-UTR binding (GO:0048027),0.37955172193662473,0.8424758401489721,0.6698795180722892,1.0,1.0,10/24,25.62%,LARP1;RPL26;RPS14;CCT5;MYH10;IGF2BP3;RPS7;RPS13;RPL41;RPL5
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.25686283571986285,-0.8419551780413334,0.7177914110429447,0.9227084542341496,1.0,14/27,29.00%,MED21;PRIMPOL;MED20;PRIM1;POLR3B;POLR2C;POLR3F;POLR1F;POLR1H;POLR2J;POLR2D;POLRMT;POLR1D;POLR1C
prerank,calcium:sodium antiporter activity (GO:0005432),0.43105445238146756,0.8401437382025109,0.6833578792341679,1.0,1.0,2/10,10.61%,SLC8A1;SLC8B1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.410704768732435,0.8370004435210032,0.6562073669849932,1.0,1.0,3/12,12.44%,CDK8;CDK7;CDK6
prerank,nuclease activity (GO:0004518),0.3461740774835077,0.8357318506476136,0.7181136120042872,1.0,1.0,20/52,26.04%,EXO1;SAMHD1;SND1;RNASEL;RNASEH1;DNA2;DDX1;ERCC5;REXO4;OGG1;N4BP2;RNASEH2A;DIS3L2;RNASE6;REXO1;DNASE1L1;XRN2;RNASE12;DFFB;RNASE3
prerank,peptidase inhibitor activity (GO:0030414),0.3683484155478767,0.831815513962696,0.6946651532349603,1.0,1.0,4/33,8.84%,CST7;RENBP;TIMP1;SPINT2
prerank,adenylate cyclase binding (GO:0008179),0.42616292517300775,0.8314213970519889,0.6842105263157895,1.0,1.0,2/10,8.17%,AKAP5;CAP1
prerank,5'-nucleotidase activity (GO:0008253),0.41349238423441126,0.829768322710545,0.6533149171270718,1.0,1.0,2/13,10.21%,NT5C3B;NT5DC3
prerank,neurexin family protein binding (GO:0042043),0.42757878378974623,0.829669976843017,0.6606145251396648,1.0,1.0,2/10,8.72%,CEL;SYTL4
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3411962021914925,0.828377156308007,0.7259978425026968,1.0,1.0,10/49,15.84%,PTPRJ;DUSP3;SAMHD1;PLCXD3;DUSP10;FRA10AC1;PTPRO;PXYLP1;PPP1CC;GDPD3
prerank,general transcription initiation factor binding (GO:0140296),-0.25594461803821716,-0.8274196173993721,0.7718120805369127,0.9441910757108599,1.0,8/25,16.36%,AR;TBP;DR1;PSMC1;RELA;TAF13;PSMC5;RUVBL1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.4004865154464032,0.825113183861171,0.6984732824427481,1.0,1.0,5/15,18.21%,LPCAT1;LPCAT2;ABHD4;PNPLA3;LCLAT1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.4307469937895261,0.8242592940393864,0.6783625730994152,1.0,1.0,3/10,19.04%,GABRA5;GABRA4;GABRG1
prerank,potassium ion leak channel activity (GO:0022841),0.4032604623175248,0.823174634353547,0.6791946308724832,1.0,1.0,2/15,7.51%,KCNK6;KCNK13
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.3201515605184769,-0.8226472936429988,0.672077922077922,0.9458926502865506,1.0,4/11,13.74%,HNRNPA2B1;HNRNPA1;NABP2;CTC1
prerank,transcription corepressor binding (GO:0001222),0.3622115914245532,0.8223663427205821,0.6932223543400713,1.0,1.0,10/27,22.00%,NEK6;FAM89B;HDAC6;MTF2;PHF1;CTBP2;PER1;EED;CTBP1;WIZ
prerank,protein phosphatase 2A binding (GO:0051721),0.3737070004328274,0.8215213767484656,0.701067615658363,1.0,1.0,8/23,16.40%,TP53;ENSA;STRN;BOD1L1;ADCY8;CTTNBP2NL;PTPA;SMG7
prerank,anion transmembrane transporter activity (GO:0008509),0.40247815448024016,0.8211104515758101,0.6742209631728046,0.999196551985118,1.0,1/12,2.23%,SLCO2B1
prerank,sialyltransferase activity (GO:0008373),0.37320650388655885,0.8208990153884355,0.7014742014742015,0.9970089075750996,1.0,4/20,10.45%,ST8SIA4;ST6GALNAC4;ST3GAL1;ST8SIA1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.4165640701922074,0.8186883123685212,0.6957746478873239,0.9979632043759077,1.0,1/11,5.90%,PPP1R11
prerank,deubiquitinase activity (GO:0101005),0.3204949645450096,0.8185051026855242,0.7826982492276005,0.995717599692473,1.0,19/88,16.00%,MINDY4;OTULIN;TANK;USP35;TNFAIP3;ATXN3;OTUD3;STAMBPL1;USP7;USP48;USP31;USP18;MINDY1;USP9X;USP8;JOSD2;USP29;USP21;USP16
prerank,"DNA binding, bending (GO:0008301)",-0.29586535082620735,-0.8179415921059591,0.7193675889328063,0.9469067528090372,1.0,2/14,1.44%,FOXC1;FOXD1
prerank,microtubule motor activity (GO:0003777),-0.2033371114441296,-0.8178924625719383,0.8554216867469879,0.9391714307125728,1.0,17/51,23.03%,KIF5B;KIF3C;DYNC1I1;SMC3;KIF16B;KIF26B;KIF3B;KIF5A;KIF24;KIF13A;KIF18A;DNAH2;KIF26A;KIF9;KIFC2;KIF7;KIF1A
prerank,N-acetyltransferase activity (GO:0008080),-0.27535244950256177,-0.8156181381709827,0.7376237623762376,0.935842714553269,1.0,3/19,9.68%,ESCO1;SAT1;NAT10
prerank,voltage-gated anion channel activity (GO:0008308),0.3936052243558662,0.8151121163982104,0.6900269541778976,0.9983634644514126,1.0,4/15,15.59%,VDAC3;VDAC2;VDAC1;CLCN4
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.4103371954681656,0.8130617914177254,0.7002923976608187,0.9988183961644356,1.0,2/10,10.80%,EXO1;MGME1
prerank,nuclear export signal receptor activity (GO:0005049),0.4219159541136249,0.8125648144732984,0.7064748201438849,0.9970918243687884,1.0,3/11,12.05%,XPO1;CSE1L;XPO6
prerank,neuropeptide binding (GO:0042923),0.3766697792051604,0.8123792216920086,0.6917197452229299,0.9948424388016966,1.0,3/18,19.97%,GPR37;SORL1;GPR149
prerank,tubulin binding (GO:0015631),0.31078073529041045,0.8108252075906601,0.916,0.9947012875895287,1.0,62/295,19.49%,HOOK3;UXT;NEFH;GAS2L1;TBCEL;FGF13;SNCA;MAP1LC3B;GAS2L3;CCDC88B;DIP2B;MDM1;TPGS1;CCDC69;ARL8A;DNM2;CLIP2;IRAG2;GJB6;STARD9;CETN3;KIF14;KIF20B;KIF23;VAPB;RAB11A;TUBGCP6;TUBGCP4;TPR;SETD2;MAP1B;CCDC181;TTLL12;MID2;HDAC6;CEP57L1;FYN;RAB11FIP5;KATNA1;AGBL5;INO80;CCT5;HAUS8;HOOK2;KIF2A;LRRK2;AGTPBP1;FMN1;DST;SVBP;TTLL1;ARL8B;EML4;ARHGEF2;KIF21A;NCALD;KIF1B;MAPRE2;TAOK1;CCDC66;RAD51D;DNM1L
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.29548117594244033,-0.8105093861031385,0.7068965517241379,0.9374753198027058,1.0,6/15,17.11%,ALDH2;ALDH1A1;ALDH3A2;ALDH1A2;ALDH1L1;ALDH1L2
prerank,deoxyribonuclease activity (GO:0004536),-0.29590627290121035,-0.8100752736002457,0.7285714285714285,0.9305517258666934,1.0,3/14,11.75%,MRE11;MAP1S;APLF
prerank,peptidoglycan binding (GO:0042834),0.4203302538067134,0.8085247046214582,0.6967455621301775,0.9954809913764313,1.0,2/10,12.25%,TLR2;NOD2
prerank,sequence-specific mRNA binding (GO:1990825),0.4211438438359176,0.8080114335823235,0.7185185185185186,0.9936901365684183,1.0,1/10,2.82%,DHX9
prerank,epidermal growth factor receptor binding (GO:0005154),-0.24709195959313324,-0.8050895646026281,0.7337278106508875,0.9317490204265159,1.0,11/25,28.65%,SNX4;EFEMP1;ATXN2;SHC1;LINGO1;HBEGF;CCDC88A;HIP1;EGF;CNOT9;FER
prerank,poly(U) RNA binding (GO:0008266),-0.25978692153480876,-0.8030632459754443,0.7710280373831776,0.9281182553956835,1.0,4/20,10.45%,DAZAP1;SSB;FMR1;RBMS3
prerank,3'-5' exonuclease activity (GO:0008408),-0.21389036143127368,-0.8025830705291194,0.8452380952380952,0.9217103358129822,1.0,16/45,25.24%,REV3L;PAN2;MRE11;DIS3;ERI1;EXOSC7;APLF;WRN;EXD2;TATDN1;EXOSC9;POLG;PARN;EXD1;EXOSC5;CNOT6L
prerank,SUMO binding (GO:0032183),0.3915728885539489,0.8000629023132608,0.710124826629681,1.0,1.0,5/13,21.18%,RNF111;RNF4;UBA2;SERBP1;HERC2
prerank,metallopeptidase activity (GO:0008237),0.31235677833825126,0.7986921313390004,0.8356997971602435,1.0,1.0,17/113,17.05%,MMP12;COPS6;ADAM8;ADAMTS8;ECE2;EEF1AKMT4-ECE2;ZMPSTE24;NLN;MMP19;PRPF8;ERAP1;ECEL1;METAP2;PSMD7;PMPCB;IDE;PITRM1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.39753446546581134,0.7983531550374929,0.7078651685393258,1.0,1.0,2/12,7.43%,ITGB3;VEGFB
prerank,mRNA binding (GO:0003729),0.30842185065843486,0.7961400101390632,0.923,1.0,1.0,66/249,21.49%,RBM47;DHX9;SF3B1;PPIE;RPS2;IREB2;THOC2;CIRBP;TP53;YTHDF3;RC3H2;ZC3H12D;GRSF1;EIF4A1;LARP4B;LARP1;RC3H1;TDRD7;PCBP3;PUM2;ANGEL2;HNRNPL;CPEB3;TPR;RPL26;SNIP1;LUC7L3;EIF4G3;RNF40;ACO1;PTBP2;SECISBP2;METTL3;TRA2B;RPS14;ADARB1;PCBP1;UPF3B;CCT5;MYH10;PUM3;IGF2BP3;CPEB4;ZC3H12C;CPEB2;MARF1;RBPMS2;PCF11;AGO2;CNBP;PABPC4;FYTTD1;RBMS2;FUBP3;SRSF6;SNRNP35;SERBP1;SLBP;PKM;RPS7;PTBP1;HNRNPA0;ZFP36L1;EIF2S2;LSM14A;DCP1B
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.34003716012827745,0.7953873343882235,0.7350230414746544,0.9993937964213973,1.0,9/33,17.90%,DHX9;ZNF326;UVSSA;RTRAF;ELOF1;ERCC5;GTF2B;PCF11;AGO2
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.399495012473994,0.7932327310967092,0.7316735822959889,1.0,1.0,6/12,24.34%,CNOT8;TOE1;PNLDC1;CNOT7;CNOT1;CNOT2
prerank,phosphatase activity (GO:0016791),0.31837852379064707,0.7927040640160439,0.7956431535269709,0.9983142049039487,1.0,10/73,14.70%,LPIN2;PTPRJ;DUSP3;PLPPR1;DUSP10;FRA10AC1;APTX;PTPRO;PXYLP1;PPP1CC
prerank,translation initiation factor activity (GO:0003743),0.3399579393003602,0.7922121163820797,0.753968253968254,0.996567755154373,1.0,18/36,28.71%,EIF3K;EIF5B;EIF4A1;EIF1;EIF2B2;EIF4G3;AGO2;MTIF3;EIF2S2;EIF3E;EIF3M;EIF3C;EIF2A;EIF2S1;EIF1B;EIF4E;EIF3A;EIF4A2
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3973080037642273,0.7895440161716394,0.712707182320442,0.9977263861615218,1.0,5/11,21.07%,NAA40;NAA50;NAA25;NAA15;NAA80
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.33904639518235724,0.789109115441564,0.7363013698630136,0.9958929580822069,1.0,12/34,20.23%,DBF4;MAP2K2;PARP16;STK3;STRADA;ALS2;INCENP;IRGM;STK4;IQGAP1;TAOK1;CDK5R1
prerank,peptidase activator activity (GO:0016504),0.3606580380486718,0.7881488138758828,0.7414634146341463,0.9947775518228726,1.0,2/22,4.42%,VSIR;TANK
prerank,protein tyrosine kinase activator activity (GO:0030296),0.3637114660132776,0.7875827179179175,0.7445721583652618,0.9931508060815116,1.0,6/19,18.40%,ANGPT4;ABI1;NRG1;GAS6;ERCC6;GREM1
prerank,CoA hydrolase activity (GO:0016289),-0.27099088694100665,-0.7863979576679888,0.7603305785123967,0.9424500261995129,1.0,4/16,10.61%,HIBCH;ACOT11;ACOT13;ACAA2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.3621955081047434,0.7856238964757329,0.7461928934010152,0.9933808749500869,1.0,1/18,5.97%,DHRS11
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.27335249168711107,-0.7838216368671014,0.7719298245614035,0.9391416136064363,1.0,4/16,9.48%,SLC25A12;SLC25A13;SLC25A14;SLC1A5
prerank,metalloendopeptidase activity (GO:0004222),0.3102729147854317,0.7790376536658239,0.8302277432712215,0.9998312074961339,1.0,7/76,10.54%,MMP12;ADAMTS8;ECE2;EEF1AKMT4-ECE2;ZMPSTE24;NLN;MMP19
prerank,chloride channel activity (GO:0005254),0.31289959371010123,0.7777994593627511,0.8014783526927138,0.9991890394064571,1.0,10/59,15.59%,PACC1;CLCC1;CLIC1;GABRA5;CLCN7;GLRA2;TTYH2;GABRA4;SLC1A4;CLCN4
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.33548983055642906,0.7777642362296202,0.7729357798165137,0.9968622045191099,1.0,9/32,21.87%,TET3;HSPBAP1;KDM7A;ALKBH5;RIOX2;KDM4C;TET2;FTO;KDM2B
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.37707030147405896,0.7749724152166076,0.732605729877217,0.9980546301445151,1.0,4/14,23.58%,NME6;AK8;AK5;AK1
prerank,N-acyltransferase activity (GO:0016410),0.33847089633173255,0.7707286389472455,0.7863849765258216,1.0,1.0,11/32,26.39%,CERS6;NAA50;PLAAT3;NMT1;NAA80;GNPNAT1;TGM2;CERS4;PLA2G4E;SIRT7;NAA10
prerank,myosin V binding (GO:0031489),0.36506258690132054,0.7686875750264253,0.7537012113055181,1.0,1.0,4/15,16.64%,RAB14;RAB39B;RAB11A;RAB27B
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.3037064840505259,-0.7680333223718517,0.7389830508474576,0.9571381516049619,1.0,4/11,17.53%,SAMD8;SGMS2;AASDHPPT;PIGF
prerank,FMN binding (GO:0010181),-0.3001652375431309,-0.7676076659876903,0.7569444444444444,0.9504648341766148,1.0,5/11,25.07%,DUS2;NOS3;MTRR;NOS1;NDOR1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.31683685123098715,0.7668472376805618,0.8035320088300221,1.0,1.0,14/49,20.39%,TNFAIP3;BABAM2;HDAC6;PRPF8;WDR81;TAB2;IKBKG;MINDY1;RNF169;TAB3;EPS15;PARP10;OPTN;RAD23B
prerank,Tat protein binding (GO:0030957),0.3957857770014418,0.7632972245746938,0.7427325581395349,1.0,1.0,3/10,13.10%,ACTB;MDFIC;SMARCB1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.3703921666197353,0.7582304060171939,0.7510489510489511,1.0,1.0,2/13,11.14%,SLC7A7;SLC66A1
prerank,leak channel activity (GO:0022840),0.35482186909340463,0.751684862233523,0.772785622593068,1.0,1.0,2/18,7.51%,KCNK6;KCNK13
prerank,cAMP response element binding (GO:0035497),0.3852373825936415,0.7515642976407854,0.7528571428571429,1.0,1.0,3/10,12.49%,CREB3L1;CREB3L2;CREB1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.3724485478821846,0.7488025338660309,0.7857142857142857,1.0,1.0,2/13,6.35%,LPCAT1;LPCAT2
prerank,N-methyltransferase activity (GO:0008170),-0.24571393889157925,-0.7469986387109475,0.8076923076923077,0.9749308990648266,1.0,14/20,42.35%,SETD3;METTL5;RNMT;NNMT;PRMT1;TRMT11;N6AMT1;FDXACB1;DIMT1;PEMT;METTL15;METTL18;TFB2M;GNMT
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.29742796185303944,-0.7440014222715086,0.7876923076923077,0.9718915208742097,1.0,5/10,29.98%,OPLAH;CRMP1;DPYSL2;CAD;DPYSL3
prerank,ligand-gated anion channel activity (GO:0099095),-0.25794979274056884,-0.7413681129545661,0.8409090909090909,0.9681586095248399,1.0,4/17,10.55%,GABRB2;GABRB1;GABRA2;GABRB3
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.22510819685437747,-0.7376458350960703,0.8223684210526315,0.9656980905147949,1.0,13/27,29.00%,MED21;MED20;TERT;POLR3B;POLR2C;POLR3F;POLR1F;POLR1H;POLR2J;POLR2D;POLRMT;POLR1D;POLR1C
prerank,pentosyltransferase activity (GO:0016763),0.3144612167216063,0.7321715797579902,0.8278221208665907,1.0,1.0,11/36,21.55%,ART4;PARP8;PNP;PARP16;TNKS2;TIPARP;LACC1;LARGE1;PARP10;SIRT5;PARP3
prerank,ribonuclease P RNA binding (GO:0033204),0.37542127729453556,0.7304490997562625,0.7811594202898551,1.0,1.0,2/10,13.15%,RPP38;RPP14
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.32510270944927677,0.7293354114645659,0.7944377267230955,1.0,1.0,10/25,25.10%,ART4;PARP8;PARP16;TNKS2;TIPARP;PARP10;SIRT5;PARP3;PARP1;PARP9
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.22304346431057662,-0.7264107952984584,0.8554913294797688,0.9733133136348064,1.0,7/22,19.27%,CPEB1;RBMS3;ELAVL3;EXOSC8;ZC3H12A;DHX36;EXOSC9
prerank,MAP kinase activity (GO:0004707),0.3528340911212621,0.7260747812733971,0.7828492392807745,1.0,1.0,2/14,11.41%,MAPK14;NLK
prerank,telomeric DNA binding (GO:0042162),0.3169788090717887,0.7227009463647754,0.8212616822429907,1.0,1.0,12/32,24.86%,XRCC5;SMG1;STN1;HNRNPD;SMG7;UPF2;TINF2;TERF2;TELO2;TERF2IP;TEN1;RPA1
prerank,transcription coactivator binding (GO:0001223),0.3302514019852833,0.7224300138826011,0.8113207547169812,1.0,1.0,2/20,8.71%,RPL23;SMAD3
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.30358025722404053,-0.7218188058910094,0.8085808580858086,0.9649636911951147,1.0,5/10,25.30%,DUSP16;DUSP1;DUSP7;DUSP8;DUSP6
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.30358025722404053,-0.7218188058910094,0.8085808580858086,0.9649636911951147,1.0,5/10,25.30%,DUSP16;DUSP1;DUSP7;DUSP8;DUSP6
prerank,histone acetyltransferase binding (GO:0035035),0.32818331106962584,0.7217104548494663,0.7907268170426065,1.0,1.0,5/21,17.14%,TP53;MEF2A;EID1;HIF1A;TRIP4
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.29111944113987154,-0.7206048784636063,0.7896551724137931,0.9593690536701074,1.0,3/11,8.34%,UBR5;UBOX5;RBX1
prerank,myosin II binding (GO:0045159),0.36665938001428,0.7203737407707005,0.7782672540381792,1.0,1.0,1/10,2.68%,MYL3
prerank,O-methyltransferase activity (GO:0008171),0.3675781641255614,0.7203137031892992,0.8123167155425219,1.0,1.0,3/10,19.85%,COMT;BCDIN3D;COQ3
prerank,proton transmembrane transporter activity (GO:0015078),-0.194643512443036,-0.7190686080739538,0.9285714285714286,0.9542399161349235,1.0,10/39,21.75%,SLC33A1;UQCRH;COX5A;NDUFA4;DMAC2L;COX15;UQCRC1;UQCRQ;NNT;COX5B
prerank,pre-mRNA binding (GO:0036002),0.317186248938609,0.7180831616298695,0.8171296296296297,1.0,1.0,9/28,21.15%,HNRNPL;PRPF8;TRA2B;RBM41;TARBP2;SLU7;SRSF6;SLBP;PTBP1
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.3172797777922371,0.7161704495309447,0.8323494687131051,1.0,1.0,3/31,6.45%,AQP1;PKD2;TMEM38A
prerank,pseudouridine synthase activity (GO:0009982),-0.2716495868749348,-0.7157973557238408,0.8120567375886525,0.9514597824291589,1.0,9/13,41.35%,PUS10;TRUB2;PUS1;PUS7L;RPUSD1;TRUB1;PUSL1;RPUSD2;RPUSD3
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.2784764083757475,-0.7156076267135447,0.8489208633093526,0.9449413303703541,1.0,3/12,16.06%,B3GNT2;B3GALT5;B3GALT1
prerank,telomerase RNA binding (GO:0070034),-0.2191253698201539,-0.7124103078982279,0.8860103626943006,0.9425112387454221,1.0,9/22,23.23%,SNRPD3;PINX1;HNRNPU;WRAP53;DHX36;TERT;SMG6;PARN;GAR1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.2804574275213133,0.7093723951201197,0.894681960375391,1.0,1.0,17/83,16.00%,OTULIN;TANK;USP35;TNFAIP3;ATXN3;OTUD3;STAMBPL1;USP7;USP48;USP31;USP18;USP9X;USP8;JOSD2;USP29;USP21;USP16
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.29740206329969093,0.7070402151966363,0.8704720087815587,1.0,1.0,8/42,20.77%,CCND3;CCND2;CCNL1;CCNE2;CCNYL1;CNPPD1;CDK5R1;HEXIM1
prerank,omega peptidase activity (GO:0008242),0.27823064232596456,0.7062511271024253,0.9069286452947259,1.0,1.0,18/89,16.00%,OTULIN;TANK;USP35;TNFAIP3;ATXN3;OTUD3;STAMBPL1;USP7;USP48;USP31;USP18;GGH;USP9X;USP8;JOSD2;USP29;USP21;USP16
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.349710564817338,0.7058689664391357,0.8082975679542204,1.0,1.0,5/12,23.10%,TAF1;GTF2B;POU2F1;H3-3A;GTF2A1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.2710401763683793,-0.7048143938849986,0.8552188552188552,0.9446581408699215,1.0,6/13,23.22%,THUMPD3;TARBP1;TRMT10B;TRMT5;WDR4;TRMT11
prerank,voltage-gated calcium channel activity (GO:0005245),0.29881938083291987,0.7019470635701179,0.8503937007874016,1.0,1.0,7/37,16.61%,PKD2;CACNA1A;CACNB4;CACNB2;CACNB1;CACNA1B;CACNA1D
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.2952033056502417,0.7015735103811565,0.8470982142857143,1.0,1.0,11/40,22.08%,DNMT3A;FBL;METTL4;COMT;PCMTD2;METTL9;SUV39H1;AS3MT;METTL2B;METTL2A;TPMT
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.33689944777770875,0.7008880752907725,0.8150208623087621,1.0,1.0,3/14,20.72%,KCNIP2;KCNA5;KCNJ2
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.33128439435644125,0.6978841150240535,0.8274044795783926,1.0,1.0,4/15,18.42%,CXXC1;RBBP5;SETD1B;WDR82
prerank,disordered domain specific binding (GO:0097718),0.31626626435655414,0.6968025600907658,0.8355828220858895,1.0,1.0,9/23,25.85%,TP53;RB1;CLTC;FYN;HSP90AA1;TEAD2;NCOA3;HSP90AB1;DFFB
prerank,ligand-gated calcium channel activity (GO:0099604),0.3217843277584174,0.6948661671699374,0.8393977415307403,1.0,1.0,2/19,5.57%,RASA3;P2RX4
prerank,carboxypeptidase activity (GO:0004180),0.2945783395909486,0.6942085326042216,0.8475540386803185,1.0,1.0,7/35,17.36%,CTSA;CTSZ;NAALADL1;AGBL5;MINDY1;AGTPBP1;PEPD
prerank,carboxy-lyase activity (GO:0016831),0.3116944656490738,0.6928751519773754,0.8405275779376499,1.0,1.0,6/23,21.85%,DDC;AMD1;PPCDC;ECHDC1;AZIN2;UROD
prerank,filamin binding (GO:0031005),0.3523341873670638,0.6922116458829545,0.8126801152737753,1.0,1.0,4/11,19.86%,MICALL2;RFLNA;FBLIM1;TMEM67
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.3588715092192539,0.6920799638727537,0.7980636237897649,1.0,1.0,4/10,23.08%,ASH1L;SUV39H1;SETD5;SETDB1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.28481988080886844,0.6920205644852543,0.8790149892933619,1.0,1.0,10/55,17.27%,PKD2;ATP2C1;ATP2B1;ITPR2;CACNB2;ATP2B3;ATP2A3;TRPV3;CACNA1D;TMEM165
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.22207793891829855,-0.6906911072567954,0.895,0.9532744897831735,1.0,10/24,28.82%,PPIP5K2;IP6K1;IP6K2;AK3;ITPKC;PMVK;AK4;CMPK2;NME2;CMPK1
prerank,FAD binding (GO:0071949),0.3153474387386651,0.6898057188698287,0.8375757575757575,1.0,1.0,3/24,7.82%,CYB5R1;MICAL1;KMO
prerank,mRNA 3'-UTR binding (GO:0003730),0.2778374655590007,0.6893971258567954,0.9212435233160622,1.0,1.0,21/79,21.24%,CIRBP;TP53;LARP4B;LARP1;RC3H1;PUM2;ANGEL2;CPEB3;RNF40;SECISBP2;CCT5;IGF2BP3;CPEB4;MEX3D;CPEB2;PABPC4;RBMS2;SERBP1;RPS7;HNRNPA0;ZFP36L1
prerank,signal sequence binding (GO:0005048),0.294425221714695,0.688250797622827,0.8603859250851306,1.0,1.0,9/35,21.02%,KCNIP2;KDELR2;TIMM22;BABAM2;AP2M1;CEMIP;KPNA1;TOMM20;IPO4
prerank,neuropeptide receptor binding (GO:0071855),0.33103367579377563,0.6872640256702867,0.8348868175765646,1.0,1.0,1/14,8.28%,PPY
prerank,actinin binding (GO:0042805),0.3151035492388824,0.6852140436682925,0.8335388409371147,1.0,1.0,6/21,16.61%,PKD2;TTN;NFKB1;KCNA5;CSRP1;CACNA1D
prerank,tRNA methyltransferase activity (GO:0008175),-0.24246325775333796,-0.6851915409902642,0.9008264462809917,0.9524508164404438,1.0,9/16,35.46%,THUMPD3;TARBP1;TRMT5;LCMT2;TRMT44;TRMT13;TYW3;TRMT12;TRMT9B
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.3118293745513427,0.6851790513825999,0.83125,1.0,1.0,1/23,1.63%,SH3PXD2B
prerank,ion channel activity (GO:0005216),0.2716191422661522,0.6843758895152869,0.9165808444902163,1.0,1.0,4/80,6.71%,P2RX1;TMC6;PKD2;CNGB1
prerank,potassium channel regulator activity (GO:0015459),0.2822767991037039,0.6841886457833474,0.8908296943231441,1.0,1.0,11/49,22.71%,KCNIP2;WNK1;ENSA;NEDD4L;WNK4;SGK3;RASA1;AKAP9;FLNA;CHP1;SGK1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.2606488577571366,-0.6837735942203786,0.8793103448275862,0.947214342029312,1.0,8/12,30.26%,SLC25A42;SLC25A23;SLC25A24;SLC19A1;SLC25A5;SLC35B2;SLC25A17;SLC17A9
prerank,acetyltransferase activity (GO:0016407),-0.19589059382989976,-0.680462762924474,0.9586206896551724,0.9438016277939747,1.0,4/31,9.68%,ESCO1;ELP3;SAT1;NAT10
prerank,cGMP binding (GO:0030553),0.34281609483162967,0.6779182767264416,0.8140495867768595,1.0,1.0,2/11,10.59%,CNGB1;PDE11A
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.30134386095365984,0.6776085555790184,0.8608490566037735,1.0,1.0,5/26,18.70%,CHSY3;B3GALNT1;CHSY1;B4GALNT1;CHPF
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.31876410396201293,0.6775741919810848,0.869837296620776,1.0,1.0,6/20,19.56%,LPCAT1;LPCAT2;PNPLA3;LCLAT1;DGAT2;MOGAT1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.20068582903587925,-0.6756708636702805,0.9570552147239264,0.9418141162745479,1.0,3/28,9.39%,GRIK4;GABRA2;CHRNA7
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.26799099668955073,-0.6752852692096359,0.8807947019867549,0.9358022630313774,1.0,4/11,24.32%,NDUFAF7;PRMT8;PRMT1;PRMT7
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.35100473178957137,0.6729978772061798,0.8345323741007195,1.0,1.0,4/10,21.87%,KDM7A;RIOX2;KDM4C;KDM2B
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.29466262030029194,0.6713617176159727,0.8807134894091416,1.0,1.0,5/34,10.60%,NDUFB8;NDUFA2;NDUFB4;NDUFV1;NDUFS6
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.29466262030029194,0.6713617176159727,0.8807134894091416,1.0,1.0,5/34,10.60%,NDUFB8;NDUFA2;NDUFB4;NDUFV1;NDUFS6
prerank,alpha-actinin binding (GO:0051393),0.3040745673045125,0.6711790003991991,0.8454106280193237,1.0,1.0,7/24,19.53%,PKD2;TTN;LDB3;KCNA5;PDLIM1;CACNA1D;PALLD
prerank,exopeptidase activity (GO:0008238),0.27761496227468724,0.6677755502854638,0.9037433155080213,1.0,1.0,12/50,20.91%,CTSA;ZMPSTE24;CTSZ;NAALADL1;GGH;ERAP1;METAP2;PRCP;RNPEP;LAP3;DPP4;CNDP2
prerank,syntaxin-1 binding (GO:0017075),0.3034009795720181,0.6652282837752397,0.8527980535279805,1.0,1.0,5/22,20.02%,VAMP3;STXBP3;LRRK2;STXBP5;UNC13A
prerank,pyrophosphatase activity (GO:0016462),0.2753626951709569,0.6649097751340473,0.9046087888531619,1.0,1.0,6/50,11.49%,DHX9;NUDT4;PPA2;ATCAY;ADPRM;ENTPD1
prerank,RNA cap binding (GO:0000339),0.3203885477004922,0.664654696037886,0.864247311827957,1.0,1.0,4/16,17.90%,EIF4A1;LARP1;CYFIP1;AGO2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.2959737013795768,0.6640331623626468,0.8676122931442081,1.0,1.0,3/25,7.82%,FMO5;MICAL1;KMO
prerank,motor activity (GO:0003774),0.2669418788279782,0.6624170559320374,0.8966244725738397,1.0,1.0,7/60,10.27%,MYO1E;MYH9;STARD9;KIF14;KIF20B;KIF23;APPBP2
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.26955836758487,-0.6536144403219308,0.9025974025974026,0.949102860568688,1.0,2/10,9.75%,FAP;DPP8
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.31705457534641396,0.651113689776209,0.8413978494623656,1.0,1.0,5/14,20.67%,IREB2;ACO1;SDHB;ETFDH;CIAO3
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.31158810232169276,0.6485877717461814,0.8683181225554107,1.0,1.0,5/15,24.26%,NDST1;HS3ST4;NDST2;NDST4;HS3ST3A1
prerank,magnesium ion binding (GO:0000287),0.2534091381836068,0.6469939986783243,0.9667673716012085,1.0,1.0,37/135,25.65%,HPGDS;RAP2A;ERN1;NEK6;SNCA;PI4K2A;RP2;MAP3K5;CERK;ENDOV;PPA2;PDCD6;NLK;PRKACB;STK3;UBA2;LRRK2;NIM1K;TOP2A;STK4;SIK2;TESC;DIS3L2;MARK1;BRSK1;XXYLT1;NUDT3;NUDT12;HMGCL;ADPRH;IDH1;NT5C3A;ABL2;PSPH;MARK2;NUAK2;DXO
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.20381264301065943,-0.6422950730804295,0.9481865284974094,0.9515374337237872,1.0,12/21,46.91%,KL;FGF9;FGF10;FGF7;FRS2;FGF1;FRS3;FGF18;KLB;FGF22;FGF5;FGF20
prerank,nucleotidyltransferase activity (GO:0016779),0.296366171208871,0.6407729663679452,0.8935897435897436,1.0,1.0,4/19,16.57%,TENT4B;PAPSS1;YRDC;TUT7
prerank,MAP kinase kinase kinase activity (GO:0004709),0.32770663805146394,0.6382316006825699,0.8524822695035461,1.0,1.0,2/11,8.63%,MAP3K5;MAP3K1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.24660195573631408,0.6372333168479486,0.9647532729103726,1.0,1.0,18/134,17.03%,SLC52A1;SLCO2B1;SLC7A8;SLC38A6;SLC36A1;SLC35B3;SLC25A38;SLC36A4;SLC16A1;ABCC1;SLC66A1;SLC25A18;CTNS;SLC35A3;SLCO1B1;SLC1A4;CD36;SLC13A3
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.2852755239237147,0.6366444264301936,0.8886255924170616,1.0,1.0,2/27,3.62%,RNF180;RNF19B
prerank,phosphatase activator activity (GO:0019211),-0.23440618190887422,-0.6364864146978289,0.9224489795918367,0.9498542789358739,1.0,6/14,38.10%,CALM3;GTF2F1;CALM2;FRS2;B3GAT3;PPP1R15A
prerank,AMP binding (GO:0016208),0.3168086843576894,0.6359088207459781,0.8640915593705293,1.0,1.0,1/11,3.12%,PFKL
prerank,histone acetyltransferase activity (GO:0004402),0.2740352596825075,0.6351660716697288,0.893348623853211,1.0,1.0,6/30,16.67%,SRCAP;TAF1;BAZ1A;NAA40;KAT7;NAA50
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.2733111766325643,0.6347246332356205,0.8976109215017065,1.0,1.0,10/34,23.08%,SETD6;DOT1L;SETD2;TTLL12;ETFBKMT;SMYD3;SUV39H1;EEF1AKMT1;NSD3;SETDB1
prerank,neuropeptide hormone activity (GO:0005184),0.28199039805450243,0.6342315343570609,0.8824969400244798,1.0,1.0,2/22,14.06%,PPY;NMB
prerank,histone methyltransferase activity (GO:0042054),0.2750724736870387,0.633729615879249,0.8954545454545455,1.0,1.0,9/32,23.08%,FBL;DOT1L;SETD2;TTLL12;SMYD3;SUV39H1;EED;NSD3;SETDB1
prerank,5'-3' exonuclease activity (GO:0008409),0.3002579310804748,0.6324795057372311,0.8738255033557047,0.9990827687692944,1.0,6/14,25.65%,EXO1;TRIR;DCLRE1C;DCP2;XRN2;DXO
prerank,store-operated calcium channel activity (GO:0015279),0.32543158315694704,0.6304820879969352,0.880057803468208,0.9986196756603951,1.0,1/10,4.89%,ORAI2
prerank,snoRNA binding (GO:0030515),0.27438775146871375,0.6304237585626279,0.8954545454545455,0.9965943807282015,1.0,6/30,15.87%,XRCC5;NUDT4;HEATR1;TSR1;IMP3;NUFIP1
prerank,iron ion binding (GO:0005506),0.2617619527915111,0.6293692575561388,0.9256110520722636,0.9954034020439306,1.0,9/48,19.68%,SNCA;HAAO;KDM7A;FTL;AGMO;FTH1;FDX1;TET2;FTO
prerank,cell-cell adhesion mediator activity (GO:0098632),0.2624390345058205,0.6265726790697885,0.9142236699239956,0.9956879241688783,1.0,9/42,20.03%,SIRPA;EMB;ANXA1;NPTN;PDLIM1;CD47;VSTM2L;PALLD;CNTN4
prerank,methyl-CpG binding (GO:0008327),0.278135278202756,0.6215991461354697,0.8940886699507389,0.99758567626918,1.0,7/22,24.58%,TET3;MBD1;LRWD1;ERH;CXXC5;MBD2;ZBTB21
prerank,cation channel activity (GO:0005261),0.24571423081765262,0.6194621251299582,0.9591002044989775,0.9972517589407217,1.0,6/94,10.47%,P2RX1;AQP1;PKD2;TMEM38A;TMEM63A;CACNB2
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.2911211920078702,0.6151559396838605,0.8923476005188068,0.9985077953227031,1.0,1/17,3.98%,NME6
prerank,exoribonuclease activity (GO:0004532),0.3056591996411705,0.6150370026805733,0.8857142857142857,0.9965918268643922,1.0,4/12,22.63%,EXOSC1;EXOSC3;CNOT7;EXOSC2
prerank,miRNA binding (GO:0035198),0.2696239056666979,0.6144560857025003,0.9134948096885813,0.9950226506688735,1.0,12/30,26.65%,RC3H1;PUM2;AGO4;AGO3;SOX2;TUT7;AGO2;ZC3H7A;ZC3H7B;AGO1;PUM1;ELAVL1
prerank,NAD+ binding (GO:0070403),0.30945601732393835,0.6138179064407577,0.8937329700272479,0.9934865767565925,1.0,1/12,4.51%,HPGD
prerank,NAD binding (GO:0051287),0.2689721604042367,0.611615052993635,0.916083916083916,0.9931528434631713,1.0,3/26,9.08%,HPGD;SORD;QDPR
prerank,DNA secondary structure binding (GO:0000217),0.25934762942734735,0.6030325225146053,0.9166666666666666,0.997679184545606,1.0,7/31,19.94%,HMGB1;YY1;MEF2C;ERCC5;RAD51B;RAD51D;LIN54
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.2990065989708373,0.5996490481379013,0.8908594815825375,0.9980223973272446,1.0,3/12,17.84%,XDH;SDHB;FDX1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.280551547965319,0.5985784613848864,0.907928388746803,0.9967808567549606,1.0,6/17,24.73%,ABCD1;ACOT9;ACOT2;ACOT8;PLA2G6;ACOT7
prerank,peptide N-acetyltransferase activity (GO:0034212),0.30796132509920926,0.5966348587085409,0.9054441260744985,0.9961309475051902,1.0,5/10,26.39%,NAA50;NAA25;NAA15;NAA80;NAA10
prerank,amino acid:sodium symporter activity (GO:0005283),0.3020021716941321,0.5956148552664355,0.9123563218390804,0.9948471438779621,1.0,1/11,9.15%,SLC6A15
prerank,ATPase activator activity (GO:0001671),0.2671808732150149,0.5849964294196399,0.935361216730038,1.0,1.0,6/20,21.63%,AHSA1;ATP1B3;TOR1AIP2;ATP1B2;DNAJB6;DNAJC15
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.24873091316019957,0.5762120654206594,0.9480225988700565,1.0,1.0,11/33,24.74%,CNOT8;ANGEL2;EXOSC3;DIS3L2;REXO2;TOE1;PNLDC1;CNOT7;EXOSC2;DCP2;XRN2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.24867135486803538,0.5740475271571459,0.9477866061293984,1.0,1.0,2/33,3.62%,RNF180;RNF19B
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.2462654364079633,0.5733657548868417,0.9556818181818182,1.0,1.0,10/35,24.82%,GATB;ELAC2;ELAC1;BCDIN3D;TARS2;DUS1L;FTO;NT5C3A;DUS3L;GATC
prerank,lysine N-methyltransferase activity (GO:0016278),0.2614413863576092,0.5726517964472532,0.9305210918114144,0.9999114109159726,1.0,3/20,13.87%,SETD6;SETD2;ETFBKMT
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.24740777507707545,0.5719224379512922,0.9523809523809523,0.9984076502760553,1.0,12/34,24.74%,CNOT8;ANGEL2;EXOSC3;DIS3L2;REXO2;TOE1;PNLDC1;CNOT7;CNOT1;EXOSC2;CNOT2;XRN2
prerank,cytochrome-c oxidase activity (GO:0004129),-0.21167109535752418,-0.5710109344863399,0.9765625,0.9814296671906173,1.0,6/15,29.60%,COX5A;NDUFA4;COX15;COX5B;COX8A;COX10
prerank,poly(A) binding (GO:0008143),0.2617015606432727,0.5662159902477977,0.9313725490196079,0.9998118429725074,1.0,4/21,18.81%,PPIE;DDX1;PABPC4;RBMS2
prerank,damaged DNA binding (GO:0003684),-0.1473961371227486,-0.5647303875311993,1.0,0.9776912931621308,1.0,20/44,36.19%,DDB2;DDB1;TDG;XRCC1;XPA;SMC6;SDE2;DCLRE1A;RAD18;POLQ;DCLRE1B;RPA3;FANCG;NEIL3;RPA2;CUL4B;PCNA;NTHL1;POLD1;MPG
prerank,four-way junction DNA binding (GO:0000400),0.2621001505134947,0.5635919879997467,0.9167717528373266,0.9993329220027889,1.0,4/17,19.48%,HMGB1;YY1;RAD51B;RAD51D
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.20328980411853342,-0.5585155498518685,0.9795081967213115,0.9737201310380267,1.0,15/15,79.70%,PLA2G12A;PLA2G4C;PLA2G4F;PLA2G4B;PLA2G4A;PLA2G3;PLA2G2C;PLA2G2D;PLA2G10;PLA2G1B;PLA2G2E;PLA2G2F;PLA2G4D;PLA2G4E;PLA2G5
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.27938885788852275,0.5573139754627817,0.9337094499294781,1.0,1.0,1/11,5.64%,SLC35B3
prerank,NF-kappaB binding (GO:0051059),0.24789731561214684,0.5557762602148604,0.928395061728395,0.9996565455055648,1.0,5/24,20.45%,SETD6;ANXA4;MTDH;FAF1;GSK3B
prerank,methyltransferase activity (GO:0008168),0.22785940282905648,0.5540914890442014,0.9668508287292817,0.9986336924227125,1.0,11/46,21.51%,METTL4;PRMT3;MGMT;METTL3;COMT;BCDIN3D;SUV39H1;AS3MT;NSUN4;COQ3;EEF1AKMT1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.2289723011203562,0.5532556293010161,0.9810725552050473,0.9971444767729406,1.0,7/57,11.91%,NDUFB8;NDUFA2;NDUFB4;NDUFV1;NDUFS6;CYB5A;CYB561D2
prerank,nucleosomal DNA binding (GO:0031492),0.25506983352105356,0.5532228750628021,0.9464508094645081,0.9952210752756478,1.0,9/21,28.19%,ACTB;SMARCB1;CHD4;RBBP4;H3-3A;MBD2;SMARCC1;MTA2;HDAC1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.2738578050007175,0.5432451338603612,0.9373219373219374,0.9983725485975071,1.0,3/12,17.90%,LARP1;CYFIP1;AGO2
prerank,pyridoxal phosphate binding (GO:0030170),0.24804763560259246,0.5430279417740106,0.9464508094645081,0.9965477453013174,1.0,6/20,20.10%,THNSL2;OAT;CBS;ACCS;PSAT1;PYGL
prerank,TBP-class protein binding (GO:0017025),0.24807284192712284,0.5426717314064132,0.9598540145985401,0.9948087015296081,1.0,7/21,24.79%,TAF1;GTF2B;TAF11;HHEX;YEATS2;GTF2A1;THRA
prerank,microtubule plus-end binding (GO:0051010),0.247865977541236,0.5385723176344955,0.9440993788819876,0.9947459822401566,1.0,6/20,22.71%,MAPRE1;CLIP2;DST;MAPRE2;FBXW11;CLASP1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.2395537797717303,0.5359199421515641,0.9642416769420469,0.9940891456335498,1.0,9/24,28.82%,OSBP;OSBPL8;ARFIP2;PLEKHA5;GOLPH3;PLA2G4E;CERT1;SESTD1;OSBPL5
prerank,cyclic nucleotide binding (GO:0030551),0.24753189170834028,0.5342802788362874,0.966707768187423,0.9929762757050313,1.0,3/21,11.40%,CNGB1;PDE11A;PDE4A
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.24574309562848928,0.5310115332843875,0.9486215538847118,0.992612315052729,1.0,5/19,25.35%,GABRA5;GABRA4;GABRG1;GRIK3;GABRG2
prerank,U6 snRNA binding (GO:0017070),0.2612081790975598,0.5294950856272207,0.9594972067039106,0.9913923375002375,1.0,3/14,16.32%,DDX39B;PRPF8;LSM8
prerank,calcium channel activity (GO:0005262),0.21040564684994317,0.5271830480212595,0.9907216494845361,0.9905026890077763,1.0,9/84,13.92%,PKD2;ORAI2;P2RX4;CACNA1A;CACNB4;CACNB2;CACNB1;CACNA1B;TRPV3
prerank,poly-purine tract binding (GO:0070717),0.22827468248115468,0.5149864964345469,0.9650756693830035,0.9936289022185562,1.0,5/27,18.81%,PPIE;MCRS1;DDX1;PABPC4;RBMS2
prerank,ubiquitin-specific protease binding (GO:1990381),0.2405689845551474,0.5087807509844697,0.9724655819774718,0.9941081692891542,1.0,8/19,28.38%,DERL1;CLTC;PTEN;PRKN;AMFR;SART3;VCP;SUMO1
prerank,protein phosphatase activator activity (GO:0072542),0.24882569311764985,0.5073961428602333,0.9681274900398407,0.9927399178219206,1.0,7/13,31.96%,PTPA;PPP2R5C;PPP2R5B;IGFBP3;PHACTR4;CALM1;PPP2R5A
prerank,snRNA binding (GO:0017069),0.21408796933874782,0.5053641120989195,0.9776785714285714,0.9916336169873962,1.0,10/42,21.18%,LSM11;DDX39B;PRPF8;RBM41;LSM8;SNRPB2;SNRNP35;SF3B3;HEXIM1;TOE1
prerank,ion gated channel activity (GO:0022839),0.21354840514780365,0.47903864553353637,0.9826946847960445,0.9980279032076523,1.0,3/24,13.35%,TMEM63A;KCNT1;TTYH2
prerank,gap junction channel activity (GO:0005243),0.21334135293350184,0.4665060612822863,0.983030303030303,0.999284057200351,1.0,1/22,7.41%,GJB6
prerank,wide pore channel activity (GO:0022829),0.20952724090309716,0.4618143450968132,0.9891826923076923,0.9984198343037718,1.0,1/23,7.41%,GJB6
prerank,SUMO transferase activity (GO:0019789),0.2092555176261336,0.43869061891026284,0.9804941482444733,1.0,1.0,5/16,26.02%,HDAC4;PIAS1;NSMCE2;UBE2I;CBX4
prerank,active ion transmembrane transporter activity (GO:0022853),0.1860474228636517,0.4378243654147788,0.9966024915062288,0.9991271943186452,1.0,6/37,21.38%,SLCO2B1;CYB5A;SLCO1B1;COX6B1;COX4I1;SLC16A7
prerank,sulfotransferase activity (GO:0008146),0.18809232582031696,0.43452350174762744,0.9954597048808173,0.99780655239379,1.0,3/33,12.83%,SULT4A1;TPST1;CHST15
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.2182525597124586,0.4255473224804905,0.9848066298342542,0.9972528055241581,1.0,1/11,6.79%,NUDT4
prerank,transaminase activity (GO:0008483),0.21512266251475315,0.42002357034109145,0.9833564493758669,0.9960803284009224,1.0,3/11,23.46%,OAT;PSAT1;BCAT1
prerank,lipid phosphatase activity (GO:0042577),0.19106058408227072,0.39628886697311055,0.9959183673469387,0.9965716666431285,1.0,3/14,22.37%,PLPPR1;INPP5K;PLPP7
